 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 

 

Diagnostic Radiology 

CORE Examination Study Guide 

Updated 6/6/2 018 

 

 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Contents 

Contents 

Preamble ...................................................................................................................................................... 3 

Exam Purpose Statements ............................................................................................................................4 

Breast Imaging ............................................................................................................................................. 5 

Cardiac Imaging............................................................................................................................................7 

Gastrointestinal Imaging............................................................................................................................. 12 

Interventional Radiology............................................................................................................................. 18 

Musculoskeletal Imaging ............................................................................................................................ 20 

Neuroradiology ........................................................................................................................................... 30 

Nuclear Radiology ....................................................................................................................................... 45 

Pediatric Radiology ..................................................................................................................................... 57 

Physics......................................................................................................................................................... 77 

Radioisotope Safety Examination (RISE) ..................................................................................................... 94 

Reproductive/Endocrine Imaging and Therapy .......................................................................................... 98 

Noninterpretive Skills.................................................................................................................................100 

 Thoracic Imaging ........................................................................................................................................102 

Ultrasound ................................................................................................................................................ .110 

Urinary Imaging......................................................................................................................................... .132 

Vascular Imaging ........................................................................................................................................ 135 

 

 

 

 

Page 2 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 
 

 
 

 

 

 

 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Preamble 

Preamble 

This study guide is a resource to guide your preparation for the Core Examination in diagnostic 
radiology. 

The Core Examination is designed to evaluate a candidate’s core radiology knowledge and 
clinical judgement, across both the subspecialties and imaging modalities of diagnostic 
radiology. It tests knowledge and comprehension of anatomy, pathophysiology, diagnostic 
radiology, and physics concepts important for the practice of diagnostic radiology. The purpose 
of this exam relative to that of other ABR exams is given on the next page. 

The 18 categories are: breast imaging, cardiac imaging, computed tomography (CT), 
gastrointestinal (GI) imaging, interventional radiology, magnetic resonance (MR), 
musculoskeletal imaging, neuroradiology, nuclear radiology, pediatric radiology, physics, 
radiography/fluoroscopy,  reproductive/endocrine imaging, noninterpretive skills, thoracic 
imaging, ultrasound (US), urinary imaging, and vascular imaging. 

Individual category study guides are presented for 15 categories. 

• 
•  For the three modalities of CT, MR and radiography/fluoroscopy, the relevant portion of 

the study guides in each of the other categories should be used to guide preparation. 

In general, the Core Examination is based on material in this study guide. However, not all 
material in the study guide is included on every form of the examination. Items that are not 
included in this study guide may appear on the examination. 

If you are reviewing this in printed format, please be sure to check the ABR website, 
www.theabr.org, for updated study guide materials and questions. 

Nonprofit educational programs have permission to use or reproduce all or parts of this document for educational purposes 
only. Use or reproduction of this document for commercial use or for-profit use is strictly prohibited. 

©American Board of Radiology, 2013 

 

 

Page 3 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 
 

 
 
 

 
 
 

 

 
 
 

 
 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Exam Purpose Statements 

 

Exam Purpose Statements 

Core Exam: 
The purpose of the ABR Core (qualifying) Exam is to validate that the candidate has acquired 
the knowledge, skills, and understanding basic to the entire field of diagnostic radiology, 
including physics. 

Certifying Exam: 
The purpose of the ABR Certifying Exam is to validate that the candidate has acquired and is 
able to apply the requisite knowledge, skills, and understanding that: 

1.   every practicing physician should possess (20%). 
2.   every practicing radiologist should possess (20%). 
3.   this particular practicing radiologist should possess to begin independent practice in his 

or her chosen clinical practice area(s) (60%). 

Subspecialty Certifying Exams: 
The purpose of the subspecialty certifying exam is to validate that the candidate has acquired 
and is able to apply the requisite knowledge, skills, and understanding essential to the practice 
of the subspecialty. 

Maintenance of Certification (MOC) Exam: 
The  purpose  of  the  MOC exam is  to  validate  that  the  certified diplomate has  maintained  and 
applies  the  essential knowledge, skills, and  understanding in  the  major  clinical  areas in  which 
the diplomate currently practices. 

 

 

Page 4 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 
 

 
 

 

 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Breast Imaging 

Breast Imaging 

1)   Regulatory/Standards of Care 

a)   Components and desired goals of the medical audit for breast cancer detection 
b)   Appropriate application of the Breast Imaging Reporting and Data System (BI-RADS) 

terminology and assessment categories 

c)    Mammography Quality Standards Act (MQSA) requirements 
d)   Quality determinants of mammography, breast ultrasound, and breast MR, including 

positioning, image processing, artifacts, optimal technique, and equipment 

2)   Screening 

a)   Indications 
b)   Normal anatomy (mammography, ultrasound, MR) 
c)    Lesion detection and localization 
d)   Computer-aided detection 
e)   Breast cancer risk factors, including the identification and management of women at 

high risk for breast cancer 

3)   Diagnostic Breast Imaging 

a)   Appropriate mammographic views for work-up of a breast lesion 
b)   Evaluate and manage women and men with breast symptoms 

i)  Palpable masses 
ii)    Breast thickening 
iii)   Nipple discharge 
iv)  Nipple retraction 
v)   Skin changes 

c)    Appearance and management of inflammatory processes in the breast 

i)  Benign 
ii)    Malignant 

d)   Role of imaging in surgical staging and surgical planning in women with recently 

diagnosed breast cancer 

e)   Normal and abnormal appearance after surgical procedures 

i)  Breast implants 
ii)    Breast augmentation 
iii)   Breast reduction 
iv)  Breast reconstruction 
v)   Normal and abnormal appearance of breast-conserving therapy 

4)   Pathology 

a)   Appearance and management of benign breast lesions, high-risk lesions, ductal 
carcinoma in situ, invasive ductal carcinoma, and other special types of breast 
carcinoma 

b)   Appearance and causes of benign and malignant male breast disease 

5)   Imaging findings 

 

 

Page 5 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Breast Imaging 

a)   Characteristics of benign and malignant breast calcifications 
b)   Characteristics of benign and malignant breast masses 
c)    Identify and appropriately manage imaging findings 

i)  Mammography 

(1)  Abnormal calcifications 
(2)  Masses 
(3)  Asymmetries 
(4)  Architectural distortion 

ii)    Ultrasound 
iii)   Breast MR 
      (1)  Masses 

(2)  Non-mass findings 

d)   Identify and understand the causes of abnormal lymph nodes on mammography, 

ultrasound, or MRI 

6)   Breast Intervention 

a)   Percutaneous breast biopsy techniques 

i)  Wire localization 
ii)    Core biopsy 
iii)   Vacuum-assisted biopsy 
iv)  Fine-needle aspiration 
v)   Galactography 
vi)  Cyst aspiration 

b)   Specimen radiography 
c)    Concordant versus discordant percutaneous biopsy results for imaging appearance of a 

breast abnormality and appropriate management 

d)   Patient safety 

7)   Physics 

a)   Mechanism of obtaining and optimizing film-screen or digital mammograms 

i)  Target/filter combinations 
ii)    Use of a grid 
iii)   Reduction of scatter 
iv)  Radiation dose 

b)   Adjustment of mammography techniques for special cases, including thin breasts 
c)    Mechanism of obtaining and optimizing breast US images 
d)   Mechanism of obtaining and optimizing breast MR images 
e)   Recognizing, understanding, and correcting artifacts in breast imaging, including 

mammography, US, and MR imaging 

f)  Workstation display of digital mammograms 

i)  Required equipment parameters 
ii)    Image processing 

Computer-assisted display software for breast MRI, including the role of dynamic enhancement 
characteristics 

 

 

Page 6 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 
 
 

 

 

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Cardiac Imaging 

Cardiac Imaging 

1)   Basics of Imaging: Radiography, CT, and MR 

a)   Indications and limitations of the modalities and comparison to echocardiography, 

angiography and cardiac catheterization, SPECT, and PET. 

b)   Physics behind image creation and potential artifacts on radiography, CT, and MR 

i)  X-ray physics 
ii)    CT physics 

(1)  Multidetector CT artifacts relevant to cardiac imaging 
(2)  Tradeoffs between noise, dose and image quality 
(3)  Spatial resolution, contrast resolution, and imaging reconstruction algorithms 
(4)  Temporal resolution, half scan, and multi-segment reconstruction 
(5)  Contrast injection—principles, protocols, bolus geometry, and iodine flux 

iii)   MR physics 

(1)  MR artifacts relevant to cardiac and vascular imaging 
(2)  Trade-off between spatial resolution, temporal resolution, contrast resolution, 

and acquisition time 

(3)  Principles of black blood, edema, and scar imaging 
(4)  Steady-state free precession cine imaging 
(5)  Velocity-encoded cine (phase contrast) imaging—principles, applications, and 

limitations 

c)    3D imaging and post-processing 

i)  Multiplanar reconstruction (MPR) 
ii)    Maximum intensity projection (MIP) 
iii)   Volume rendering (VR) 

d)   Patient safety 

i)  Radiation exposure and how technical modifications may modify dose 
ii)    Drugs and contrast agents used for cardiac imaging 
iii)   Cardiac devices and the effect of the magnetic field of the MR unit 

2)   Normal Anatomy, Including Variants, Encountered on Radiography, CT, and MR 

a)   Heart, including chambers, valves, pericardium, and coronary arteries 
b)   Aorta and pulmonary arteries 
c)    Venae cavae and pulmonary veins 

3)   Physiological Aspects of Cardiac Imaging as Assessed with Radiography, CT, and MR 

a)   Normal cardiac cycle 
b)   Physiological anatomy of cardiac muscle 
c)    Mechanics of cardiac contraction 
d)   Physical basis for blood flow, pressure, and resistance 

i)  Ventricular volume and pressure relationship 
ii)    Functional cardiac measurements 

 

 

Page 7 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Cardiac Imaging 

(1)  Ejection fraction 
(2)  Stroke volume 
(3)  Left ventricular mass 
(4)  Flow (Q = V x A) 
(5)  Pressure gradient (modified Bernoulli equation, ΔP = 4v2) 
(6)  Pulmonary-to-systemic flow (Qp/Qs) ratio 
(7)  Regurgitant volume and regurgitant fraction 
(8)  Diastolic heart function 

iii)   Normal cardiac and pulmonary pressures 
iv)  Vascular regions supplied by the coronary arteries 

4)   Ischemic Heart Disease 

a)   Risk factors, primary prevention, and screening 
b)   Roles of echocardiography, angiography, SPECT, PET, CT, and MR in the evaluation of a 
patient with suspected ischemic heart disease, including the advantages and  limitations 
of each modality 

c)    Inducible myocardial ischemia 
d)   Acute myocardial infarction 
e)   Chronic myocardial infarction 
f)  Post-myocardial infarction complications 

i)  Cardiac rupture 
ii)    Left ventricular aneurysm and pseudoaneurysm 
iii)  Papillary  muscle  rupture 
iv)  Congestive heart  failure  
v)   Dressler syndrome 

g)   Myocardial perfusion and viability 

i)    Stunned myocardium 
ii)    Hibernating myocardium 

h)   Role of myocardial delayed-enhancement imaging in guiding management of left 

ventricular dysfunction 

i)  Coronary artery stenosis and aneurysm 
j)  Role of coronary CT angiography in guiding management of chest pain 
k)   Therapeutic and interventional options 

5) 

  Cardiomyopathy 
a)  Hypertrophic 
b)   Dilated 
c)    Restrictive 

i)  Distinguish restrictive cardiomyopathy from constrictive pericarditis 

d)   Arrhythmogenic right ventricular dysplasia 
e)   Therapeutic and interventional options 

6)   Cardiac Masses 

a)   Thrombus 

 

 

Page 8 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Cardiac Imaging 

i)  Distinguish thrombus from tumor 

b)   Primary benign tumors 

i)  Myxoma 
ii)    Lipoma 
iii)   Rhabdomyoma 
iv)  Fibroma 
v)   Lipomatous hypertrophy of the interatrial septum 

c)    Primary malignant tumors 

i)  Angiosarcoma 
ii)    Lymphoma 

d)   Metastasis 
e)   Therapeutic and interventional options 

7)   Valvular Disease 

a)   Myxomatous degeneration 
b)   Rheumatic heart disease 
c)    Infective endocarditis 
d)   Congenital valve disease 
e)   Specific lesions 

i)  Aortic stenosis 
ii)    Aortic regurgitation 
iii)   Mitral stenosis 
iv)  Mitral regurgitation 
v)   Mitral annular calcification 
vi)  Tricuspid regurgitation 
vii) Pulmonary stenosis 
viii) Pulmonary regurgitation 

f)  Therapeutic and interventional options 

8)   Pericardial Disease 

a)   Acute pericarditis 
b)   Constrictive pericarditis 

i)  Distinguish restrictive cardiomyopathy from constrictive pericarditis 

c)    Pericardial effusion 

i)  Hemopericardium 
ii)    Tamponade 
d)   Pericardial cyst 
e)   Pericardial defect 
f)  Pneumopericardium 
g)   Therapeutic and interventional options 

9)   Congenital Heart Disease 

a)   Left-to-right shunts 

i)  Atrial septal defect 

 

 

Page 9 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Cardiac Imaging 

ii)    Ventricular septal defect 
iii)   Partial anomalous pulmonary venous connection 

(1)  Scimitar syndrome 

iv)  Patent ductus arteriosus 

b)   Eisenmenger syndrome 
c)    Admixture lesions (bidirectional shunts) 

i)  Transposition of the great arteries 
ii)    Truncus arteriosus 
iii)   Total anomalous pulmonary venous connection 

d)   Right-to-left shunts 

i)  Tetralogy of Fallot and pulmonary atresia with ventricular septal defect 
ii)    Ebstein anomaly 

e)   Great vessel anomalies 

i)  Coarctation of the aorta 

(1)  Distinguish from pseudocoarctation 

ii)    Double aortic arch 
iii)   Right aortic arch 
(1)  Mirror image 
(2)  Non-mirror image 

iv)  Pulmonary sling 
v)   Persistent left superior vena cava 

f)  Coronary artery anomalies 

i)  Retroaortic course 
ii)    Interarterial course 

g)   Miscellaneous anomalies 

i)  Cardiac malposition, including situs abnormalities 
ii)    Congenitally corrected transposition of the great arteries 

h)   Therapeutic and interventional options 

10) Acquired Disease of the Thoracic Aorta and Great Vessels 

a)   Aneurysms 

i)  Atherosclerotic 
ii)    Marfan syndrome 
iii)   Ehlers-Danlos syndrome 

b)   Pseudoaneurysms 

i)  Mycotic 
ii)    Post-traumatic and post-surgical 

c)    Dissection 

i) 

Intramural hematoma 

d)   Aortitis and arteritis 
e)   Atherosclerosis 

i)  Plaque 
ii)    Ulcerated plaque 
iii)   Penetrating ulcer 

 

 

Page 10 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Cardiac Imaging 

f)  Thromboembolism 

i)     Acute pulmonary embolism 
ii)    Chronic pulmonary embolism 

g)   Pulmonary hypertension 
h)   Pulmonary arteriovenous malformation 
i)  Compression 

i)     Superior vena cava syndrome 

j)  Pulmonary vein complications after radiofrequency ablation 
k)   Therapeutic and interventional options 

11) Devices and Postoperative Appearance 

a)   Monitoring and support devices 

Intra-aortic balloon pump 

i) 
ii)    Pacemaker generator and pacemaker leads 
iii)   Implantable cardiac defibrillator 
iv)  Left ventricular assist device 
v)   Pericardial drain 
b)   Postoperative chest 

i)  Coronary artery bypass graft surgery 
ii)    Cardiac valve replacement 
iii)   Transluminal  septal  closure 
iv)   Aortic  graft  and aortic  stent 
v)   Heart transplant 

 

 

Page 11 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Gastrointestinal Imaging 

Gastrointestinal Imaging 

1)   Pharynx 

a)   Benign diseases 

i)  Zenker diverticulum 
ii)    Foreign bodies 
iii)   Trauma 

b)   Motility disorders 

2)   Esophagus 

a)   Benign diseases 
i)  Diverticula 
ii)    Trauma 
iii)   Esophagitis 

(1)  Reflux 
(2)  Infectious 
(3)  Caustic 
(4)  Drug-induced 
iv)  Barrett esophagus 
v)   Rings, webs, and strictures 
vi)  Varices 
vii) Benign tumors and tumor-like conditions 
viii) Extrinsic processes affecting the esophagus 

(1)  Pulmonary lesions 
(2)  Mediastinal structures 

ix)  Hiatal hernia (types and significance) 

b)   Malignant tumors 

i)  Squamous 
ii)    Adenocarcinomas 
iii)   Other malignant tumors 

(1)  Lymphoma 
(2)  Kaposi 
(3)  Metastases (lymphatic and hematogenous) 

c)    Motility disorders 

i)  Primary motility disorders 
ii)    Secondary motility disorders 

d)   Postoperative esophagus 

3)   Stomach 

a)   Benign diseases 

i)  Diverticula 
ii)    Gastritis 

(1)  Erosive 

 

 

Page 12 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Gastrointestinal Imaging 

(2)  Atrophic 
(3)  Infectious 
(4)  Other 

(a)  Crohn disease 

iii)   Peptic ulcer disease 
iv)  Hypertrophic gastropathy 
v)   Varices 
vi)  Volvulus 
vii) Entrapment after diaphragmatic injury 

b)   Malignant diseases 

i)  Primary 

(1)  Adenocarcinoma 
(2)  Lymphoma 
(3)  GI stromal tumors 
(4)  Carcinoid 

ii)    Metastatic 

c)    Postoperative stomach 

i)  Expected surgical appearance 

(1)  Bariatric, including gastric banding 
(2)  Nissen and other fundoplications 
(3)  Whipple 
(4)  Billroth procedures 

d)   Complications 

4)   Duodenum 

a)   Benign diseases 

i)  Congenital abnormalities 
ii)    Diverticula 
iii)   Trauma 
iv)  Inflammation (1) 

Duodenitis (2) 
Ulcer disease 
(3)  Crohn disease 

v)   Aortoduodenal fistula 
vi)  Benign tumors 
b)   Malignant diseases 

(1)  Adenocarcinoma 
(2)  Lymphoma 
(3)  Metastatic disease 

5)   Small Intestine 

a)   Benign diseases 

i)  Congenital disorders 
ii)    Diverticula 

 

 

Page 13 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Gastrointestinal Imaging 

iii)   Trauma 
iv)  Vascular diseases 

(1)  Intestinal ischemia and infarction 
(2)  Radiation enteritis 
(3)  Scleroderma 
(4)  Vasculitides 

(a)  Henoch-Schönlein purpura 
(b)  Polyarteritis nodosa 
(c)  Systemic lupus erythematosus 

v)   Malabsorption 

(1)  Sprue 
(2)  Lymphangiectasia 
vi)  Inflammatory diseases 

(1)  Crohn disease 
(2)  Infectious and parasitic diseases 

vii) Benign tumors 

(1)  Sporadic 
(2)  Associated with polyposis syndromes 

viii) Malrotation/Volvulus 
ix)   Obstruction  
x)    Hemorrhage  
xi)  Other 

(1)  Status post bone marrow transplant 
(2)  Drug effects 

(a)  NSAIDs enteritis 
(b)  ACE inhibitors 

b)   Malignant tumors 

i)    Adenocarcinoma 
ii)    Lymphoma 
iii)   Carcinoid 
iv)  GI stromal tumors 
v)   Metastases 

6)    Colon and Appendix 

a)   Benign disease 

i)  Congenital abnormalities 
ii)    Diverticular disease 
iii)   Inflammatory diseases 

(1)  Crohn disease 
(2)  Ulcerative colitis 
(3)  Infectious colitis 

(a)  Pseudomembranous 
(b)  Viral 
(c)  Bacterial 

 

 

Page 14 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Gastrointestinal Imaging 

(d)  Colitis in AIDS 

(4)  Appendicitis 
iv)  Ischemic colitis 
v)   Benign neoplasms 

(1)  Adenoma 
(2)  Mesenchymal tumors 
(3)  Polyposis syndromes 

b)   Malignant diseases 

i)  Adenocarcinoma 
ii)    Other malignant tumors 

(1)  Lymphoma 
(2)  Carcinoid 
(3)  Melanoma 
(4)  Squamous (anal) 
(5)  Metastases 

7)   Pancreas 

a)   Congenital abnormalities and variants 
b)   Pancreatitis 

i)  Acute 
ii)    Chronic 
iii)   Complications 
iv)  Autoimmune 

c)    Pancreatic neoplasms 

i)  Duct cell adenocarcinoma 
ii)    Cystic pancreatic neoplasms 

(1)  Intraductal papillary mucinous neoplasm (IPMN) 
(2)  Mucinous cystadenomas 
(3)  Serous cystadenomas 

iii)   Islet cell tumors 
iv)  Lymphoma 
v)   Metastases 

8)   Liver 

a)   Normal anatomy 
b)   Diffuse diseases of the liver 

i)  Cirrhosis 
ii)    Diseases associated with infiltration 

(1)  Fatty infiltration/nonalcoholic steatohepatitis (NASH)/NAFLD 
(2)  Hemochromatosis 
(3)  Storage diseases 

iii)   Vascular diseases 

(1)  Portal hypertension 
(2)  Portal vein occlusion 

 

 

Page 15 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Gastrointestinal Imaging 

(3)  Hepatic venous hypertension/Budd Chiari syndrome, and nutmeg liver 

c)    Focal diseases of the liver 

i)  Benign 

(1)  Cavernous hemangioma 
(2)  Liver cell adenoma 
(3)  Focal nodular hyperplasia 

ii)    Malignant 

(1)  Hepatocellular carcinoma 
(2)  Metastases 
(3)  Other malignant liver lesions 

d)   Liver transplantation 

(1)  Surgical candidates 
(2)  Expected postoperative appearance 
(3)  Complications 

9)   Spleen 

a)   Splenomegaly 
b)   Focal lesions 

i)  Cysts 
ii)    Hemangioma 
iii)   Infarction 
iv)  Abscess/microabscesses 
v)   Granulomatous disease 

c)    Trauma 

10) Bile Ducts and Gallbladder 

i)  Congenital abnormalities and variants 

(1)  Choledochal cysts 
(2)  Caroli disease 

ii)    Inflammatory diseases 

(1)  Gallbladder 

(a)  Acute cholecystitis 
(b)  Emphysematous cholecystitis 
(c)  Porcelain bladder 

(2)  Biliary ducts 

(a)  Primary sclerosing cholangitis 
(b)  Ascending cholangitis 
(c)  Recurrent pyogenic cholangitis 
(d)  AIDS cholangiopathy 
(e)  Ischemic injury 
(f)   Surgical injury 
(g)  Stone disease 

iii)   Tumors 

(1)  Gallbladder cancer 

 

 

Page 16 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Gastrointestinal Imaging 

(2)  Cholangiocarcinoma 
(3)  Metastases 

11) Peritoneal Spaces 

a)   Normal anatomy 
b)   Fluid collections 
c)    Diseases of the peritoneum 
Inflammatory    diseases 
(1)   Bacterial peritonitis 
(2)  Tuberculosis 
(3)  Other 

i) 

ii)    Primary tumors 
iii)   Metastatic tumors 

d)   Mesenteries 

i)  Normal anatomy 
ii)    Pathologic conditions 

(1)  Sclerosing mesenteritis/misty mesentery 
(2)  Mesenteric fibromatosis 

e)   Retroperitoneum 

i)  Normal anatomy 
ii)    Retroperitoneal spaces 
iii)   Benign diseases 

(1)  Fibrosis 
(2)  Inflammatory diseases 

iv)  Malignant tumors 

12) Multisystem Disorders 

a)   Acute abdomen 
b)   Trauma to the abdomen 
c)    Syndromes involving the GI tract 
d)   Hernias, including internal hernias 
e)   All obstruction 

 

 

Page 17 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Interventional Radiology 

Interventional Radiology 

1)   Basic Procedures 

Questions will assess whether the candidate possesses the knowledge, skills, and abilities 
needed for safe and effective care before, during, and after the procedure. Candidates 
are expected to have a detailed knowledge of the procedure itself, as well as pre- and 
postprocedure care. 

a)    Biopsies: neck, chest, abdomen, pelvis, and extremities, including thyroid, lung, chest 

wall, liver, pancreas, renal, retroperitoneal, pelvic, and extremity. Note: breast biopsies 
will be covered in the mammography section. Bone biopsies will be covered in the 
musculoskeletal section. 

b)    Aspirations: neck, chest, abdomen, pelvis, and extremities including thyroid, pleural, 

peritoneal, and abdominal/pelvic/extremity cysts. Note that lumbar puncture and 
myelography will be covered in the neuroradiology section. 

c)    Central venous: PICCs and uncomplicated non-tunneled catheters 
d)    Abscess drainage: uncomplicated chest, abdomen, pelvic, and superficial abscesses 
e)    Extremity venography 
f)  Catheter injections: cholangiography, abscessogram, nephrostograms, and feeding tube 

checks 

2)   Complex Procedures 

Because these procedures are typically performed by radiologists with more specialized 
training, Core Exam candidates are not expected to possess the knowledge, skills, and 
abilities required to perform these procedures. However, candidates are responsible for 
a general knowledge of these procedures. Test items will also cover pre- and 
postprocedure care in more detail because general radiologists are often the first to 
encounter patients whose clinical presentation and imaging findings warrant these 
complex interventions. Candidates are also expected to correctly distinguish between 
expected and unexpected clinical and imaging findings after these procedures. 

a)   Arteriography and arterial interventions, including angioplasty, stent placement, stent 

graft placement, lysis, embolization, thrombectomy, and therapeutic infusion 

b)   Central venography and venous interventions, including inferior vena cava (IVC) filter 

placement, IVC filter retrieval, angioplasty, stent placement, lysis, thrombectomy, 
sclerosis, tunneled/implanted catheter placement, dialysis interventions, and TIPS 
c)    Biliary interventions, including percutaneous transhepatic cholangiography (PTC), 

internal/external drainage, stent placement, stone removal, and percutaneous 
cholecystostomy 

d)   Nephrostomy and ureteral stent placement, manipulation, and exchange 
e)   Tumor ablation (radiofrequency, cryoablation, bland embolization, chemoembolization, 

and radioembolization) 

f)  Feeding tube placement, manipulation, and exchange 
g)   Complicated drainages, including transrectal drainage, tunneled catheter placement for 

pleural/peritoneal collections, and pediatric procedures 

 

 

Page 18 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Interventional Radiology 

3)   Physics Knowledge Needed to Safely Perform These Procedures 

a)   Optimal use of radiation 
b)   Imaging artifacts 

 

 

Page 19 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 
 

 
 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Musculoskeletal Imaging 

 

 

Musculoskeletal Imaging 

1)   Imaging Techniques—Indications and Limitations 

a)   Musculoskeletal modalities 

i)  Radiography 
ii)   CT 
iii)  MRI 
iv)  Nuclear scintigraphy/PET 
v)   Ultrasound 
vi)  Fluoroscopy 
vii) Considerations for musculoskeletal modalities 

(1)  Appropriateness, limitations, contraindications, and safety issues 
(2)  Protocols, standard positioning, technique 
(3)  Indications for contrast with MRI and CT 
(4)  Scintigraphic agents 
(5)  Artifacts and pitfalls 

b)   Interventional musculoskeletal procedures 

i)  Types 

(1)  Arthrography 
(2)  Joint aspiration and injection 
(3)  Percutaneous biopsy 
(4)  Therapeutic procedure 

ii)   Considerations for musculoskeletal procedures 

(1)  Appropriateness, limitations, contraindications, and safety issues 
(2)  Universal protocol 
(3)  Approach and technique 
(4)  Injectate (composition and amount) 
(5)  Laboratory studies 
(6)  Complications 

c)    Dual-energy X-ray Absorptiometry (DEXA) 

Indications and follow-up 

i) 
ii)   WHO classification 
iii)  DEXA positioning 
iv)  DEXA artifacts and pitfalls 

2)   Normal/Normal Variants 

a)   Musculoskeletal anatomy pertinent to the various imaging modalities 
b)   Primary and secondary ossification centers and sequence of ossification 
c)    Physiologic radiolucencies and radiodensities 
d)   Physiologic bowing 
e)   Sesamoids, accessory ossicles, and related syndromes 
f)    Accessory muscles 
g)   Tug lesions 
h)   Cortical desmoid 

 

 

Page 20 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Musculoskeletal Imaging 

 

 

 
i)  Dorsal defect of the patella 
j)  Glenoid labrum variants 

3)   Congenital Anomalies and Dysplasias 

a)   Lower extremity 

i)  Developmental hip dysplasia 
ii)   Discoid meniscus 
iii)  Talipes equinovarus 
iv)  Metatarsus adductus 
v)   Pes cavus and planus 
vi)  Tarsal coalition 
vii) Proximal focal femoral deficiency 
viii) Protrusio acetabuli 
ix)  Acetabular version 
x)    Patella baja and alta 

b)   Upper extremity 

i)  Madelung deformity 
ii)   Congenital dislocation of the radial head 
iii)  Carpal coalition 
iv)  Sprengel deformity 
v)   Supracondylar process 
vi)  Radial ray anomaly 
vii) Ulnar variance 

c)    Spine (see neuroradiology section) 
d)   Diffuse/multifocal 

i)  Achondroplasia 
ii)   Osteogenesis imperfecta 
iii)  Sclerosing osseous dysplasias 

(1)  Melorheostosis 
(2)  Osteopathia striata 
(3)  Osteopoikilosis 

iv)  Osteopetrosis 
v)   Cleidocranial dysplasia/dysostosis 
vi)  Neurofibromatosis 
vii) Cerebral palsy 
viii) Mucopolysaccharidosis 
ix)  Trisomy 21 
x)    Macrodystrophia lipomatosa 
xi)  Nail-patella syndrome 
xii) Wormian bones 
xiii) Thanatophoric dwarf 
xiv) Marfan syndrome 
xv) Tuberous sclerosis 

4)   Infections (including routes of spread and predisposing factors) 

a)   Osteomyelitis 

 

 

Page 21 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 
 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Musculoskeletal Imaging 

 

 

 
i)  Demographics 
ii)  Acute vs subacute vs chronic osteomyelitis 
iii)   Features with  different imaging  modalities 
iv)  Terminology 
v)   Bacterial vs nonbacterial 
vi)  Congenital syphilis 

b)   Septic arthritis, bursitis, and tenosynovitis 
c)    Soft tissue 

i)  Abscess 
ii)   Cellulitis 
iii)  Pyomyositis 
iv)  Gas gangrene 
v)   Necrotizing fasciitis 
vi)  Cat-scratch disease 
vii) Cysticercosis 

5)   Tumors and Tumor-Like Conditions 

a)   Demographics 
b)   Imaging features and description 
c)    Benign and malignant primary bone lesions 

i)  Cartilaginous tumors 
(1)  Osteochondroma 
(2)  Enchondroma 
(3)  Chondroblastoma 
(4)  Periosteal chondroma 
(5)  Chondromyxoid fibroma 
(6)  Chondrosarcoma 
ii)   Osteogenic tumors 
(1)  Osteoid osteoma 
(2)  Osteoblastoma 
(3)  Osteoma 
(4)  Osteosarcoma 

(a)  Conventional osteosarcoma 
(b)  Telangiectatic osteosarcoma 
(c)  Parosteal (surface) osteosarcoma 

iii)  Fibrohistiocytic tumors 
(1)  Non-ossifying fibroma 

iv)  Ewing sarcoma 
v)   Hematopoietic tumors 

(1)  Plasma cell myeloma (Myeloma) 
(2)  Solitary plasmacytoma of bone 
(3)  Primary non-Hodgkin lymphoma of bone 
(4)  Giant cell tumor of bone 

vi)  Notochordal tumors 

(1)  Chordoma 

 

 

 

Page 22 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Musculoskeletal Imaging 

 

 

 

vii) Vascular tumors 
(1)  Hemangioma 

viii) Lipogenic and epithelial tumors 

(1)  Lipoma 
(2)  Adamantinoma 

ix)  Tumors of undefined neoplastic nature 

(1)  Aneurysmal bone cyst (primary and secondary) 
(2)  Unicameral bone cyst 
(3)  Fibrous dysplasia 
(4)  Osteofibrous dysplasia 
(5)  Langerhans cell histiocytosis 

d)   Bone metastases 

i)  Primary bone tumor vs metastases 
ii)   Blastic vs. lytic and other differentiating features 

e)   Tumor syndromes 

i)  Enchondromatosis (Ollier and Maffucci) 
ii)   Polyostotic fibrous dysplasia, McCune-Albright, and Mazabraud 
iii)  Hereditary multiple osteochondromas 
iv)  Neurofibromatosis 

f)    Malignant transformation 

i)  Paget 
ii)   Radiation induced 
iii)  Tumor syndromes (see above) 

g)   Benign and malignant soft tissue tumors 

i)  Adipocytic tumors 

(1)  Lipoma 
(2)  Liposarcoma 
(3)  Lipomatosis of nerve (fibrolipomatous hamartoma of nerve) 

ii)   Fibroblastic/myofibroblastic tumors 

(1)  Nodular fasciitis 
(2)  Fibromatosis 
(3)  Elastofibroma 
(4)  Dermatofibrosarcoma protuberans 
(5)  Fibrosarcoma 

iii)  So-called fibrohistiocytic tumors 

(1)  Tenosynovial giant cell tumor (includes localized and diffuse forms of pigmented villonodular 

synovitis as well as extra-articular giant cell tumor) 

iv)  Smooth-muscle tumors 

(1)  Leiomyosarcoma 

v)   Pericytic tumors 

(1)  Glomus 

vi)  Skeletal-muscle tumors 
(1)  Rhabdomyosarcoma 

vii) Vascular tumors 
(1)  Hemangioma 
(2)  Lymphangioma 

 

 

Page 23 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 
 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Musculoskeletal Imaging 

 

 

viii) Nerve sheath tumors 

(1)  Schwannoma 
(2)  Neurofibroma 
(3)  Malignant peripheral nerve sheath tumor 

ix)  Tumors of uncertain differentiation 

(1)  Myxoma 
(2)  Synovial sarcoma 

x)    Undifferentiated/unclassified sarcoma 

(1)  Undifferentiated pleomorphic sarcoma (malignant fibrous histiocytoma) 

h)   Non-neoplastic masses 

i)  Ganglion 
ii)   Geode 
iii)  Morton neuroma 
iv)  Postamputation neuroma 
v)   Epidermal inclusion cyst 
vi)  Xanthoma of the tendon 

6)   Trauma and Overuse 

a)   General principles of osseous trauma and overuse 

i)  Types 

(1)  Closed vs open 
(2)  Pathologic 
(3)  Fatigue 
(4)  Insufficiency 

(a)  Subchondral insufficiency fracture 

(5)  Pediatric 

(a)  Nonaccidental 
(b)  Salter-Harris 
(c)  Greenstick, bowing, and torus 
(d)  Slipped capital femoral epiphysis 

ii)   Relationship of force and deformation to fracture 
iii)  Mechanisms of injury 
iv)  Fracture patterns, bone contusions, and associated injuries 
v)   Fracture description 
vi)  Fracture healing 
vii) Complications of fracture healing 
viii) Fracture eponyms and overuse syndromes 

b)   Dislocations 
c)    General principles of soft-tissue trauma and overuse 

i)  Tendinosis, tendon tears, and tenosynovitis 
ii)   Muscle injuries and grading 
iii)  Ligamentous injuries and grading 
iv)  Bursitis 
v)   Hematomas 
vi)  Degloving injuries and Morel-Lavallee lesions 
vii) Myositis ossificans 
viii) Compartment syndrome  

 

 

 

Page 24 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Musculoskeletal Imaging 

 

 

        ix)  Myonecrosis 
d)   Site-specific entities (should know important fractures and dislocations for all sites) 

i)  Shoulder 

(1)  Labral and ligamentous tears 

(a)  Bankart and Bankart variants 
(b)  Superior labrum anterior posterior (SLAP; not including subtypes) 
(c)  Paralabral cysts 
(d)  Humeral avulsion glenohumeral ligament (HAGL) 

(2)  Rotator cuff 

(a)  Partial vs full-thickness 
(b)  Acute vs chronic 
(c)  Tendinopathy (including hydroxyapatite deposition disease/calcific tendinosis) 

(3)  Acromial-clavicular injuries 
(4)  Biceps tears and dislocations 
(5)  Pectoralis major injuries 
(6)  Adhesive capsulitis 
(7)  Impingement disorders 
(8)  Little leaguer shoulder 

ii)   Elbow 

(1)  Biceps and triceps tears 
(2)  Epicondylitis and tears of the common flexor and extensor tendons 
(3)  Tears of the medial and lateral collateral ligamentous complexes 
(4)  Osteochondral lesions 
(5)  Little leaguer elbow 

iii)  Wrist and hand 

(1)  Ulnar abutment 
(2)  Triangular fibrocartilage, scapholunate, and lunatotriquetral ligament tears 
(3)  De Quervain tenosynovitis 
(4)  Intersection syndrome 
(5)  Tendon tears and dislocations 
(6)  Scapholunate advanced collapse 
(7)  DISI, VISI, and perilunate wrist instability 
(8)  Gamekeeper and Stener lesions 
iv)  Spine (see neuroradiology section) 
v)   Hip 

(1)  Labral tears and paralabral cysts 
(2)  Femoroacetabular impingement 
(3)  Tears of the gluteal and hamstring tendons 
(4)  Apophyseal injuries 
(5)  Psoas tendon abnormalities 

vi)  Knee and leg 

(1)  Meniscus 

(a)  Normal variants and pitfalls 
(b)  Types of tears 
(c)  Parameniscal and Intrameniscal cysts 

(2)  Tears and abnormalities of the cruciate and collateral ligaments 
(3)  Posterolateral corner injury 

 

 

Page 25 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Musculoskeletal Imaging 

 

 

(4)  Iliotibial band syndrome 
(5)  Osteochondral lesions 
(6)  Patellar tracking disorder 
(7)  Tennis leg 
(8)  Tendon tears 
(9)  Jumper’s knee, Sinding-Larsen-Johansson, and Osgood-Schlatter disease 

vii) Ankle and foot 

(1)  Plantar fasciitis 
(2)  Sinus tarsi syndrome 
(3)  Tendon tears and dislocations 
(4)  Impingement disorders 
(5)  Haglund deformity 
(6)  Ligamentous tears 
(7)  Osteochondral defect 

7)   Nerve Entrapment and Associated Disorders 

a)   General principles of nerve entrapment 
b)   Specific disorders 

i)  Suprascapular nerve entrapment 
ii)   Acute brachial neuritis (Parsonage-Turner) 
iii)  Quadrilateral space syndrome 
iv)  Carpal, cubital, and tarsal tunnel syndromes 
v)   Sciatic and peroneal nerve entrapment 
vi)  Radial, median, posterior interosseous, and ulnar nerve entrapment 
vii) Obturator and femoral nerve entrapment 

8)   Metabolic Disorders 

a)   Osteoporosis and osteopenia 
b)   Hyperparathyroidism 
c)    Thyroid acropachy 
d)   Hypothyroidism 
e)   Scurvy 
f)    Rickets and osteomalacia 
g)   Renal osteodystrophy 
h)   Tumoral calcinosis 
i)  Calciphylaxis 
j)  Acromegaly 
k)   Bisphosphonate-related fractures 
l) 

Intoxication/poisoning 
i)  Heavy metal/lead 
ii)   Hypervitaminosis A and D 
iii)  Fluorosis 

9)   Hematologic and Marrow Disorders 

a)   Sickle cell and thalassemia 
b)   Hemophilia 
c)    Myelofibrosis 

 

 

Page 26 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 
 

 
 

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Musculoskeletal Imaging 

 

 

 
d)   Extramedullary hematopoiesis 
e)   Marrow reconversion 
f)    Leukemia and myelodysplasia 
g)   Radiation-induced marrow changes 
h)   Mastocytosis 
i)  Gaucher disease 

10) Osteonecrosis and Related Disorders 

a)   Osteonecrosis 
i)  Etiology 
ii)   Imaging characteristics 

b)   Osteochondritis dissecans 
c)    Bone marrow edema syndromes (transient osteoporosis of the hip) 
d)   Osteochondroses 

i)  Legg-Calve-Perthes 
ii)   Kienböck 
iii)  Kohler 
iv)  Panner 
v)   Freiberg 
vi)  Sever 
vii) Scheuermann 
viii) Tibia vara (Blount disease) 

11) Miscellaneous 

a)   Paget disease 
b)   Sarcoidosis 
c)    Hypertrophic osteoarthropathy (primary and secondary) 
d)   Periosteal changes from venous stasis 
e)   Infantile cortical hyperostosis/Caffey disease 
f)    Complex regional pain syndrome (reflex sympathetic dystrophy) 
g)   Muscle infarction 

12) Arthropathy 

a)   General features 

i)  Distribution and demographics 
ii)   Imaging findings 

b)   Osteoarthritis (including erosive osteoarthritis) 
c)    Inflammatory 

i)  Rheumatoid arthritis 
ii)   Psoriatic arthritis 
iii)  Reactive arthritis 
iv)  Ankylosing spondylitis 
v)   Enteropathic arthritis 
vi)  Juvenile idiopathic arthritis 

 

 

Page 27 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Musculoskeletal Imaging 

 

 

 
vii) SAPHO syndrome and chronic recurrent multifocal osteomyelitis (CRMO) 

d)   Connective tissue diseases 

i)  Systemic lupus erythematosus (SLE) 
ii)   Scleroderma 
iii)  Dermatomyositis 
iv)  Polymyositis 
e)   Crystal-associated 

i)  Gout 
ii)   Calcium pyrophosphate deposition disease (CPPD) 
iii)  Hydroxyapatite deposition disease (HADD) 

f)    Neuropathic 
g)   Miscellaneous 

i)  Hemochromatosis 
ii)   Pigmented villonodular synovitis 
iii)  Synovial chondromatosis 
iv)  Osteitis condensans ilii 
v)   Osteitis pubis and pubic instability 
vi)  Degenerative disk disease 
vii) Diffuse idiopathic sclerosing hyperostosis (DISH) 
viii) Ossification of the posterior longitudinal ligament 
ix)  Alkaptonuria/ochronosis 
x)    Lipoma arborescens 
xi)  Post-traumatic osteolysis 
xii) Scheuermann disease 

13) Postoperative Imaging 

a)   Internal and external fixation (including spine) 

Important types of hardware 

i) 
ii)   Appropriate positioning of hardware 
iii)  Complications 

(1)  Infection 
(2)  Loosening 
(3)  Component fracture 

b)   Arthroplasty 

Important types 

i) 
ii)   Appropriate positioning 
iii)  Complications 

(1)  Infection 
(2)  Loosening, cement fractures, component shift, and subsidence 
(3)  Osteolysis (particle disease) 
(4)  Component (polyethylene liner or prosthesis) wear, breakage, and dislocation 
(5)  Periprosthetic fracture 
(6)  Heterotopic ossification 
(7)  Metallosis 

c)    Other postoperative imaging 

i)  Normal vs abnormal appearance of the following surgeries: 

 

 

Page 28 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Musculoskeletal Imaging 

 

 

 
(1)  Anterior cruciate ligament 
(2)  Meniscus 
(3)  Vertebral augmentation 
(4)  Sarcoma resection 
(5)  Rotator cuff 
(6)  Glenoid labrum 
(7)  Osteochondral lesions 

14) ACR Appropriateness Criteria specific to Musculoskeletal Imaging 

 

 

Page 29 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 
 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

 

 

 

Neuroradiology 

Neuroradiology 

1)   Technique and Indications: Understand the Basic Principles Behind and Indications for Use 

of Methods of Examination 
a)   Radiography 
b)   CT 
c)    MR 
d)   Ultrasound 
e)   Angiography 
f)  Advanced imaging techniques 

i)  MR angiography 
ii)    CT angiography 
iii)   CT perfusion 
iv)  MR perfusion 
v)   Diffusion-weighted imaging 
vi)  MR spectroscopy 
vii) Functional MRI 
viii) Diffusion tensor imaging 
ix)  Myelography 
x)    Cisternography 
xi)  PET CT and other nuclear medicine imaging techniques 

Be able to appropriately choose study types for a variety of clinical situations, and 
recognize the strengths and weaknesses of each type of imaging exam. 

2)   Brain 

a)   Normal anatomy 

i)    Brain  parenchyma  
ii)   Ventricular system 
 iii)  Extra-axial spaces 
iv)  Pial and dural coverings 
v)   Cranial nerves 
vi)  Arterial and venous structures 
vii) Skull and surrounding soft tissues 
viii) Intracranial arterial and venous structures on imaging studies 

 

 

Page 30 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Neuroradiology 

 

 

 
(1)  CT angiography 
(2)  MR angiography 
(3)  Catheter angiography 

Understand the function of the anatomic structures and how they are affected by 
various pathologies. 

b)   White matter disease (inherited) 

i)  Adrenoleukodystrophy 
ii)    Metachromatic leukodystrophy 
iii)   Alexander disease 
iv)  Canavan disease 
v)   Krabbe disease 
vi)  Pelizaeus- Merzbacher disease 
vii) Phenylketonuria and other amino acid disorders 

c)    Neurodegenerative disorders 

i)  Aging brain 
ii)    Alzheimer disease 
iii)   Other cortical dementias 
iv)  Parkinson disease 
v)   Cerebellar degeneration 
vi)  Amyotrophic lateral sclerosis 
vii) Wallerian degeneration 
viii) Huntington disease 
ix)  Fahr disease 
x)    Wilson disease 
xi)  Hallervorden-Spatz disease 
xii) Leigh disease 
xiii) Tay-Sachs disease 
xiv) Hurler syndrome 
xv) MELAS syndrome 

d)   Infection/inflammation/demyelinating 

i)  Viral 
ii)    Bacterial 
iii)   Mycobacterial 
iv)  Fungal 
v)   Parasitic 
vi)  Prion infections 
vii) Congenital and neonatal infections 

(1)  Cytomegalovirus (CMV) 
(2)  Toxoplasmosis 
(3)  Herpesvirus (HSV) 
(4)  HIV 
(5)  Varicella 

Page 31 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Neuroradiology 

 

 

 
(6)  Rubella 
(7)  Enterovirus 

viii) Non-infectious inflammatory processes 

(1)  Chemical meningitis 
(2)  Limbic encephalitis 
(3)  Lymphocytic hypophysitis 
(4)  Granulomatous processes 

(a)  Sarcoidosis 
(b)  Histiocytosis 

ix)  White matter inflammatory conditions 

(1)  Multiple sclerosis 
(2)  Viral and post-viral demyelination 

e)   Congenital/ developmental 

i)  Chiari malformations 
ii)    Cephaloceles 
iii)   Corpus callosum anomalies 
iv)  Holoprosencephalies 
v)   Septo-optic dysplasia 
vi)  Sulcation and migrational disorders 
vii) Posterior fossa malformations 
viii) Cysts 
ix)  Neurocutaneous syndromes 

(1)  Neurofibromatosis (NF) I and II 
(2)  Tuberous sclerosis 
(3)  von Hippel-Lindau disease 
(4)  Sturge-Weber syndrome 
(5)  Basal cell nevus syndrome 
(6)  Klippel-Trenaunay-Weber syndrome 
(7)  Wyburn-Mason syndrome 
(8)  Rendu-Osler-Weber syndrome 
(9)  Ataxia- telangiectasia 
(10) Neurocutaneous melanosis 

x)    Normal patterns of cortical and white matter development, and deviations from 

normal 
(1)  Cortical dysplasias 
(2)  Hemimegalencephaly 

Recognize and be familiar with the imaging appearance and clinical presentation of 
mesial temporal sclerosis and other seizure-associated conditions. 

f)  Cyst and hydrocephalus 

i)  Communicating and obstructive hydrocephalus 
ii)    Arachnoid cyst 
iii)   Colloid cyst 

Page 32 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Neuroradiology 

 

 

iv)  Rathke cleft cyst 
v)   Neuroepithelial cyst 
vi)  Disorders of cerebrospinal fluid hydrodynamics 

(1)  Increased intracranial pressure from hydrocephalus and shunt malfunction 
(2)  Intracranial hypotension 
(3)  Complications of cerebrospinal fluid diversion procedures 

g)   Tumors and tumorlike conditions 

i)  Locations 

(1)  Parenchymal 
(2)  Meningeal 
(3)  Pineal region 
(4)  Intraventricular 
(5)  Sellar/suprasellar 
(6)  Cerebellopontine angle 
(7)  Skull base 
(8)  Cavernous sinus 
(9)  Foramen magnum 

ii)    Tumor types 

(1)    Low-grade and malignant astrocytomas 
(2)    Glioblastoma multiforme 
(3)    Gliosarcoma 
(4)    Gliomatosis cerebri 
(5)    Pleomorphic xanthoastrocytoma 
(6)    Pilocytic astrocytoma 
(7)    Subependymal giant cell astrocytoma 
(8)    Oligodendroglioma 
(9)    Ependymoma 
(10) Subependymoma 
(11) Choroid plexus tumors 
(12) Meningioma 
(13) Hemangiopericytoma 
(14) Hemangioblastoma 
(15) Ganglioglioma 
(16) Gangliocytoma 
(17) Central neurocytoma 
(18) Dysembryoplastic neuroepithelial tumor (DNET) 
(19) Lhermitte-Duclos syndrome 
(20) Germ cell tumors 
(21) Primitive neuroectodermal tumor (PNET) 
(22) Lymphoma 
(23) Leukemia 
(24) Myeloma 
(25) Schwannoma 
(26) Neurofibroma 
(27) Malignant peripheral nerve sheath tumor 

Page 33 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 
 

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Neuroradiology 

 

 

 
(28) Craniopharyngioma 
(29) Pituitary adenoma 
(30) Chordoma 
(31) Chondrosarcoma 
(32) Dermoid 
(33) Epidermoid 
(34) Lipoma 

In the case of primary brain tumors, be familiar with differentiating imaging findings 
for various tumor grades. 
Recognize imaging appearance in postoperative and post-treatment changes. 

h)   Trauma 

i)  Subarachnoid hemorrhage 
ii)    Epidural and subdural hematoma 
iii)   Contusion 
iv)  Axonal injury 
v)   Diffuse cerebral edema 
vi)  Herniation patterns 
vii) Complications and sequelae of head trauma 

(1)  Ischemia 
(2)  Infarction 
(3)  Secondary hemorrhage 
(4)  Pneumocephalus 
(5)  Cerebrospinal fluid leak 
(6)  Encephalomalacia 
viii) Non-accidental trauma 

i)  Vascular pathology: Clinical presentation of, complications from, and treatment options 

for: 
i)  Aneurysm  
(1) Saccular  
(2) Mycotic  
(3) Traumatic  
(4) Oncotic 
(5)  Flow-related 
(6)  Drug-related  
(7)  Vasculopathic  
(8)  Fusiform 
(9)  Dissecting 
(10) Pseudoaneurysm 

ii)    Vascular malformations 

(1)  Pial  
(2) Dural 
(3) Mixed 
(4)  Arteriovenous-fistulae 

Page 34 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e  C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Neuroradiology 

 

 

(5)  Cavernous angiomas 
(6)  Capillary telangiectasias 
(7)  Developmental venous anomalies 
(8)  Vein of Galen malformations 
(9)  Venous varix 

iii)   Stroke 

(1)  Arterial 
(2)  Venous 
(3)  Vasculitic, including specific patterns 
(4)  Hypoxic-anoxic encephalopathy 
(5)  Vasculitis 
(6)  Posterior reversible encephalopathy syndrome 
(7)  Vascular occlusive disease 

iv)  Intracranial hemorrhage 

(1)  Age of blood products on CT and MRI 
(2)  Patterns of hemorrhage with regard to causative factors 

(a)  Trauma 
(b)  Neoplasm 
(c)  Aneurysm 
(d)  Vascular malformation 
(e)  Vasculitis 
(f)   Non-aneurysmal subarachnoid hemorrhage 
(g)  Hypertension 
(h)  Hemorrhagic infarct (arterial and venous) 
(i)   Amyloid angiopathy 

3)   Spine 

a)   Normal anatomy 

i)  Bony vertebral anatomy 
ii)    Intervertebral discs 
iii)   Facet joints 
iv)  Ligaments 
v)   Spinal cord 
vi)  Nerve roots and plexuses 
vii) Meninges 
viii) Intradural and extradural spaces 
ix)  Surrounding soft tissues 

b)   Congenital/developmental 

i)  Chiari malformations 
ii)    Spinal dysraphism (open and occult) 
iii)   Tethered cord 
iv)  Caudal regression syndrome 
v)   Spinal lipomas 
vi)  Sacral meningocele 

 

 
 

 
 

 

Page 35 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 
 

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Neuroradiology 

 

 

vii) Sacrococcygeal teratoma 
viii) Split notochord syndromes 
ix)  Enterogenous cyst 
x)    Scoliosis 
xi)  Fusion anomalies 
xii)   Segmentation anomalies  
xiii) Neurofibromatosis type  I  
xiv)  Neurofibromatosis type  II 
xv) von Hippel-Lindau disease 

c)    Degenerative disease 

i)  Normal aging 
ii)    Disc degeneration 
iii)   Disc bulges and herniations (including appropriate descriptive terminology) 
iv)  Spondylosis 
v)   Arthrosis 
vi)  Synovial cyst 
vii) Spondylolisthesis 
viii) Spondylolysis 
ix)  Spinal stenosis 
x)    Ossification of the posterior longitudinal ligament (OPLL) 
xi)  Diffuse idiopathic sclerosing hyperostosis (DISH) 
xii) Scheuermann disease 
xiii) Arthritides 
xiv) Postoperative spine 

d)   Infection/inflammatory/demyelinating in specific anatomic sites 

i)  Arachnoiditis 
ii)    Diskitis 
iii)   Osteomyelitis 
iv)  Epidural infection 
v)   Subdural infection 
vi)  Subarachnoid infection 
vii) Meningitis 
viii) Myelitis 
ix)  Spinal cord abscess 

e)   Infection/inflammatory/demyelinating-specific  pathologies 

i)  Bacterial 
ii)    Mycobacterial 
iii)   Fungal 
iv)  Viral 
v)   Parasitic 
vi)  Granulomatous 

Page 36 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e  C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Neuroradiology 

 

 

vii) Transverse myelitis 
viii) HIV myelopathy 
ix)  Radiation-induced myelitis 
x)    Acute disseminated encephalomyelitis (ADEM) 
xi)  Multiple sclerosis 

f)  Trauma 

i)    Cervical, thoracic, and lumbosacral fracture 
ii)    Osteoporotic compression fracture 
iii)   Subluxation 
iv)  Dislocation 
v)   Spinal  cord  injury and  its  sequelae 
vi)   Epidural  and  subdural  hematoma 
vii) Plexus injuries 

g)   Vascular 

i)    Spinal cord ischemia and infarction (arterial & venous) 
ii)    Arteriovenous malformations 

(1)  Dural arteriovenous fistula (AVF) 
(2)  Glomus malformations 
(3)  Juvenile type malformations 
(4)  Intradural extramedullary AVF 
(5)  Cavernous angiomas 

h)   Tumors and tumorlike masses: benign and malignant neoplasms of the vertebral 

Dermoid 

Paraganglioma 

column, spinal cord, and nerves 
i)         Schwannoma 
ii)        Neurofibroma 
iii)       Malignant peripheral nerve sheath tumor 
iv)  Meningioma 
v) 
vi)       Epidermoid 
vii) 
viii)  Astrocytoma 
ix)       Ependymoma 
x) 
xi) 
xii)      Leukemia 
xiii)     Myeloma 
xiv)  Plasmacytoma 
xv) 
xvi)     Chondrosarcoma 
xvii)  Osteosarcoma 
xviii)    Fibrosarcoma 

Hemangioblastoma 
Lymphoma 

Chordoma 

 

 
 

 

 

 

 

Page 37 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Neuroradiology 

 

 

xix)  Ewing sarcoma 
xx)  Hemangiomas 
xxi)  Osteoblastoma 
xxii)  Osteoid osteoma 
xxiii)    Osteochondroma 
xxiv)    Giant cell tumor 
xxv)  Aneurysmal bone cyst 
xxvi)    Angiolipoma 
xxvii)   Eosinophilic granuloma 
xxviii)  Pathologic fractures 
xxix)    Metastatic disease 

i)  Miscellaneous 

i)  Arachnoid cyst 
ii)    Parameningeal cyst 
iii)   Spinal cord herniation 

4)   Extracranial Head and Neck 

a)   Normal anatomy—bone and soft tissues 

i)  Orbits 
ii)    Paranasal sinuses 
iii)   Facial bones 
iv)  Skull base 
v)   Temporal bone, including temporomandibular joint (TMJ) 
vi)  Nasal cavity 
vii) Oral cavity 
viii) Oropharynx 
ix)  Nasopharynx 
x)    Hypopharynx 
xi)  Larynx 
xii) Neck spaces (suprahyoid and infrahyoid) 
xiii) Classification of lymph node level 

b)   Normal anatomy—vascular: normal extracranial arterial and venous structures on 

vascular imaging modalities 
i)  CT angiography 
ii)    MR angiography 
iii)   Ultrasound 
iv)  Catheter angiography 

c)    Infectious/inflammatory/granulomatous 

i)  Orbit 

(1)    Preseptal cellulitis 
(2)    Orbital cellulitis 

Page 38 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Neuroradiology 

 

 

(3)    Subperiosteal phlegmon and abscess 
(4)    Extension of fungal sinus disease 
(5)    Pseudotumor 
(6)    Thyroid orbitopathy 
(7)    Sarcoid 
(8)    Lacrimal adenitis 
(9)    Wegener granulomatosis 
(10) Tolosa-Hunt syndrome 
(11) Optic neuritis 

ii)    Sinonasal cavity/facial bones 

(1)    Osteomyelitis  
(2) Acute sinusitis  
(3) Chronic sinusitis 
(4)    Complications of sinusitis 
(5)    Fungal infection 

(a)  Immunocompromised and immunocompetent patients 
(b)  Allergic fungal sinusitis 

(6)    Polyps 
(7)    Polyposis 
(8)    Mucocele 
(9)    Retention cyst 
(10) Antrochoanal polyp 
(11) Sarcoid 
(12) Wegener granulomatosis 
iii)   Skull base and temporal bone 

(1)    Osteomyelitis 
(2)    Necrotizing otitis externa 
(3)    Petrous apicitis 
(4)    Otitis externa 
(5)    Otitis media 
(6)    Mastoiditis 
(7)    Cholesteatoma 
(8)    Ramsey-Hunt syndrome 
(9)    Labyrinthitis 
(10) Labyrinthitis ossificans 
(11) Bell palsy 
(12) Otosclerosis 

iv)  Oral cavity, pharynx, supra- and infrahyoid neck 

(1)  Odontogenic infections 
(2)  Infections of salivary gland origin 
(3)  Tonsillitis 
(4)  Adenoiditis 
(5)  Cellulitis, phlegmon, and abscess involving neck spaces 
(6)  Sjögren disease 

Page 39 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Neuroradiology 

 

 

(7)  Non-neoplastic lymphadenopathy 

(a)  Viral 
(b)  Bacterial 
(c)  Mycobacterial 
(d)  Granulomatous 

(8)  Thyroiditis (acute and chronic, e.g., Hashimoto) 

d)   Tumors and tumor-like conditions 

i)  Orbit 

(1)  Optic nerve sheath meningioma 
(2)  Optic glioma 
(3)  Lacrimal gland tumors 
(4)  Rhabdomyosarcoma 
(5)  Retinoblastoma 
(6)  Ocular hamartoma 
(7)  Uveal melanoma 
(8)  Metastases 
(9)  Cavernous hemangiomas 
(10) Vasoformative lesions 

(a)  Infantile hemangiomas 
(b)  Lymphatic/venous malformations 

(11) Lymphoma/leukemia 

ii)    Sinonasal cavity and facial bones 

(1)    Squamous cell carcinoma 
(2)    Undifferentiated carcinoma 
(3)    Lymphoma 
(4)    Melanoma 
(5)    Esthesioneuroblastoma 
(6)    Inverted papilloma 
(7)   Minor  salivary  gland  neoplasms  
(8)    Schwannoma  and meningioma  
(9)    Juvenile nasal angiofibroma 
(10) Vasoformative lesions 

(a)  Infantile hemangiomas 
(b)  Lymphatic/venous malformations 
(c)  Arteriovenous malformations 

(11) Hemangiopericytoma 
(12) Rhabdomyosarcoma 
(13) Osteoma 
(14) Osteoblastoma 
(15) Giant cell tumor 
(16) Rhabdomyosarcoma 
(17) Malignant fibrous histiocytoma 
(18) Plasmacytoma 

Page 40 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Neuroradiology 

 

 

(19) Paget disease 
(20) Fibrous dysplasia 
(21) Ossifying fibroma and other fibroosseous lesions 
(22) Myxoma 
(23) Chondroma 
(24) Chondrosarcoma 
(25) Osteosarcoma 
(26) Ewing sarcoma 
(27) Ameloblastoma 
(28) Aneurysmal bone cyst 
(29) Odontogenic cysts and tumors 
(30) Langerhans cell histiocytosis 
(31) Metastases 

iii)   Skull base and temporal bone 

(1)    Hemangiomas 
(2)    Angiofibroma 
(3)    Schwannoma 
(4)    Neurofibroma 
(5)    Teratoma 
(6)    Dermoid 
(7)    Pituitary adenoma 
(8)    Germinoma 
(9)    Lymphoma 
(10) Nasopharyngeal carcinoma 
(11) Salivary gland tumors 
(12) Chloroma 
(13) Plasmacytoma 
(14) Metastases 
(15) Myeloma 
(16) Chondrosarcoma 
(17) Chordoma 
(18) Endolymphatic sac tumor 
(19) Paraganglioma 
(20) Adenoma 
(21) Neuroma 
(22) Langerhans cell histiocytosis/eosinophilic granuloma 
(23) Osteoblastoma 
(24) Giant cell tumor 
(25) Pigmented villonodular synovitis 
(26) Rhabdomyosarcoma 
(27) Paget disease  
(28) Fibrous dysplasia 
(29) Osteoma/exostosis 
(30) Meningioma 

Page 41 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Neuroradiology 

 

 

iv)  Oral cavity, pharynx, supra, and infrahyoid neck 

(1)   Malignant adenopathy 
(2)    Lymphoma 
(3)    Squamous cell carcinoma 
(4)    Schwannoma 
(5)    Neuroma 
(6)    Neurofibroma 
(7)    Goiter 
(8)    Thyroid neoplasms 
(9)    Parathyroid neoplasms 
(10) Salivary gland neoplasms 
(11) Vasoformative lesions 

(a)  Infantile hemangiomas 
(b)  Lymphatic/venous malformations 
(c)  Arteriovenous malformations 

(12) Paraganglioma 
(13) Lipoma/liposarcoma 

e)    Cystic  lesions  of  the  head  and  neck 

i)  Branchial cleft cysts (types I-IV)  
ii)    Thyroglossal duct cyst 
iii)   Ranula 
iv)  Dermoid/epidermoid 
v)   Thymic cyst 
vi)  Cystic hygroma (lymphangioma) 
vii) Laryngopyocele 
viii) Cystic lymph nodes 

f)  Trauma 

i)  Orbital fractures 
ii)    Soft tissue injuries of the globe and orbit 
iii)   Maxillofacial fracture 
iv)  Mandibular fractures 
v)   Temporomandibular joint (TMJ) fracture/dislocation 
vi)  Skull base fractures 
vii) Temporal bone fractures (including classification systems) 

(1)  Longitudinal/transverse 
(2)  Otic capsule spared/involved 

viii) Laryngeal fractures 

g)   Vascular 
i)  Orbit 

(1)  Venous varix 
(2)  Hemangiomas 

Page 42 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Neuroradiology 

 

 

(3)  Lymphangioma 
(4)  Superior ophthalmic vein thrombosis 
(5)   Carotid-cavernous  fistula 
ii)    Sinonasal  cavity/facial  bones 
iii)   Skull base/temporal bone 

(1)  Dissection 
(2)  Aneurysm 
(3)  Pseudoaneurysm 
(4)  Aberrant internal carotid artery 
(5)  Persistent stapedial artery 
(6)  Jugular dehiscence 
(7)  Jugular diverticulum 
(8)  High-riding jugular bulb 

iv)  Oral cavity, pharynx, supra- and infrahyoid neck 

(1)  Medial course of internal carotid artery 
(2)  Dissection 
(3)  Thrombosis 
(4)  Occlusion 
(5)  Pseudoaneurysm 
(6)  Fibromuscular dysplasia 
(7)  Aneurysm 

h)   Congenital 

i)  Orbit 

(1)    Sphenoid wing dysplasia 
(2)    Septooptic dysplasia 
(3)    Coloboma 
(4)    Congenital glaucoma 
(5)    Persistent hyperplastic primary vitreous (PHPV) 
(6)    Coats disease 
(7)    Toxocariasis 
(8)    Infantile hemangiomas 
(9)    Lymphatic malformation 
(10) Dermoid 

ii)    Sinonasal cavity/facial bones 

(1)  Hypoplasia 
(2)  Aplasia 
(3)  Down syndrome 
(4)  Kartagener syndrome 
(5)  Cephaloceles/nasal glioma 
(6)  Choanal atresia 

iii)   Skull base/temporal bone 

(1)  Cephaloceles 
(2)  Arachnoid cyst 

Page 43 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e  C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Neuroradiology 

 

 

(3)  External auditory canal atresia 
(4)  Aberrant facial nerve course 
(5)  Congenital cholesteatoma 
(6)  Ossicular deformities 
(7)  Large vestibular aqueduct syndrome 
(8)  Mondini defect 
(9)  Michel aplasia 

iv)  Oral cavity, pharynx, and supra- and infrahyoid neck 

i)    Branchial cleft cysts (types I-IV) 

i)  Thyroglossal duct cyst 
ii)    Lingual thyroid 
iii)   Dermoid/epidermoid 
iv)  Thymic cyst 
v)   Vasoformative lesions 

(1)  Infantile hemangiomas 
(2)  Lymphatic/venous malformations 
(3)  Arteriovenous malformations 

 

 
 

 

 

Page 44 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Nuclear Radiology 

 

Nuclear Radiology 

1)   Breast 

a)   Benign neoplasm 

i)  Radiopharmaceuticals: 18F FDG 
ii)    Imaging techniques: PET and PET-CT 
iii)   Typical indications: breast lesion 

b)   Malignant neoplasm, primary 

i)  Radiopharmaceuticals:  18F  FDG 
ii)    Imaging techniques: PET and PET-CT 
iii)   Typical indications: breast lesion 

c)    Malignant neoplasm, metastatic 

i)  Radiopharmaceuticals:  99mTc HDP/MDP; 18F FDG, and 18F NaF 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: staging disease and treatment strategy 

d)   Lymphatic mapping/sentinel lymph node (SLN) 
i)  Radiopharmaceuticals:  99mTc sulfur colloid 
ii)    Injection techniques: intradermal, peritumoral, and periareolar 
iii)   Imaging and localization techniques: planar, SPECT and/or SPECT-CT, and 

intraoperative gamma probe 

iv)  Typical indications: identification and localization of SLN for intraoperative gamma 

probe-directed sampling 
e)   Infection and inflammation 

i)  Radiopharmaceuticals: 67Ga citrate, 111In/99mTc WBCs; 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: breast abscess and inflammation 

f)  Normal and other 

i)  Radiopharmaceuticals: all of above 
ii)    Imaging techniques: all of above 
iii)   Typical indications: all of above 

g)   Artifacts and quality control 

i)  Patient Issues: preparation, motion, positioning, and contamination 
ii)    Radiopharmaceutical issues: preparation, administration technique, and altered 

biodistribution 

iii)   Technical issues: instrumentation, acquisition and processing, transmission imaging, 

and quantification (SUV) 

2)   Cardiac 

a)   Perfusion imaging, coronary artery disease 

i)  Radiopharmaceuticals: 99mTc sestamibi/tetrofosmin, 201Tl chloride; 13N NH3 

(ammonia), and 82Rb chloride 

ii)    Stress protocols: exercise, pharmacologic (regadenoson [Lexiscan] and dobutamine) 
iii)   Imaging techniques: SPECT, ECG-gated SPECT and/or SPECT-CT; PET and PET-CT 

Page 45 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Nuclear Radiology 

 

iv)  Quantitative analysis: left ventricular ejection fraction (LVEF), systolic function, 

diastolic function, summed stress score (SSS), and transient ischemic dilatation (TID) 
v)   Typical indications: perfusion, function, and wall motion; ischemia vs infarction and 

risk stratification 

b)   Perfusion imaging, non-coronary artery disease 

i)  Radiopharmaceuticals: 99mTc sestamibi/tetrofosmin,  201Tl chloride; 13N NH3 

(ammonia), 82Rb chloride 

ii)    Stress protocols: exercise, pharmacologic (regadenoson [Lexiscan] and dobutamine) 

iii)   Imaging techniques: SPECT, ECG-gated SPECT and/or SPECT-CT; PET and PET-CT 
iv)  Quantitative analysis: left ventricular ejection fraction (LVEF), systolic function, 
diastolic function, summed stress score (SSS), transient ischemic dilatation (TID) 

v)   Typical indications: perfusion, function, and wall motion; cardiomyopathy 

c)    Metabolism and viability 

i)  Radiopharmaceuticals:  201Tl chloride; 18F FDG 
ii)    Imaging techniques: SPECT, ECG-gated SPECT and/or SPECT/CT; PET and PET/CT 
iii)   Typical Indications: hibernating/viable  myocardium; pre-operative evaluation 

d)   Function: multigated acquisition (MUGA) and first-pass studies 

i)  Radiopharmaceuticals:  99mTc RBCs and 99mTc DTPA 
ii)    Imaging techniques: ECG-gated planar; ECG-gated SPECT 
iii)   Quantitative analysis:  left ventricular ejection fraction (LVEF), right ventricular 

ejection fraction (RVEF) 

iv)  Typical indications: baseline function, cardiotoxicity after chemotherapy 

e)   Shunts 

i)  Radiopharmaceuticals:  99mTc MAA 
ii)    Imaging techniques: planar, SPECT 
iii)   Quantitative analysis: quantification of shunt 
iv)  Typical indications: right-to-left shunt 
Infection and inflammation 
i)  Radiopharmaceuticals:  67Ga citrate, 111In/99mTc WBCs; 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: pericarditis/myocarditis, myocardial/valvular abscess, and 

f) 

sarcoidosis 

g)   Normal and  other 

i)  Radiopharmaceuticals: all of above 
ii)    Imaging techniques: all of above 
iii)   Typical indications: all of above 

h)   Artifacts and quality control 

i)  Patient issues: preparation, motion, positioning, and contamination; arrhythmia 
ii)    Radiopharmaceutical issues:  preparation, administration technique and timing, and 

altered biodistribution 

iii)   Technical issues: instrumentation, acquisition and processing, attenuation- 

correction, ECG-gating, and quantification (LVEF,  RVEF, ED and ES function, SSS, and 
TID) 

Page 46 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Nuclear Radiology 

 

3)  Gastrointestinal  (GI) 

a)   Liver and spleen 

i)  Radiopharmaceuticals:  99mTc sulfur colloid, 99mTc MAA, 99mTc RBCs, damaged 99mTc 

RBCs 

ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Typical indications: cirrhosis, hepatic arterial perfusion/systemic shunting before 

radioembolization, cavernous hemangioma, and accessory spleen/splenosis 

b)   Biliary 

i)  Radiopharmaceuticals:  99mTc IDA analogs 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Pharmacologic protocols: morphine sulfate and sincalide (CCK) 
iv)  Quantitative analysis: gallbladder ejection fraction (GBEF) 
v)   Typical indications: acute cholecystitis, chronic acalculous cholecystitis, common bile 

duct obstruction, biliary ectasia, bile leak, and postoperative complications 

c)    Bowel:  GI bleeding 

i)  Radiopharmaceuticals:  99mTc RBCs and 99mTc pertechnetate 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Typical indications: active GI bleeding site and varices; Meckel diverticulum 

d)   Bowel:  GI motility 

i)  Radiopharmaceuticals: 99mTc sulfur colloid as solid meal (e.g., eggs)/as liquid meal 
ii)    Imaging techniques: planar 
iii)   Quantitative analysis: T ½, 4-hour retained activity, and geometric mean 

methodology 

iv)  Typical indications: gastroparesis, gastroesophageal reflux, and aspiration 

e)   Benign neoplasm 

i)  Radiopharmaceuticals:  99mTc sulfur colloid, 99mTc IDA; 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: liver mass (e.g., fibronodular hyperplasia) 

f)  Malignant neoplasm, primary 

i)  Radiopharmaceuticals: 67Ga citrate; 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: hepatocellular cancer (HCC), GI stromal tumor, lymphoma, and 

esophageal/gastric/biliary/pancreatic/colorectal/peritoneal    cancer 

g)   Malignant neoplasm, metastatic 

i)  Radiopharmaceuticals: 18F FDG 
ii)    Imaging techniques: PET and PET-CT 
iii)   Typical indications: staging disease and treatment strategy 

h)   Infection and inflammation 

i)  Radiopharmaceuticals:  67Ga citrate, 111In/99mTc WBCs; 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: abscess and inflammatory bowel disease 

i)  Normal and other 

Page 47 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Nuclear Radiology 

 

i)  Radiopharmaceuticals: all of above 
ii)    Imaging techniques: all of above 
iii)   Typical indications: all of above 

j)  Artifacts and quality control 

i)  Patient issues: preparation, motion, positioning, and contamination 
ii)    Radiopharmaceutical issues: preparation, administration technique, and altered 

biodistribution 

iii)   Technical issues: instrumentation, acquisition and processing, pharmaceutical 

infusion protocols, and quantification (GBEF, T ½; SUV) 

4)  Musculoskeletal 

a)   Benign neoplasm 

i)  Radiopharmaceuticals:  99mTc HDP/MDP; 18F NaF, 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: radiographically visible or occult lesions, e.g., osteoid osteoma 

b)   Malignant neoplasm, primary 

i)  Radiopharmaceuticals: 99mTc HDP/MDP; 18F NaF, 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: osteosarcoma, Ewing sarcoma, multiple myeloma, and 

lymphoma 

c)    Malignant neoplasm, metastatic 

i)  Radiopharmaceuticals: 99mTc HDP/MDP; 18F NaF, 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: staging disease, treatment strategies 

d)   Therapy 

i)  Radiopharmaceuticals:  153Sm lexidronam pentasodium, 89Sr chloride 
ii)    Patient issues: selection, preparation, informed consent, understanding and 

calculation of administered activity, counseling of patients and families on radiation 
safety issues, release criteria, and follow-up 

iii)   Typical indications: painful skeletal metastases 

e)   Tumor-like conditions 

i)  Radiopharmaceuticals:  99mTc HDP/MDP; F-18 NaF, F-18 FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: fibrous dysplasia, Paget disease 

f)  Metabolic & vascular abnormalities 

i)  Radiopharmaceuticals:  99mTc HDP/MDP, 99mTc sulfur colloid; 18F NaF, 18F FDG 
ii)    Imaging techniques: three-phase, planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: hyperparathyroidism, “Superscan” (renal osteodystrophy, 

myelofibrosis), avascular necrosis, complex regional pain syndrome, and 
hypertrophic arthropathy 

g)   Trauma 

i)  Radiopharmaceuticals: 99mTc HDP/MDP 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT 

Page 48 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Nuclear Radiology 

 

iii)   Typical indications: stress/insufficiency fracture, occult fracture, nonaccidental 

trauma, and heterotopic bone formation 

h)   Infection & Inflammation 

i)  Radiopharmaceuticals:  67Ga citrate, 111In/99mTc WBCs, 99mTc sulfur colloid; 18F FDG 
ii)    Imaging techniques: three-phase, dual-tracer; planar, SPECT and/or SPECT/CT; PET 

and PET/CT 

iii)   Typical indications:  osteomyelitis, cellulitis, synovitis/arthritis, septic joint, hardware 

infection 

i)  Extraskeletal processes 

i)  Radiopharmaceuticals:  99mTc HDP/MDP 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT 
iii)   Typical findings: benign (e.g., lung in hypercalcemia, myocardial 

infarction/myocarditis/pericarditis,  and cardiac amyloidosis) vs malignant (e.g., 
breast carcinoma primary, liver metastases from colon cancer, pleural effusion in 
lung cancer, and peritoneal ovarian carcinomatosis); and renal anomalies 

j)  Bone mineral density (BMD) (dual-energy x-ray absorptiometry, DEXA) 

Imaging techniques: DEXA 

i) 
ii)    Quantitative analysis and pitfalls: T-score, Z-score, region-of-interest (ROI) selection, 

artifacts 

iii)   Typical indications: osteoporosis vs osteopenia, fracture risk assessment, and serial 

evaluations to evaluate effects of medication 

k)   Normal and other 

i)  Radiopharmaceuticals: all of above 
ii)    Imaging techniques: all of above 
iii)   Typical indications: all of above 

l)  Artifacts and quality control 

i)  Patient issues: preparation, motion, positioning, and contamination 
ii)    Radiopharmaceutical issues: preparation, administration technique, and altered 

biodistribution 

iii)   Technical issues: instrumentation, acquisition and processing, quantification (SUV; T- 

score, Z-score) 

5)   Neurology 

a)   Brain death 

i)  Radiopharmaceuticals:  99mTc ECD/HMPAO, and 99mTc DTPA 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Typical indications: confirmation of clinical brain death 

b)   Stroke, cerebrovascular disease and vascular reserve 

i)  Radiopharmaceuticals:  99mTc ECD/HMPAO; 18F FDG 
ii)    Imaging techniques: SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Stress protocols: Wada test, acetazolamide (Diamox) challenge, and balloon 

occlusion 

iv)  Typical indications: ischemia vs infarct, and vascular reserve 

c)    Cerebrospinal fluid (CSF) 

Page 49 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Nuclear Radiology 

 

i)  Radiopharmaceuticals:  111In/99mTc DTPA 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT 
iii)   Typical indications: normal pressure hydrocephalus, leak, and V-P shunt patency 

d)   Dementias, behavioral disorders, and movement disorders 

i)  Radiopharmaceuticals: 99mTc ECD/HMPAO, 123I DaTscan; 18F FDG, 18F amyloid agents 
ii)    Imaging techniques: SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: Alzheimer disease, Lewy body-associated, frontotemporal, multi- 

infarct, senile, depression, Parkinson disease 

e)   Seizure 

i)  Radiopharmaceuticals: 99mTc ECD/HMPAO; 18F FDG 
ii)    Imaging techniques: SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Stress protocols: injection during active seizure, and interictal setting 
iv)  Typical indications: localization of seizure focus, and interictal vs ictal protocols 

f)  Benign neoplasm 

i)  Radiopharmaceuticals: 99mTc HDP/MDP, 111In pentetreotide (OctreoScan), and 18F 

FDG 

ii)    Imaging techniques: Planar, SPECT and/or SPECT-CT; PET and PET-CT) 
iii)   Typical indications: meningioma 

g)   Malignant neoplasm, primary 

i)  Radiopharmaceuticals:  18F FDG 
ii)    Imaging techniques: PET and/or PET-CT 
iii)   Typical indications: glioblastoma, astrocytoma, and lymphoma 

h)   Malignant neoplasm, metastatic 

i) 

i)  Radiopharmaceuticals:  18F FDG 
ii)    Imaging techniques: PET and PET-CT 
iii)   Indications: staging disease, treatment strategy, and tumor viability 
Infection and inflammation 
i)  Radiopharmaceuticals:  67Ga citrate, 111In/99mTc WBCs; 18F FDG 
ii)    Imaging techniques: SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: abscess, encephalitis, toxoplasmosis, and radionecrosis 

j)  Normal and other 

i)  Radiopharmaceuticals: all of above 
ii)    Imaging techniques: all of above 
iii)   Typical indications: all of above 

k)   Artifacts and quality control 

i)  Patient issues: preparation, motion, positioning, and contamination 
ii)    Radiopharmaceutical issues: preparation, administration technique, and altered 

biodistribution 

iii)   Technical issues: instrumentation, acquisition and processing, and quantification 

(SUV) 

6)   Pediatrics 

a)   Brain and cerebrospinal fluid (CSF) 

Page 50 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Nuclear Radiology 

 

i)  Radiopharmaceuticals:  99mTc ECD/HMPAO; 18F FDG; 111In/99mTc DTPA) 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: seizure, neoplasm; V-P shunt patency, and hydrocephalus 

b)   Cardiac 

i)  Radiopharmaceuticals:  99mTc RBCs, 99mTc sestamibi/tetrofosmin 
ii)    Imaging techniques: ECG-gated planar, SPECT, ECG-gated SPECT, and/or SPECT-CT 
iii)   Quantitative analysis: left ventricular ejection fraction (LVEF) 
iv)  Typical indications: congenital heart disease, Kawasaki disease 

c)    Thoracic 

i)  Radiopharmaceuticals:  99mTc MAA, 133Xe gas, 99mTc DTPA aerosol 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Typical indications: pulmonary artery atresia, right-to-left shunt, cystic fibrosis, and 

Swyer-James syndrome 
d)   GI and hepatobiliary system 

i)  Radiopharmaceuticals:  99mTc sulfur colloid, 99mTc IDA analog, 99mTc pertechnetate 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Pharmacologic protocols: phenobarbital, H2 blockers (e.g., cimetidine) 
iv)  Quantitative analysis: gastric emptying T ½, and gallbladder ejection fraction (GBEF) 
v)   Typical indications: aspiration, gastroesophageal reflux, gastric emptying, biliary 

atresia, and Meckel diverticulum 

e)   Musculoskeletal 

i)  Radiopharmaceuticals:  99mTc HDP/MDP; 18F NaF, and 18F FDG 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: osteoid osteoma, fracture, avascular necrosis, osteomyelitis, 

nonaccidental trauma, and metastases 

f)  Endocrine 

i)  Radiopharmaceuticals:  123I NaI, 99mTc pertechnetate; 131I NaI 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Typical indications: hypothyroidism (lingual thyroid, agenesis, organification defect), 

hyperthyroidism, thyroid cancer, and radioiodine therapy 

g)   Infection and inflammation 

i)  Radiopharmaceuticals:  67Ga citrate, 111In/99mTc WBCs; 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: osteomyelitis/septic joint, lung inflammation, inflammatory 

bowel disease, and abscess 

h)   Neoplasm 

18F FDG 

i)  Radiopharmaceuticals:  99mTc HDP/MDP, 123I MIBG, 111In pentetreotide (OctreoScan); 

ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical Indications: Osteosarcoma/Ewing sarcoma, histiocytosis/eosinophilic 

granuloma, neuroblastoma, lymphoma, and hepatic tumors 

i)  Urinary Tract 

i)  Radiopharmaceuticals:  99mTc DMSA, 99mTc DTPA, 99mTc MAG3, and 99m  Tc sulfur 

colloid 

Page 51 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Nuclear Radiology 

 

ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Pharmacologic protocols: diuretics (e.g., furosemide) 
iv)  Quantitative analysis: relative renal function, response to diuretic challenge 
v)   Typical indications: congenital anomalies, ectopia, multicystic dysplastic kidney, 

horseshoe kidney, pyelonephritis, hypertension, hydronephrosis, and vesicoureteral 
reflux 

j)  Normal and other 

i)  Radiopharmaceuticals: all of above 
ii)    Imaging Techniques: all of above 
iii)   Typical Indications: all of above 

k)   Artifacts and quality control 

i)  Patient issues: preparation, motion, positioning, and contamination; dosimetry 
ii)    Radiopharmaceutical issues: preparation, administration technique, and altered 

biodistribution 

iii)   Technical issues: instrumentation, acquisition and processing, and quantification (T 

½, GBEF, and SUV) 

7)   Reproductive/Endocrine 

a)   Thyroid gland 

i)  Radiopharmaceuticals:  123I NaI, 99mTc pertechnetate 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Quantitative techniques: uptake probe (24-hour radioiodine uptake) 
iv)  Typical indications: goiter (in situ, substernal), benign thyroid nodules, multinodular 

gland, and hyperthyroidism (Graves disease, thyroiditis, and toxic nodules) 

b)   Thyroid cancer 

i)  Radiopharmaceuticals:  123I/131I NaI, 111In pentetreotide (OctreoScan), and; 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: thyroid bed remnant, and staging locoregional disease/distant 

metastases for papillary and follicular and medullary cancers 

c)    Therapy 

i)  Radiopharmaceuticals:  131I NaI, calculation of administered activity (benign vs 

malignant conditions) 

ii)    Patient issues: selection, preparation, informed consent, understanding and 

calculation of administered activity, counseling of patients and families on radiation 
safety issues, release criteria, and follow-up; pregnancy 

iii)   Typical indications: benign (hyperthyroidism), malignant (thyroid cancer remnant vs 

metastases) 

d)   Adrenal 

i)  Radiopharmaceuticals:  123I MIBG, 111In pentetreotide (OctreoScan) 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Typical indications: pheochromocytoma,  cortical adenoma 

e)   Neuroendocrine 

i)  Radiopharmaceuticals:  111In pentetreotide (OctreoScan) 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 

Page 52 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Nuclear Radiology 

 

iii)   Typical indications: carcinoid, islet cell tumors, medullary thyroid cancer, and 

pheochromocytoma/paraganglioma/neuroblastoma 

f)  Parathyroid gland 

i)  Radiopharmaceuticals:  99mTc sestamibi, 99m Tc pertechnetate, and 123I NaI 
ii)    Imaging techniques: dual-phase, dual-tracer, planar, SPECT, and/or SPECT-CT 
iii)   Typical Indications: hyperparathyroidism (adenoma, hyperplasia, and ectopic) 

g)   Female reproductive system neoplasms 

i)  Radiopharmaceuticals:  99mTc HDP/MDP; 18F NaF, and 18F FDG 
ii)    Imaging techniques: Planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: Staging disease, treatment strategy 

h)   Male reproductive system neoplasms 

i)  Radiopharmaceuticals:  99mTc HDP/MDP; 18F NaF, 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: staging disease, treatment strategy 

i)  Normal and other 

i)  Radiopharmaceuticals: all of above 
ii)    Imaging techniques: all of above 
iii)   Typical indications: all of above 

j)  Artifacts and quality control 

i)  Patient issues: preparation, motion, positioning, and contamination 
ii)    Radiopharmaceutical issues: preparation, administration technique, and altered 

biodistribution 

iii)   Technical issues: instrumentation, acquisition and processing, and quantification 

(24-hour uptake, SUV) 

8)   THORACIC 

a)   Ventilation/perfusion, thromboembolic disease 

i)  Radiopharmaceuticals:  99mTc MAA, 133Xe gas, and 99mTc DTPA aerosol 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Typical indications: acute or chronic pulmonary embolism and pulmonary 

hypertension 

b)   Ventilation/perfusion,  nonthromboembolic disease 

i)  Radiopharmaceuticals:  99mTc MAA, 133Xe gas, and 99mTc DTPA aerosol 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Quantitative techniques: regional/split (differential) lung function 
iv)  Typical indications: fat emboli, hilar mass, vasculitis, prepulmonectomy and 

pulmonary transplant evaluation, and pulmonary hypertension 

c)    Ventilation/perfusion, chronic obstructive airways disease (COPD) and airways disease 

i)  Radiopharmaceuticals:  99mTc MAA, 133Xe gas, and 99mTc DTPA aerosol 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Quantitative techniques: Regional/split (differential) lung function 
iv)  Typical indications: COPD, asthma, cystic fibrosis, mucus plug, and prebullectomy 

evaluation 

d)   Benign neoplasm/mass/solitary pulmonary nodule 

Page 53 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Nuclear Radiology 

 

i)  Radiopharmaceuticals:  18F FDG 
ii)    Imaging techniques: PET and PET-CT 
iii)   Typical indications: hamartoma, granuloma, and excluding malignancy 

e)   Malignant neoplasm, primary 

i)  Radiopharmaceuticals:  111In pentetreotide (OctreoScan) and 18F FDG 
ii)    Imaging techniques: SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: carcinoid, esophageal cancer, mediastinal tumor, lung cancer, 

pleural neoplasm, and lymphoma 

f)  Malignant neoplasm, metastatic 

i)  Radiopharmaceuticals:  99mTc HDP/MDP; 18F NaF, and 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT) 
iii)   Typical indications: staging disease, treatment strategy 

g)   Trauma 

i)  Radiopharmaceuticals:  99mTc HDP/MDP, 99mTc MAA, 133Xe, and 99mTc DTPA aerosol 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Typical indications: rib fractures, pneumothorax, hemothorax,  and bronchopleural 

fistula 

h)   Infection and inflammation 

i)  Radiopharmaceuticals:  67Ga citrate, 111In/99mTc WBCs, and 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: sarcoidosis, occupational lung disease, pneumonia, abscess, 

tuberculosis, MAI, pneumocystis pneumonia (PCP), histoplasmosis, and talc pleuritis 

i)  Normal and other 

i)  Radiopharmaceuticals: all of above 
ii)    Imaging techniques: all of above 
iii)   Typical indications: all of above 

j)  Artifacts and quality control 

i)  Patient issues: preparation, motion, positioning, and contamination 
ii)    Radiopharmaceutical issues: preparation, administration technique, and altered 

biodistribution 

iii)   Technical issues: instrumentation, acquisition and processing, and quantification 

(split (differential) lung and SUV) 

9)  URINARY 

a)   Perfusion and function 

i)  Radiopharmaceuticals:  99mTc MAG-3, 99mTc DTPA 
ii)    Imaging techniques: planar 
iii)   Quantitative analysis: relative renal function, renogram, and glomerular filtration 

rate (GFR) 

iv)  Typical indications: renal dysfunction/failure, renal artery occlusion, and renal vein 

thrombosis 

b)   Diuretic challenge 

i)  Radiopharmaceuticals:  99mTc MAG-3, 99mTc DTPA 
ii)    Imaging techniques: planar 

Page 54 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Nuclear Radiology 

 

iii)   Pharmacologic protocols: diuretics (e.g., furosemide) 
iv)  Quantitative analysis: relative renal function, and response to diuretic challenge 
v)   Typical indications: obstructive vs nonobstructive hydronephrosis, and stent 

function 

c)    Cortical 

i)  Radiopharmaceuticals:  99mTc DMSA 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Quantitative analysis: relative renal function 
iv)  Typical indications: relative function, scarring, and prenephrectomy assessment 

d)   Leak 

i)  Radiopharmaceuticals:  99mTc MAG-3 and 99mTc DTPA 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Typical indications: urinoma, and leak after transplant/other 

surgery/instrumentation,  trauma 

e)   Transplant 

i)  Radiopharmaceuticals:  99mTc MAG-3 and 99mTc DTPA 
ii)    Imaging techniques: planar, SPECT, and/or SPECT-CT 
iii)   Quantitative analysis: renogram 
iv)  Typical indications: acute tubular necrosis, rejection, drug toxicity (cyclosporine), 

and late complications (obstruction, infection, infarction, and lymphocele/urinoma) 

f)  Benign neoplasm 

i)  Radiopharmaceuticals:  18F FDG 
ii)    Imaging techniques: PET and PET-CT 
iii)   Typical indications: angiomyolipoma and complex cystic mass 

g)   Malignant neoplasm, primary 

i)  Radiopharmaceuticals:  18FFDG 
ii)    Imaging techniques: PET and PET-CT 
iii)   Typical indications: lymphoma and renal cell cancer 

h)   Malignant neoplasm, metastatic 

i) 

i)  Radiopharmaceuticals:  99mTc HDP/MDP; 18FNaF, and 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: staging disease and treatment strategy 
Infection and  inflammation 
i)  Radiopharmaceuticals:  99mTc DMSA, 67Ga citrate, 111In/99mTc WBCs, and 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: pyelonephritis and abscess 

j)  Normal and other 

i)  Radiopharmaceuticals: all of above 
ii)    Imaging techniques: all of above 
iii)   Typical indications: all of above 

k)   Artifacts and quality control 

i)  Patient issues: preparation, motion, positioning, and contamination 
ii)    Radiopharmaceutical issues: preparation, administration technique, and altered 

biodistribution 

Page 55 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Nuclear Radiology 

 

iii)   Technical issues: instrumentation, acquisition and processing, and quantification 

(relative renal function, GFR, and SUV) 

10) VASCULAR 

a)   Patency 

i)  Radiopharmaceuticals:  99mTc pertechnetate, 99mTc RBCs 
ii)    Imaging techniques: planar 
iii)   Typical indications: preoperative evaluation, postoperative evaluation, and deep 

venous thrombosis 

b)   Malignant neoplasm, primary 

i)  Radiopharmaceuticals:  18F FDG 
ii)    Imaging techniques: PET and PET-CT 
iii)   Typical indications: sarcoma 
c)    Malignant neoplasm, metastatic 

i)  Radiopharmaceuticals:  99mTc sulfur colloid and 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: lymphatic mapping/sentinel lymph node (SLN) in melanoma, 

staging disease, and treatment strategy 

d)   Infection and inflammation 

i)  Radiopharmaceuticals:  67Ga citrate, 111In/99mTc WBCs, and 18F FDG 
ii)    Imaging techniques: planar, SPECT and/or SPECT-CT; PET and PET-CT 
iii)   Typical indications: vascular graft infection, catheter infection, vasculitis, and 

atherosclerosis 

e)   Normal and other 

i)  Radiopharmaceuticals: all of above 
ii)    Imaging techniques: all of above 
iii)   Typical indications: all of above 

f)  Artifacts and quality control 

i)  Patient Issues: preparation, motion, positioning, and contamination 
ii)    Radiopharmaceutical issues: preparation, administration technique, and altered 

biodistribution 

iii)   Technical Issues: instrumentation, acquisition and processing, and quantification 

(SUV) 

Page 56 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

Pediatric Radiology 

1)  General Pediatric Imaging: Basic Knowledge/Competency with: 
a)   National patient safety goals as they apply to pediatric imaging 
b)   Contrast reactions in children (features, prevention, and treatment) 
c)    General knowledge of practice-based imaging guidelines and appropriateness criteria 

(ACR Appropriateness Criteria and Practice Guidelines and Technical Standards) 

d)   ALARA principles (e.g., Image Gently Campaign) for modalities using ionizing radiation 
e)   Age-related development  and normal anatomy 
f)  Appropriate appearance of surgical devices and support apparatus 
g)   Communication of urgent/emergent findings 

i)  List of urgent/emergent findings in children 

h)   Unique considerations for modalities: 

i) 

Indications 
(1)  General for each 
(2)  Ultrasound 

(a)  Hips (effusion, congenital hip dysplasia) 
(b)  Spine 
(c)  Brain 
(d)  Chest/mediastinum 
(e)  Neck 
(f)   Imperforate anus (level of pouch) 
(g)  Intussusceptions 
(h)  Appendicitis 
(i)   Pyloric stenosis 
(j)   Diaphragm motion (infant) 
(k)  Interventional guidance 

(3)  CT urography 
(4)  MR urography, MR cholangiopancreatography  (MRCP) 

ii)    Limitations 
iii)   General techniques 

(1)  Radiography 

(a)  Collimation 
(b)  Settings 
(c)  Numbers of views 

(2)  Fluoroscopy/angiography 

(a)  Pulsed fluoroscopy 
(b)  Other fluoroscopy settings 
(c)  Shielding 
(d)  Dose reduction techniques 
(e)  Special contrast use/considerations 

(3)  CT: dose reduction techniques and contrast doses 
(4)  MRI: coil optimization; contrast types and dose 

Page 57 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

(5)  RNI: see nuclear medicine study guide 

iv)  Risks 

2)   Brain, Head and Neck, and Spine 

a)   Skull 

i)  Congenital 

(1)  Synostoses 
(2)  Congenital dermal sinus 
(3)  Dermoid/epidermoid 

ii)    Inflammatory 

(1)  Osteomyelitis 

iii)   Trauma 

(1)  Caput succedaneum 
(2)  Subgaleal hemorrhage 
(3)  Cephalohematoma 
(4)  Fractures (especially non-accidental injury/abuse) 

iv)  Basic temporal bone anatomy 

(1)  Congenital 

(a)  Mondini malformation 
(b)  Michele malformation 

v)    Inflammatory disorders 

(1)  Cholesteatoma 
(2)  Mastoiditis 

vi)  Variants 

(1)  Lückenschädel 
 (2) Wormian bones   
 (3) Parietal foramina 

b)   Vertebral column 

i)  Congenital 

(1)    Absence or hypoplasia of odontoid 
(2)    Os odontoideum 
(3)    Segmentation anomalies 
(4)    Klippel-Feil anatomy 
(5)    Sprengel deformity 
(6)    Butterfly vertebra 
(7)    Spinal dysraphism 
(8)    Diastematomyelia 
(9)    Sacral agenesis (including caudal regression syndrome) 
(10) Partial absence (including Currarino triad/ASP) 

ii)    Inflammatory 

(1)  Discitis 
(2)  Infectious spondylitis  (tuberculosis) 

iii)   Neoplasms 

(1)  Ewing sarcoma 

Page 58 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

(2)  Aneurysmal bone cyst 
(3)  Osteoblastoma 
(4)  Osteoid osteoma 
(5)  Langerhans cell histiocytosis 
(6)  Metastases (including leukemia and lymphoma) 

iv)  Trauma 

(1)  Fractures/dislocations 
(2)  Atlanto-dens and atlanto-occipital injuries 
(3)  Spondylolysis/spondylolisthesis 
(4)  Insufficiency fracture (and etiologies) 

v)   Miscellaneous 
vi)  Dysplasia/syndromes 

(1)  Mucopolysaccharidoses 
(2)  Spondylometaphyseal dysplasia 

vii) Scheuermann disease 
viii) Scoliosis (repair and hardware complications) 

c)    Brain 

i)  Congenital 

(1)    Migrational disorders 
(2)    Lissencephaly 
(3)    Pachygyria 
(4)    Schizencephaly 
(5)    Heterotopic gray matter 
(6)    Polymicrogyria 
(7)    Holoprosencephaly 
(8)    Anomalies of corpus callosum 
(9)    Hydranencephaly 
(10) Dandy-Walker malformations 
(11) Chiari malformation types I and II 
(12) Cephalocele 
(13)  Neurocutaneous  syndromes 
(14)  Vein  of  Galen  malformation 
(15) Causes of hydrocephalus 
(a)  Aqueductal stenosis 
(b)  Syndromic 
(c)  Masses 

ii)    Inflammatory 

(1)    Bacterial infections 

(a)  Meningitis 
(b)  Cerebritis 
(c)  Abscess 

(2)    Tuberculosis infections 
(3)  Viral infections (encephalitis) 

(a)  TORCH infections 

Page 59 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

iii)   Neoplasms 
iv)  Posterior fossa 

(1)  Medulloblastoma 
(2)  Ependymoma 
(3)  Brainstem glioma 
(4)  Astrocytoma 

v)   Supratentorial 

(1)  Pineal region tumors 
(2)  Craniopharyngioma 
(3)  Astrocytoma 
(4)  Oligodendroglioma 
(5)  Primitive neuroectodermal tumor (PNET) 
(6)  Choroid plexus tumors 

vi)  Cerebral infarction/ischemia 

(1)  Childhood  infarcts 
(2)  Arteritis 
(3)  Sickle cell (including moyamoya) 
(4)  Carotid occlusion 
(5)  Venous sinus thrombosis 
(6)  Intracranial hemorrhage 
(7)  Neonatal hypoxic ischemic injury 

(a)   Vascular borderzone infarctions 
(b)   Multicystic encephalomalacia 

vii) Trauma (including nonaccidental injuries) 

(1)  Cerebral injury (including shearing injuries and concussion) 
(2)  Subdural hematoma 
(3)  Epidural hematoma 
(4)  Subarachnoid hemorrhage 

viii) Syndromic/systemic 

(1)   Neurocutaneous syndromes 
(2)  Chiari malformation types I and II 

ix)  Vascular 

(1)  Arteriovenous malformations, congenital “aneurysms” (vein of Galen) 

x)    Metabolic brain disorders 

(1)  Leukodystrophies 

d)   Spinal cord 

i)  Congenital 

(1)  Myelomeningocele/meningocele 
(2)  Lipomyelomeningocele 
(3)  Diastematomyelia 
(4)  Tethered cord 
(5)  Dermal sinus 
(6)  Intradural lipoma 
(7)  Hydrosyringomyelia 

Page 60 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

(8)  Neurenteric cysts 

ii)    Tumors 

(1)  Neurofibroma 
(2)  Astrocytoma 
(3)  Ependymoma 
(4)  Metastases 
(5)  Neuroblastoma, ganglioneuroblastoma,  ganglioglioma 

iii)   Sacrococcygeal masses 

(1)  Germ cell tumors (i.e., teratoma) 
(2)  Neuroblastoma 
(3)  Lymphoma 
(4)  Rhabdomyosarcoma 

iv)  Other 

(1)  Infections 
(2)  Demyelinating disorders 
(3)  Trauma 
(4)  Vascular malformations 

e)   Neck 

i)  Congenital 

(1)  Fibromatosis colli 
(2)  Lymphatic malformations 
(3)  Branchial cleft cysts 
(4)  Thyroglossal duct cysts 

ii)    Neoplasms 

(1)  Lymphoma 
(2)  Neuroblastoma 
(3)  Rhabdomyosarcoma 
(4)  Nasopharyngeal carcinoma 
(5)  Hemangiomas 

iii)   Infectious/inflammatory 

(1)  Adenitis 
(2)  Retropharyngeal abscess 

iv)  Thyroid disorders 

(1)  Absence/hypoplasia/ectopic 
(2)  Thyroiditis 
(3)  Thyroid masses 
(4)  Goiter 

f)  Head/face 

i)  Congenital 

(1)  Vascular malformations 
(2)  Persistent hyperplastic primary vitreous (PHPV) 
(3)  Coloboma 
ii)    Inflammatory 

(1)  Orbital masses 

Page 61 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

(2)  Ocular masses 
(3)  Orbital cellulitis 
(4)  Sinusitis 

iii)   Neoplastic/mass like 
(1)  Retinoblastoma 
(2)  Nasopharyngeal masses 
(3)  Carcinoma 
(4)  Juvenile angiofibroma 
(5)  Sinus masses 

iv)  Trauma 

(1)  Facial fracture (Le Fort classification) 

3)   Chest and Airway 
a)   Upper airway 
i)  Congenital 

(1)  Tracheomalacia/bronchomalacia/laryngomalacia 
(2)  Laryngeal stenosis, web, cleft 
(3)  Choanal atresia 
(4)  Masses: hemangioma 

ii)    Inflammatory 

(1)  Tonsillar enlargement/adenoidal hypertrophy 
(2)  Croup 
(3)  Epiglottitis 
(4)  Tracheitis 
(5)  Retropharyngeal abscess 

iii)   Neoplasm 

(1)  Juvenile angiofibroma 
(2)  Subglottic hemangioma 
(3)  Laryngeal papilloma 

iv)  Trauma 

(1)  Foreign body 
(2)  Acquired subglottic stenosis 

b)   Chest 

i)  Congenital 

(1)    Agenesis/hypoplasia 
(2)  Venolobar syndrome 
(3)  Bronchial atresia 
(4)  Bronchopulmonary foregut malformations 

(a)  Sequestration 
(b)  Bronchogenic cyst 
(c)  Congenital pulmonary airway malformation  (CPAM)/cystic adenomatoid 

malformation (CCAM) 

(d)  Congenital lobar emphysema 
(e)  Hybrid lesions 

Page 62 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

(5)  Tracheal bronchus 
(6)  Tracheoesophageal fistula 
(7)  Lymphangiectasia 

ii)    Inflammatory 
(1)  Infections 

(a)  Bacterial pneumonia 

 Pertussis 

Streptococcus 

(i) 
(ii)  Staphylococcus 
(iii) 
(iv)    Chlamydia 
(v)  Mycoplasma 
(vi)    H. influenza 
(vii)   Round pneumonia 
(viii)  Abscess 
(ix)    Complications 

1.  Necrosis 
2.  Abscess 
3.  Fistulae 
4.  Empyema 
5.  Pneumatocele 

(b)  Viral pneumonia 

(i)   Respiratory syncytial virus (RSV) 
(ii)  Varicella 
(iii) Measles 
(c)  Tuberculosis 
(d)  Fungal infections 
(e)  Other opportunistic infections 
(f)   Plasma cell granuloma/inflammatory pseudotumor and myofibroblastic 

inflammatory tumor 

(2)  Small airways disease 

(a)  Reactive airways disease 
(b)  Viral pneumonia (3) 
Bronchiectasis: causes (a) 

Cystic fibrosis 

(b)  Immotile cilia syndrome 
(c)  Chronic infection (primary immune disorders) 
(d)  Foreign body 
(e)  Aspiration 

iii)   Neoplasms/mass-like lesions 

(1)  Mediastinal masses 

(a)  Anterior 

(i)   Lymphoma/leukemia 
(ii)  Germ cell tumors 
(iii) Thymoma/carcinoma 

Page 63 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

(iv) Other masses: thymic cysts and bronchogenic cysts 
(v)  Normal prominent thymus and thymic rebound 

(b)  Middle 

(i)   Adenopathy (lymphoma/mets) 
(ii)  Congenital masses: bronchogenic cysts, esophageal duplication cyst and 

neurenteric cyst 

(iii) Neurogenic tumors 

(c)  Posterior 

(i)   Neurogenic tumors 
(ii)  Other masses: bronchogenic cyst, infection, hematoma and adenopathy 

(2)  Primary lung tumors 

(a)  Adenoma/carcinoid tumor 
(b)  Hamartoma 
(c)  Hemangioma 
(d)  Mesenchymal sarcoma (and its association with developmental cystic lesions 

of the lung) 

(e)  Metastatic lung lesions 

(3)  Chest wall neoplasms/masses 

(a)  Ewing sarcoma family (including Askin tumor) 
(b)  Benign rib and spine neoplasms 
(c)  Vascular malformations 
(d)  Infections 

iv)  Trauma 

(1)  Contusion 
(2)  Air leak 

(a)  Pneumothorax 
(b)  Pneumomediastinum 
(c)  Bronchopleural fistula 

(3)  Fracture of tracheobronchial tree 
(4)  Airway foreign body 
(5)  Post-traumatic bronchial stenosis 
(6)  Post-traumatic diaphragmatic hernia 

v)   Vascular 

(1)  Pulmonary thromboembolic disease 
(2)  Other venous thrombosis or occlusion, anomalous vessels 
(3)  Arteriovenous malformations 
vi)  Unique chest problems in neonate 

(1)  Hyaline membrane disease 
(2)  Transient tachypnea of newborn 
(3)  Neonatal pneumonia 
(4)  Congenital diaphragmatic hernia 
(5)  Chronic lung disease of infancy (bronchopulmonary dysplasia) 
(6)  Meconium aspiration syndrome 
(7)  Persistent fetal circulation 

Page 64 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

(8)  Extracorporeal membrane oxygenation (ECMO) therapy and its complications 
(9)  Air leak in the neonate 

(a)  Including pulmonary interstitial emphysema 

vii) Miscellaneous: includes chest manifestations of systemic disorders 

(1)  Idiopathic pulmonary hemosiderosis 
(2)  Alveolar proteinosis 
(3)  Collagen vascular diseases 
(4)  Spontaneous pneumothorax and pneumomediastinum 
(5)  Cardiogenic and noncardiogenic pulmonary edema 
(6)  Histiocytosis 
(7)  Vasculitis (Wegener disease) 

4)   Cardiovascular: Cardiac 

a)   Congenital heart disease 

i)  Segmental approach to imaging of congenital heart disease 

(1)  Normal segmental anatomy 
(2)  Anomalies of visceroatrial situs 

(a)  Asplenia 
(b)  Polysplenia 
(c)  Situs inversus 

ii)    Left-to-right shunts 

(1)  Ventricular  septal  defect 
(2)  Patent  ductus  arteriosus 
(3)  Atrial septal defect 
(4)  Endocardial cushion defect 
(5)  Aortopulmonary window 
(6)  Partial anomalous pulmonary venous return 

iii)   Intermixing (admixture) states with increased pulmonary blood flow 

(1)  Total anomalous pulmonary venous connection (TAPVC) without obstruction 
(2)  D-transposition of the great arteries 
(3)  Truncus arteriosus 
(4)  Single ventricle 

iv)  Intermixing (admixture) states with decreased pulmonary blood flow 

(1)  Tetralogy of Fallot 
(2)  Pulmonary atresia with ventricular septal defect (VSDV 
(3)  Single ventricle with right ventricular outflow tract (RVOT) obstruction 

v)   Left-sided obstruction 

(1)  Coarctation 
(2)  Hypoplastic left heart syndrome 
(3)  Cor triatriatum 
(4)  Obstructed TAPVC 

vi)  Other congenital heart disease 

(1)  Pulmonary valve stenosis 
(2)  L-transposition of great arteries 

Page 65 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

(3)  Pulmonary atresia with intact ventricular septum 
(4)  Ebstein anomaly 
(5)  Congenital absence of the pericardium 

vii) Vascular rings and slings 

(1)  Right aortic arch with aberrant left subclavian artery 
(2)  Double aortic arch and variants 
(3)  Circumflex aortic arch 
(4)  Pulmonary sling 

viii) Anomalous coronary artery origins 

(1)   Anomalous  right  coronary artery from  the  left  sinus  of  Valsalva 
(2)   Anomalous  left  coronary artery from  the  right  sinus  of  Valsalva 
(3)  Anomalous left coronary artery from the pulmonary artery 

ix)  Systemic venous variants 

(1)  Left superior vena cava (SVC) 
(2)  Interrupted inferior vena cava (IVC) with azygos continuation 

x)    Late or adult presentations of coronary heart disease (CHD) 

(1)  Bicuspid aortic valve, aortic valve stenosis and aortic root dilatation 

b)   Cardiac masses 

i)  Rhabdomyoma, fibroma 
ii)    Thrombus 

c)    Trauma 

i)  Hemopericardium 
ii)    Hemopericardium 

d)   Syndromes with congenital heart disease or vascular disease 

i)  Marfan syndrome 
ii)    Loeys-Dietz syndrome 
iii)   Ehlers-Danlos syndrome 
iv)  Williams syndrome 
v)   Alagille syndrome 
vi)  Neurofibromatosis type 1 
vii) Down syndrome 
viii) Holt Oram syndrome 
ix)  Turner syndrome 
x)    PHACE syndrome 

e)   Acquired cardiac disease 

i) 

Infectious/inflammatory 
(1)  Pericarditis 
(2)  Myocarditis 
(3)  Kawasaki disease 

ii)    Cardiomyopathies 

(1)  Hypertrophic 
(2)  Dilated 
(3)  Restrictive 
(4)  Arrhythmogenic right ventricular dysplasia (ARVD) 

Page 66 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

f)    Cardiac operations 

i)  Postoperative cross-sectional imaging assessment of the following procedures: 

(1)  Atrial switch for transposition of great arteries (Senning and Mustard 

procedures) 

(2)  Arterial switch for transposition of great arteries (Jatene arterial switch and 

Lecompte maneuver) 

(3)  Single ventricle repair: Norwood 1 and Dames-Kaye Stansel anastomosis 
(4)  Superior cavopulmonary connection, including the bidirectional Glenn procedure 
(5)  Total cavopulmonary connection: Fontan procedure 
(6)  Pulmonary blood flow augmentation as initial palliation for coronary heart 

disease (CHD), including Blalock-Taussig, Waterston, and Pott shunts 

5)   Cardiovascular: Vascular 

a)   Congenital 

i)  Vascular malformations 

b)   Variants: Caval anomalies (e.g., left superior vena cava, absent hepatic inferior vena 

cava) 

c)    Trauma 

i)  Acute traumatic aortic injury 
ii)    Arterial contrast extravasation 
iii)   Pseudoaneurysm 
iv)  Arteriovenous fistulae 
v)   Hypoperfusion complex 

d)   Inflammatory/infectious 

i)  Aortitis 
ii)    Vasculitides 

(1)  Takayasu disease and Kawasaki disease 

e)   Syndromic/systemic vascular diseases 

i)  Syndromes 

(1)  Ehlers-Danlos 
(2)  Marfan 
(3)  Neurofibromatosis and other causes of mid-aortic syndrome 
(4)  Williams 

f) 

Idiopathic 
i)  Fibromuscular dysplasia 
ii)    Mid-aortic syndrome 

g)   Thrombotic 

i)  Deep venous thrombosis 
ii)    Catheter-related thrombosis and evaluation 

6)   Gastrointestinal (GI) tract 

a)   Biliary system 
i)  Congenital 

Page 67 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

ii)    Biliary atresia 
iii)   Neonatal hepatitis 
iv)  Choledochal cyst (classification) 
v)   Acquired miscellaneous 

(1)  Cholelithiasis 
(2)  Hydrops of gallbladder 
(3)  Cholangitis 

vi)  Cholecystitis 

b)   Liver 

i) 

Infection 
(1)  Abscess 
(2)  Hepatitis 

ii)    Tumors and tumor-like conditions 

(1)  Benign 

(a)  Mesenchymal hamartoma 
(b)  Hemangioendothelioma 

(2)  Malignant 

(a)  Hepatoblastoma 
(b)  Hepatoma 
(c)  Metastases 

iii)   Trauma 

(1)  Lacerations 
(2)  Subcapsular hematoma 
(3)  Contusion 

iv)  Vascular 

(1)  Portal vein thrombosis 

(a)  Cavernous transformation 

(2)  Portal hypertension 
(3)  Budd-Chiari syndrome 
v)   Transplant complications 
vi)  Other: systemic conditions involving liver 

(1)  Glycogen storage disease 
(2)  Beckwith-Wiedemann syndrome 

c)    Spleen 

i)  Congenital 

(1)  Abnormal visceroatrial situs 
(2)  Wandering spleen 

ii)    Neoplasms 

(1)  Infection 

(a)  Fungal abscesses 

(2)  Benign 

(a)  Lymphangioma 

(3)  Malignant 

(a)  Lymphoma/leukemia 

Page 68 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

(4)  Trauma 

(a)  Laceration 
(b)  Contusion 
(c)   Subcapsular hematoma 

(5)  Splenic infarction 

(a)  Sickle cell disease 

(6)  Etiologies for splenomegaly 

d)   Pancreas 

i)  Congenital 

(1)  Pancreas divisum 
(2)  Cystic fibrosis 

ii)    Pancreatitis (and pseudocyst) 

(1)  Trauma 

(a)  Non-accidental trauma 

(2)  Choledochal cyst 
(3)  Familial pancreatitis 
(4)  Iatrogenic 

iii)   Fatty replacement 
(1)  Cystic fibrosis 

e)   Aerodigestive track 

i)    Pharynx and esophagus 

(1)  Congenital and developmental anomalies 

(a)  Esophageal atresia and tracheoesophageal fistula (classification) 

(2)  Inflammatory lesions 

(a)  Retropharyngeal abscess/cellulitis 
(b)  Infectious esophagitis 

(3)  Trauma 

(a)  Foreign bodies 
(b)  Iatrogenic perforation 

(4)  Esophageal stricture (etiologies) 
(5)  Gastroesophageal reflux 

ii)    Stomach 

(1)  Congenital 

(a)      Duplications 
(b)     Antral    webs 
(c)  Volvulus 

(2)  Gastric outlet obstruction 

(a)  Acquired 

(i)   Hypertrophic pyloric stenosis 
(ii)  Inflammatory 
(iii) Corrosive ingestion 
(iv) Chronic granulomatous disease 

(3)  Inflammatory 

(a)  Eosinophilic enteritis 

Page 69 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

(b)  Peptic diseases 
(c)  Chronic granulomatous disease 

(4)  Miscellaneous 

(a)  Bezoars 
(b)  Foreign bodies 
(c)  Spontaneous rupture of stomach 

iii)   Small Bowel 

(1)  Congenital 

(a)  Duodenal webs, stenosis, and other obstructions 
(b)  Malrotation with/without midgut volvulus 
(c)  Duodenal, jejunal, and ileal stenosis and/or atresia 
(d)  Post-inflammatory/infectious or iatrogenic strictures 
(e)  Meconium ileus 
(f)   Meconium peritonitis 
(g)  Mesenteric and omental cysts 
(h)  Duplication cysts 
(i)   Meckel diverticula (including other omphalomesenteric anomalies) 
(j)   Abdominal wall defects 

(i)   Omphalocele and gastroschisis 
(ii)  Hernias 

(2)  Neoplasms 
(a)  Benign 

(i)   Polyps and leiomyomas 

(b)  Malignant 

(i)   Lymphoma 

(3)  Malabsorption 

(a)  Cystic fibrosis 

(4)  Trauma 

(a)  Blunt abdominal trauma 
(b)  Transplant 
(5)  Miscellaneous 

(a)  Necrotizing enterocolitis 
(b)  Ischemic bowel 
(c)  Intussusception 
(d)  Henoch-Schölein purpura 
(e)  Graft vs host disease 

(6)  Cause of small bowel obstruction 

iv)  Colon 

(1)  Congenital 

(a)  Imperforate anus /anorectal malformation 
(b)  Duplications 
(c)  Colonic atresia 
(d)  Hirschsprung disease 
(e)  Meconium plug/neonatal small left colon syndrome 

Page 70 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

(2)  Infectious/inflammatory 

(a)  Appendicitis 
(b)  Infectious colitis/typhlitis 

(3)  Neoplasms 

(a)  Benign: polyps, leiomyoma 
(b)  Malignant 

(i)    Lymphoma 

(4)  Trauma 

v)   Other 

(1)  Mesenteric adenitis 

7)   Genitourinary system 

a)   Growth and development/normal variants: kidney (echogenic pyramids, lobulation) 
b)   Kidneys 

i)  Congenital anomalies 

(1)  Ureteropelvic junction (UPJ) 
(2)  Duplication 
(3)  Multicystic dysplasia 
(4)  Agenesis 
(5)  Hypoplastic kidney 
(6)  Horseshoe kidney 
(7)  Ectopia 

(a)  Ptosis 
(b)  Pelvic 
(c)  Crossed ectopia 

(8)  Relationship of congenital renal anomalies with other congenital anomalies 

(VATER association, spinal dysraphism, etc.) 

ii)    Cystic renal disease 

(1)  Autosomal recessive 
(2)  Autosomal dominant 
(3)  Cysts associated with syndromes 
(4)  Associated liver disease (fibrosis) 

iii)   Inflammatory 

(1)  Acute pyelonephritis 
(2)  Abscess 
(3)  Reflux nephropathy 

iv)  Neoplasms 

(1)  Wilms tumor and variants 
(2)  Nephrogenic rests 
(3)  Mesoblastic nephroma 
(4)  Multilocular cystic nephroma 
(5)  Leukemia/lymphoma 

v)   Trauma 

(1)  Subcapsular hematoma 

Page 71 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

(2)  Laceration (including those communicating with collecting system) 
(3)  Contusion 
(4)  Avulsion of vascular pedicle 
(5)  UPJ avulsion or laceration 

vi)  Vascular 

(1)  Arterial stenosis 
(2)  Renal vein thrombosis 
(3)  Tumor thrombus 

vii) Involvement by systemic disorders 

(1)  Tuberous sclerosis 
(2)  Von Hippel-Lindau disease 

viii) Miscellaneous 

(1)  Urolithiasis/nephrocalcinosis 
(2)  Renal transplantation 

c)    Adrenal gland 
i)  Neoplasms 

(1)  Neuroblastoma 
(2)  Adrenocortical carcinoma 

ii)    Congenital adrenal hyperplasia 
iii)   Trauma 

(1)  hemorrhage (neonatal) and adrenal calcification 

d)   Bladder, ureters, and urethra 

i)  Congenital 

(1)    Posterior urethral valves 
(2)    Ureterovesical junction obstruction 
(3)    Primary megaureter 
(4)    Bladder diverticula 
(5)    Ureteral duplication 
(6)    Ureterocele 
(7)    Urachal abnormalities 
(8)    Hypospadias 
(9)    Epispadias/exstrophy 
(10) Prune belly syndrome 
(11) Urologic sequela of anorectal anomalies 

ii)    Infectious/inflammatory 
(1)  Urinary tract infection 
(2)  Viral cystitis 
(3)  Hemorrhagic cystitis 

iii)   Trauma 

(1)  Extravasation 

iv)  Neoplasms 

(1)  Rhabdomyosarcoma 

v)   Miscellaneous 

(1)  Vesicoureteral reflux 

Page 72 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

(2)  Neurogenic bladder 
(3)  Dysfunctional voiding 

e)   Male genital tract: scrotal 

i)  Testicular torsion 
ii)    Infectious/inflammatory 
(1)  Epididymitis/orchitis 

iii)   Differential for scrotal fluid collections 
iv)  Hernia 
v)   Undescended testis 
vi)  Microlithiasis 
vii) Neoplasms 

(1)  Germ cell tumors 
(2)  Stroma cell tumors 
(3)  Metastases 
(4)  Leukemia 

f)  Female genital tract 

i)  Congenital 

(1)  Cloacal anomalies 

ii)    Ovaries 

(1)  Torsion 
(2)  Ovarian cysts (including neonatal physiologic) 
(3)  Germ cell tumors 
(4)  Cystic neoplasms 
(5)  Polycystic ovarian disease 

iii)   Uterus and vagina 

(1)  Congenital anomalies: vaginal occlusion (hydrometrocolpos, etc.) 
(2)  Fusion anomalies of the müllerian duct (uterus didelphys, etc.) 
(3)  Masses 

(a)  Rhabdomyosarcoma 
(b)  Clear cell adenocarcinoma 

iv)  Intersex states 

(1)  Differential diagnosis 
(2)  Work-up 

v)   Other 

(1)  Prune belly syndrome 

8)   Musculoskeletal imaging 

a)   Normal growth and development/variants 
b)   Congenital 

i)  Osteochondrodysplasias  affecting growth of tubular bones and spine (identifiable at 

birth) 
(1)  Thanatophoric dysplasia 
(2)  Chondrodysplasia punctata 
(3)  Achondroplasia 

Page 73 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

(4)  Asphyxiating thoracic dystrophy 

ii)    Osteochondrodysplasias  affecting growth of tubular bones and spine (identifiable in 

later life) 
(1)  Metaphyseal chondrodysplasia 
(2)  Multiple epiphyseal dysplasia 

iii)   Osteochondrodysplasias  with disorganized development of cartilage and fibrous 

components of the skeleton 
(1)  Multiple cartilaginous exostoses 
(2)  Enchondromatosis 
(3)  Polyostotic fibrous dysplasia 
(4)  Neurofibromatosis 

 

iv)  Abnormalities of density of cortical diaphyseal structure and metaphyseal modeling 

(1)  Osteogenesis imperfecta 
(2)  Osteopetrosis 
(3)  Pycnodysostosis 
(4)  Diaphyseal dysplasia 
(5)  Metaphyseal dysplasia 

v)   Limb reduction anomalies (including proximal focal femoral deficiency and radial ray 

anomalies) 

vi)  Amniotic band syndrome 
vii) Congenital bowing deformities and pseudoarthroses 
viii) Congenital foot deformities 

(1)  Tarsal coalition 
(2)  Pes planus 
(3)  Talipes equinovarus 
(4)  Pes cavus 
(5)  Metatarsus adductus 

ix)  Skeletal abnormalities associated with syndromes 

(1)  Trisomy 21 syndrome, Marfan syndrome and neurofibromatosis 

x)    Skeletal abnormalities associated with metabolic disorders 

(1)  Mucopolysaccharidoses and mucolipidoses 

xi)  Developmental dysplasia of hip 
xii) Skeletal abnormalities associated with neuromuscular diseases 

(1)  Meningomyelocele 
(2)  Cerebral palsy 
(3)  Muscular dystrophy 

c)    Infectious inflammatory 

i)  Pyogenic osteomyelitis 
ii)    Septic arthritis 
iii)   Toxic synovitis of the hip 
iv)  Tuberculosis 
v)   Caffey disease 
vi)  Multifocal osteomyelitis 
vii) Dermatomyositis/polymyositis  and other inflammatory myopathies 

Page 74 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

viii) Arthropathies 

(1)  Juvenile rheumatoid arthritis (juvenile idiopathic arthritis) 

d)   Hemophilic arthropathy 
e)   Neoplasm 
i)  Benign 

(1)  Osteochondroma 
(2)  Unicameral bone cyst 
(3)  Aneurysmal bone cyst 
(4)  Nonossifying fibroma/fibrous cortical defect 
(5)  Fibrous dysplasia 
(6)  Langerhans cell histiocytosis 
(7)  Osteoid osteoma 
(8)  Osteoblastoma 
(9)  Chondroblastoma 
(10)  Chondromyxoid fibroma 

ii)    Malignant 

(1)  Ewing sarcoma 
(2)  Osteogenic sarcoma 
(3)  Metastases (including leukemia/lymphoma) 

iii)   Vascular 

(1)  Vascular malformations 

iv)  Trauma 

(1)  Fractures 

(a)  Accidental trauma (including Salter-Harris, greenstick-bowing, and buckle 

fractures) 

(b)  Nonaccidental trauma (battered child syndrome) 

v)   Growth arrest/bone bar and non union 
vi)  Toddler’s fracture 
vii) Slipped capital femoral epiphysis 

f)  Endocrine/Metabolic 

i)  Rickets 
ii)    Renal osteodystrophy 
iii)   Hyperparathyroidism 
iv)  Hypoparathyroidism 
v)   Hypophosphatasia 
vi)  Scurvy 
vii) Bone age determination 

g)   Osteochondroses 

i)  Legg-Perthes disease 
ii)    Kohler disease 
iii)   Freiberg disease 
iv)  Osteochondritis dissecans 
v)   Blount disease and physiologic bowing 

Page 75 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Pediatric Radiology 

9)   Select general/multiorgan system syndromes with salient imaging findings 

a)   Neurocutaneous syndrome 
b)   Sturge-Weber syndrome 
c)    Trisomy 21 syndrome 
d)   CHARGE syndrome 
e)   Marfan syndrome 
f)  Beckwith-Wiedemann syndrome 
g)   Turner syndrome 
h)   Ehlers-Danlos syndrome 
i)  DiGeorge syndrome 
j)  Klippel-Trenaunay-Weber syndrome 

10) Multisystemic disorders/processes 

a)   Systemic lupus erythematosus  and other systemic vasculitides 
b)   Juvenile idiopathic arthritis 
c)    Wegener disease 
d)   Primary immune deficiencies (severe combined immunodeficiency (SCIDS), chronic 

granulomatous disease, and DiGeorge syndrome ) 

e)   Sickle cell anemia 
f)  Child abuse 
g)   Immunocompromised host (transplant immune suppression, antibiotics, steroids, and 

chemotherapy) 
i) 

Includes post-transplant lymphoproliferative syndrome 

h)   VATER/VACTERYL 
i)  Retained surgical material 
j)  Ventriculoperitoneal (VP) shunt complications 

11) Interventional 

a)   Abscess drainage/aspiration 
b)   Solid organ soft tissue mass biopsy 

i)  Thyroid, liver, kidney, bone, lymph node and nodule 

c)    Thoracentesis/thoracostomy  tube placement 
d)   Paracentesis 
e)    Hip aspirations 
f)  Arthrography (diagnostic and therapeutic) 

Page 76 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e  C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

Physics 

1) Atomic Structure:  Composition of the Atom 
a)   Electrons 

i)    Electron orbits 
ii)    Naming of orbits 
iii)   Binding energy 
iv)  Transitions  of  electrons 
v)   Characteristic radiation 
vi)  Auger electrons 

b)   Nucleus 

i)     Composition 
 ii)    Nuclear  force 
iii)   Mass defect 
iv)  Binding energy 
v)   Instability of the nucleus 

2)   Electromagnetic Radiation 

a)   Wave-particle duality 

i)    Characteristics of waves 
ii)    Characteristics of particles 

b)   Electromagnetic spectrum 

i)  Non-ionizing 
ii)    Ionizing 

3)   Particulate Radiation 

a)   Light particles 
b)   Heavy charged particles 
c)    Uncharged particles 

i)  Neutrons 
ii)    Neutrinos 

4)   Ionizing Radiation Interactions with Matter 

a)   Charged particles 

Ionization and excitation 

i) 
ii)    Bremsstrahlung 
iii)   Secondary ionization 

(1)  Specific ionization 
(2)  Linear energy transfer (LET) 

iv)  Positron annihilation 

b)   Photons 

i)  Coherent scattering 
ii)    Compton scattering 

 

 
 

 

 

 

 

 

Page 77 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e  C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

iii)   Photoelectric effect 
iv)  Tissue interactions 
v)   Contrast media 

c)    Attenuation of photons 

i)  Linear attenuation coefficient 
ii)    Attenuation equation 
iii)   Mono- and polyenergetic x-ray beams 
iv)  Half-value layer (HVL) 

(1)  Effective energy 
(2)  Beam hardening 

5)   Radiation Units 
a)   Unit systems 

i)  SI 
ii)    Classical 

b)   Exposure 

i)  Coulomb/kilogram 
ii)    Roentgen (R) 

c)    Kerma- kinetic energy released in matter 

i)  Gray (Gy) 
ii)    Rad 

d)   Absorbed dose 

i)  Gray (Gy) 
ii)    Rad 

e)   Equivalent dose 

i)  Radiation weighting factors 
ii)    Sievert (Sv) 
iii)   Rem 

f)    Effective dose 

i)  Tissue weighting factors 
ii)    Sievert (Sv) 
iii)   Rem 
iv)  Reference levels 
v)   Use in radiation protection 

g)   Peak skin dose 

6)   X-ray Production 

a)   Properties of x-rays 
i)  Bremsstrahlung 

(1)  Importance in imaging 
(2)  Influence of electron energy 
(3)  Influence of target material 
(4)  Influence of filtration 

ii)    Characteristic radiation 

 

 
 

 

 

 

Page 78 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e  C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

(1)  Importance in imaging 
(2)   Influence  of electron  energy 
(3)   Influence of target  material 
(4)  Influence of filtration 

b)   X-ray tube 

i)  Cathode 

(1)  Filament 
(2)  Focusing cup 
(3)  Filament current and tube current 

ii)    Anode 

(1)  Composition 
(2)  Focal spot 
(3)  Line-focus principle 
(4)  Heel effect 

iii)   Application-specific tubes 

(1)  Mammography 
(2)  CT 
(3)  Interventional 

c)    Generators 

i)  Frequency 
ii)    Technique factors 

(1)  kVp 
(2)  mA 
(3)  Time 
(4)  Automatic exposure control (AEC) 

d)   X-ray beam 
e)   Beam filtration 

(1)  Inherent 
(2)  Added (Al, Cu, Mo, Rh, other) 
(3)  Minimum HVL 
(4)  Shaped filters 

ii)    Spectrum 
iii)   Collimators 

 

 

(1)  Field size limitation 
   (2) Light/x-ray alignment 
(3) Effect on image quality 

7)   Imaging Science 

a)   Statistics 

i)  Precision and accuracy 
ii)    Systematic and random errors 
iii)   Metrics 
iv)  Confidence intervals 
v)   Error propagation 

 

 
 

 

 

 

Page 79 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

b)   Properties of images 

i)     Imaging information domains 

(1)  Spatial 
(2)  Frequency 
(3)  Temporal 

ii)    Image characteristics 

(1)  Contrast 
(2)  Spatial resolution and modulation transfer function (MTF) 
(3)  Quantum noise and other noise sources 
(4)  Dynamic range 
(5)  Contrast-to-noise ratio (CNR), signal-to-noise ratio (SNR), and detective quantum 

efficiency (DQE) 

(6)  Temporal resolution 

iii)   Analog and digital image representation 

(1)  Conversion process (analog-to-digital converter [ADC] and digital-to-analog 

converter [DAC]) 

(2)  Sampling, quantization, and the Nyquist limit 

iv)  Image processing 

(1)  Preprocessing for uniformity and defect corrections 
(2)  Segmentation and region of interest selection 
(3)  Grayscale manipulation and lookup tables 
(4)  Filtering 
(5)  Reconstruction approaches 
(6)  3D presentation methods 
(7)  Image fusion and image registration 
(8)  Computer-aided detection and diagnosis (CAD) 

c)    Display of images 

i)     Display  systems: hard  copy and  soft  copy 
ii)   Display  characteristics and  quality  control 
iii)   Viewing conditions for image review 

d)   Human perception of medical images 

i)    Human vision characteristics 
ii)    Measures of observer performance and receiver operating characteristic (ROC) 

analysis 

e)   Informatics and management of imaging departments 

i)  Computer technology basics 
ii)    Picture archiving and communications systems (PACS) 
iii)   Radiology information systems (RIS) 
iv)  Hospital information systems (HIS) 
v)   DICOM and other protocols for radiology data management 
vi)  Security and privacy issues and approaches 

8)   Biological Effects of Ionizing Radiation: Radiation Biology 

a)   Principles 

Page 80 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e  C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

 

 
 

i)  Linear energy transfer  (LET) 
ii)    Relative biologic effectiveness (RBE) 
iii)   Rad ia tio n and  tissue  w eighting factors 

b)   Molecular effects of radiation 
      i)     Radiolysis of water and 

radical formation 

ii)    Direct and indirect effects 
iii)   Radiation damage of DNA 
c)    Cellular response of radiation 

i)  Time scale of radiation effects 
ii)    Cell kinetics, mitotic death and apoptosis 
iii)   Chromosomal aberrations 
 iv)  Cell cycle stage and radiation sensitivity 
v)   Sublethal damage 
vi)  Cell survival curves (function, key basic concept 
vii) Dose rate effect 
viii) The oxygen effect 
        (1) Oxygen Enhancement Ratio (OER) 

  

 

 d)   Tissue Reactions (Deterministic, non-stochastic) effects 

i)  Radiation-induced skin damage; erythema, epilation, desquamation and necrosis 
ii)  Radiation cataractogenesis 

e)   Radiation-induced injury to the gonads 

i)  Spermatogenesis 
ii)    Oogenesis 
iii)  Radiation doses to  
      produce sterility 

f)  Probabilistic (stochastic) radiation effects  
       i) Radiation Carcinogenesis 

    (1) Irradiated populations from which quantitative data have been obtained for cancer incidence 
    (2) The latent period 
    (3) Sensitivity to radiation-induced cancer as a function of age 
    (4) Risk estimates for radiation-induced cancer 
    (5) Large population-based studies of cancer risk following CT 
    (6) Conditions that increase the risk of radiation carcinogenesis 
ii)  Hereditary effects of radiation 

g)   Radiation effects on the developing  
       embryo and fetus 
i)  Preimplantation 
ii) Organogenesis 
iii) Fetal period 
iv) Population-based studies: Survivors of the A-bomb attacks on Hiroshima and Nagasaki  
     irradiated in utero 
v) Childhood cancer following in utero irradiation 
vi) Occupational exposure of a declared pregnant woman 

h)   Whole-body radiation effects 
       i)  Acute radiation 

 

Page 81 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

      syndrome 

(1)  Prodromal 
(2)  Latent 
(3) Cerebrovascular 
(4) Gastrointestinal 
(5) Hematopoietic 

ii)    Kinetics of depression and recovery of blood cell components 
iii)  LD50/60 
iv)  Treatment of radiation accident victims 

     i)   Radiation risk 
           i) Risk/benefit in  
               radiology 
           ii) Risk models 
(1)  Relative 
(2)  Absolute 

                                 iii)  Information sources 

(1)  Biological Effects of Ionizing Radiation (BEIR VII) reports 
(2)  International Council on Radiation Protection (ICRP) reports 
(3)  National Council on Radiation Protection and Measurements (NCRP 116) reports 
(4)  United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) reports 

           

9)   Radiation Protection and Associated Regulations 

a)   Sources of radiation to the  
       human population (NCRP 160) 
       i) Medical sources 
       ii) Cosmic rays 
       iii) Man-made sources      
       iv) Average annual doses from background and diagnostic procedures 
b)    Medical sources: occupational and patient doses 

i)  Projection radiography 
ii)    Mammography 
iii)   Fluoroscopy 
iv)  Interventional radiology and diagnostic angiography 
v)   CT 

c)   Factors affecting patient dose from medical sources 

i)    Regulatory dose limits and “trigger” levels 
ii)    Th e   Joint Commission (TJC) reviewable and nonreviewable events 

d)   Persons at risk 

i)     Occupational 
ii)    Nonoccupational staff  
iii)   Members of the  public 
iv)  Fetus 
v)   Patient 
e)  Dose limits 

i)  Occupational dose limits 
ii)    Members of the public 

 

 

Page 82 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

f)   Radiation detectors 

i)     Personal dosimeters 

(1)  Available technologies 
(2)  Appropriate use and limitations 

ii)    Area monitors 
(1)  Dosimeters 

g)   Principles of radiation protection 

i)  Time 
ii)    Distance 
iii)   Shielding for facilities, workers, and others 
iv)  Shielding materials 
v)  Procedure appropriateness 

h)  Advisory bodies 
       i) International Commission on Radiological Protection (ICRP) 
       ii) National Council on Radiation Protection and Measurements (NCRP) 
       iii) The Joint Commission (TJC) 
       iv) American College of Radiology (ACR) 
i)   Estimating effective fetal dose (procedure-specific doses) 
j)    Radiological emergencies 
      i) Incidents  
      ii) Purposeful exposures 
      iii) Treatment of radiological casualties 
 k) Biologic hazards of magnetic resonance imaging 
      i)  Static magnetic fields 
          (1) Projectiles 
          (2) Implanted metal objects 
          (3) Embedded metal objects 
          (4) Pacemakers 
          (5) Vertigo 
          (6) Equipment compatibility (Safe, Conditional, Unsafe) 
     ii)  Radiofrequency fields 

(1)  Radiofrequency waves and Specific Absorption Rate (SAR) 
(2)  Response of implanted metal objects 
(3)  Potential risk for burns (Closed loops) 

        iii)   Gradient fields 

(1)  Nerve stimulation 
(2)  Loud noise 
(3)  Magnetophosphenes 
(4)  Claustrophobia 
(5)  Quenching (asphyxiation) 
(6)  Contrast Agent Reactions 
(7)  Regulatory Limits 

i) 5 gauss line 
ii) Noise limits 
iii) SAR 

    l)     Biologic hazards of ultrasonography 
                    i) Tissue heating, ultrasound frequency and SPTA intensity 
                        (1) Thermal Index (TI) 

Page 83 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

                    ii) Ultrasound induced cavitation 

(1)  Mechanical Index (MI) 
(2)  Pulsed Doppler 
(3)  Regulatory Limits 

International Commission on Radiological Protection (ICRP) 

i) 
ii)    National Council on Radiation Protection and Measurements (NCRP) 
iii)   Conference of Radiation Control Program Directors (CRCPD) 
iv)  International Atomic Energy Agency (IAEA) 
v)   Joint Commission on Accreditation of Healthcare Organizations (JCAHO) 
vi)  American College of Radiology (ACR) 
vii) National Electrical Manufacturers Association (NEMA) (Medical Imaging and 

Technology Alliance or MITA) 

m)  Regulatory agencies 

i)  State regulations for machine-produced sources 
iii)   U.S. Food and Drug Administration (FDA) 

(1)  Center for Devices and Radiological Health (CDRH) 
(2)  Center for Drug Evaluation and Research (CDER) 

iv)    U.S. Office of Human Research Protections 
vi)  U.S. Department of Labor Occupational Safety and Health Administration (OSHA) 
vii) International Electrotechnical Commission (IEC) 

 n)  Estimating effective fetal dose (procedure-specific doses) 
 o)   Radiological emergencies 

Incidents 

i) 
ii)    Purposeful exposures 
iii)   Treatment of radiological casualties 

10) X-ray Projection Imaging: Concepts and Detectors 

a)   Radiography concepts 

i)  Geometry 

(1)  Magnification 
(2)   Inverse-square law 
ii)    Radiographic contrast 

(1)  Subject 
(2)  Detector 

iii)   Scatter and scatter reduction 

(1)  Scatter-to-primary ratio 
(2)  Grids 
(3)  Air gap 

iv)  Artifacts and image degradation 

(1)  Distortion 
(2)  Geometric unsharpness 
(3)  Grid 
(4)  Detector 

b)   Radiographic detectors 
i)  Screen-film systems 

(1)  Intensifying screens 
(2)  Film and film processing 

Page 84 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

ii)    Computed radiography (CR) 

(1)  Storage phosphors 
(2)  CR readers 

iii)   Flat panel detectors 
(1)  Direct detectors 
(2)  Indirect detectors 

11) General Radiography 

a)   X-ray system components 

i)    Tube and filtration 
ii)    Collimation 
iii)   Automatic exposure control (AEC) 
iv)  Grids and Bucky factor 

b)   Geometrical effects and requirements 

i)  Focal spot size 
ii)    Collimation 
iii)   Heel effect 

c)    Acquisition systems 

i)  Screen/film 
ii)    Digital 

(1)  CR systems 
(2)  Flat-panel systems 

iii)   Dual-energy 
iv)  Linear tomography 
v)   Tomosynthesis 

d)   Image characteristics 
i)  Spatial resolution 
ii)    Contrast sensitivity 
iii)   Noise 
iv)  Temporal resolution 
v)   Artifacts 

e)   Application requirements 

i)  Chest 
ii)    Abdomen 
iii)   Spine 
iv)  Extremities 
v)   Pediatrics and neonatal 
vi)  Portable/mobile 

f)  Dosimetry 

i)  Entrance skin exposure 
ii)    Effective dose 
iii)   Appropriate organ doses 
iv)  Doses for different procedures 
v)   Technique optimization 

g)   Factors affecting patient dose 

i)  Technique (e.g., kVp, mA, time) 
ii)    Imaging geometry 

Page 85 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

iii)   Beam filtration and grid 
iv)  Field size 
v)   Exposure class 

h)   Quality control (QC) tests and frequencies 

12) Mammography 

a)   Clinical importance 
b)   Mammography equipment 

i)  Dedicated x-ray tube 
(1)  Anode materials 
(2)  kVp 
(3)  Focal spot size and characteristics 
(4)  Target-filter combinations 
(5)  X-ray spectra 
(6)  Low peak kilovoltage (kVp) 
(7)  Half-value layer (HVL) 

ii)    Breast compression paddle 
iii)   Collimation 
iv)  Grids 
v)   Automatic exposure control (AEC) 

c)    Geometry 

i)  Source-to-image receptor distance (SID) 
ii)    Source-to-object distance (SOD) 
iii)   Object-to-image receptor distance (OID) 
iv)  Chest-wall coverage 
v)   Heel effect 
vi)  Magnification 
vii) Advantages of magnification 

d)   Acquisition systems 

i)  Screen/film and  film  processing  
ii) Full-field  digital  mammography  
iii) Tomosynthesis systems 
iv)  Stereotactic biopsy systems 

e)   Artifacts 
f)  Radiation dose 

i) Entrance  skin  exposure  
ii)   Average glandular  dose 
iii)   Dose limits 
iv)  Factors affecting patient radiation dose 
v)   Radiation risk versus benefits of screening 

g)   Viewing images 

i)    Lighting requirements: luminance and illuminance 
ii)    Dedicated view boxes and displays 
iii)   Dedicated PACS 

h)   Quality control 

i)    Mammography Quality Standards Act (MQSA) 

(1)  Personnel requirements 

Page 86 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

(2)  Dose limits 
(3)  Image quality and accreditation phantom 

ii)    American College of Radiology (ACR) accreditation 

13) Fluoroscopy and Interventional Imaging 

a)   System components 

i)    Tube 
ii)    Filtration 
iii)   Collimation 
iv)  Grids 
v)   Automatic brightness control (ABC) 
vi)  Automatic brightness stabilization (ABS) 
vii) Compensation filters 

b)   Configurations and geometry 

i)  Focal spot size 
ii)    Magnification 
iii)   Under-table versus over-table x-ray tube 
iv)  C-arms 

c)    Image intensifier (II) acquisition systems 

II structure 

i) 
ii)    Gain 
iii)   Field of view (FOV), magnification, and resolution 
iv)  Cameras and video systems 
v)   Image distortions 

(1)  Lag 
(2)  Veiling glare 
(3)  Vignetting 
(4)  Other: pincushion, barrel, “S”-distortion 

d)   Flat-panel acquisition systems 

i)  Detectors 
ii)    Magnification 
iii)   Binning 
iv)  Comparison to II 
v)   Image distortions 

(1)  Correlated noise 
(2)  Lag 
(3)  Ghosting 

e)   Real-time imaging 

i)  Continuous fluoroscopy 
ii)    High-dose rate fluoroscopy 
iii)   Variable frame-rate pulsed fluoroscopy 
iv)  Spot images 
v)   Operating mode variables 

(1)  Effective mA 
(2)  Pulse width 
(3)  Variable beam filtration 
(4)  Software processing 

Page 87 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

f) 

Image quality 
i)  Low-contrast sensitivity 
ii)    High-contrast (spatial) resolution 
iii)   Temporal resolution 
iv)  Noise 

g)   Image processing 

i)  Frame averaging 
ii)    Last-image hold and last-series hold 
iii)   Digital subtraction angiography (DSA) 
iv)  Road mapping 
v)   Cone beam CT 

h)   Applications 
i)  Dose and dosimetry 

i)  Federal and state regulations 

(1)  Dose rates and limits 
(2)  Audible alarms 
(3)  Recording of “beam-on” time 
(4)  Minimum source-to-patient distance 
(5)  Sentinel event 

ii)    Dose-area-product (DAP) and Kerma-area-product (KAP) meters 
iii)   Entrance skin exposure 
iv)  Peak skin dose 
v)   Cumulative dose 
vi)  Patient dose for various acquisition modes 
vii) Operator and staff dose considerations and protection 
j)  Technique optimization and factors affecting patient dose 

14) CT 

a)   System components 
b)   System geometry 
c)    Parameters for image acquisition 

i)  kVp 
ii)    mA 
iii)   Rotation time 
iv)  Table speed 
v)   Pitch 
vi)  Image thickness versus beam width 

d)   Image formation 

i)  Attenuation coefficient 
ii)    Hounsfield unit (HU) definition 
iii)   Axial filtered back-projection 
iv)  Helical reconstruction 
v)   Iterative reconstruction 

Image contrast, detail and noise 

e)   Modes of operation 
f) 
g)   Artifacts 
h)   Image processing and display 

Page 88 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

i)  Clinical application and protocols 
j)  Dose and dosimetry 

i)  Dose profile 
ii)    CT dose index and CTDIvol 
iii)   Multiple scan average dose (MSAD) 
iv)  Dose-length product (DLP) 
v)   Organ dose and effective dose 
vi)  Size-specific estimated dose 
vii) Adult and pediatric technique optimization 
viii) Beam width and pitch 
ix)  Over-beaming and over-ranging 

k)   Technique optimization and factors affecting patient dose 

i)  kVp, mA, and rotation time 
ii)    Patient size 
iii)   Table increment, table speed, and pitch 
iv)  Scan length 
v)   Number of phases (e.g., pre- and post-contrast) 
vi)  Technique selection 
vii) Dose modulation schemes 
viii) Dual source 
ix)  Patient shielding (pros and cons) 

15) Ultrasound (Please see Ultrasound Section of the Core Exam Study Guide for a more 

detailed physics outline.) 
a)   Properties of ultrasound waves 
b)   Interaction of sound waves and tissue 

i)  Acoustic properties of tissues 

c)    Transducer components and design 

i)  Transducer selection for clinical applications 

d)   Ultrasound beam characteristics and beam formation 
e)   Grayscale ultrasound image formation and scanning modes 

i)  Grayscale image optimization 

f)  Doppler phenomenon and scanning modes 

i)  Optimization of Doppler parameters 

g)   Gray-scale and Doppler artifacts 
h)   Advanced imaging methods 

i)  3D/4D volumetric imaging 
ii)    Harmonic imaging 
iii)   Spatial compounding 
iv)  Ultrasound contrast agents 
v)   Elastography 

i)  Thermal and non-thermal effects on tissue, and ultrasound safety 
j)  Equipment quality assurance 

16) MRI 

a)   Magnetism and magnetic fields 

i)  Magnetic susceptibility 

Page 89 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

ii)    Types of magnetic materials 
iii)   Magnetic fields (B) 
iv)  Magnetic moment interaction with an external field (B0): the Larmor equation and 

precessional frequency 

v)   Net magnetization due to B0 and field strength 

b)  Nuclear MR and excitation 
c)    MR signal properties 

i)  Spin density (proton) 
ii)    T2 (transverse) relaxation 
iii)   T2* relaxation 
iv)  T1 (longitudinal) relaxation 
v)   T1-weighting, T2-weighting, proton density-weighting 

d)   Pulse sequences and contrast mechanisms 

i)  Echo time (TE), repetition time (TR), and inversion time (TI) 
ii)    Spin-echo (SE) pulse sequences 
iii)   Inversion-recovery spin-echo pulse sequences 
iv)  Gradient-echo (GE or GRE) pulse sequences 
v)   Echo-planar (EPI) pulse sequences 
vi)  Fast- or turbo-spin-echo (FSE) pulse sequences 
vii) Manipulation of pulse sequence characteristics 

e)   MR instrumentation 

i)  Static magnetic field (B0) systems 
ii)    Gradient fields and the gradient subsystem 
iii)   Shimming and shim coils 
iv)  Radiofrequency transmitter (B1) subsystem 
v)   Radiofrequency receiver subsystem 
vi)  Radiofrequency coils 

f)  Spatial localization 
i)  Slice-selection 
ii)    Phase-encoding 
iii)   Frequency-encoding 

g)   Two-dimensional Fourier transform (2DFT) image reconstruction 

i)  k-space description 
ii)    Methods of filling k-space 

h)   Image characteristics 

i)  Factors affecting spatial resolution 
ii)    Factors affecting signal-to-noise ratio (SNR) 
iii)   Tradeoffs among spatial resolution, SNR, and acquisition time 
iv)  Factors affecting image contrast 

i)  Contrast agents 
j)  Spatial saturation and fat suppression 
k)   Special acquisition techniques 

i)  Angiography 
ii)    Diffusion, perfusion and neuro imaging 
iii)   Functional MRI (fMRI) 
iv)  Magnetization transfer contrast (MTC) 

l)  Artifacts 

Page 90 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

m)  Safety, bioeffects, and FDA limits 

i)  Static magnetic field (ferromagnetic materials) 
ii)    Radiofrequency field (heating) 
iii)   Gradient field (nerve stimulation) 
iv)  Contrast agent safety issues 

n)   Accreditation, quality control (QC) and quality improvement 

i)  Components of an ACR MRI accreditation program 
ii)    Quality control phantoms and measurements 
iii)   Quality improvement program considerations 

17) Nuclear Radiology Physics and Instrumentation 

a)   Physics of the nucleus 

i)  Nuclear nomenclature (isotope, isobar, isotone, isomer) 
ii)    Nuclear stability 
iii)   Radioactivity 

b)   Radioactive decay modes 

i)  Gamma emission 
ii)    Alpha decay 
iii)   Beta decay 

(a)  Beta minus 
(b)  Beta plus (positron) 
(c)  Electron capture 

iv)  Isomeric transition:  99m Tc 

c)    Radioactivity 

i)  Definition of terms 

(a)  Radioactivity 
(b)  Decay constant, half life 

ii)    Tracer principle 
iii)   Exponential decay equation 
iv)  Radionuclide equilibrium 

(a)  Secular and transient equilibrium 
(b)  Radionuclide generators: 99Mo/99mTc, 82Sr/82Rb, 68Ge/68Ga 

d)   Radionuclide production 

i)  Neutron activation 
ii)    Fission byproducts 
iii)   Charged particle accelerators 

e)   Radiation detectors 

i)  Detection parameters 

(a)  Efficiency 
(b)  Energy resolution 
(c)  Count rate capability 
(d)  Spatial resolution 

ii)    Counting statistics 

f)    Ionization detectors 

i) 

Ionization versus voltage curve:  recombination, saturation, proportional, and 
Geiger–Müller regions 

ii)    Instruments 

Page 91 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

(a)  Dose calibrator 
(b)  Survey meters: cutie-pie, G-M detector 

g)   Solid state (semi-conductor) detectors 

i)  General principles 
ii)    Cadmium telluride and cadmium zinc telluride 

h)   Scintillation detectors 

i)  Scintillators 

(a)  Conventional nuclear radiology:  sodium iodide, cesium iodide 
(b)  PET: lutetium oxyorthosilicate (LSO), lutetium yttrium orthosilicate (LYSO) 

ii)    Thyroid probe and well counters 
iii)   Coincidence detection 

i)  Gamma cameras 

i)  Scintillation camera 
ii)    Collimation 
iii)   Quality control 

(a)  Uniformity 
(b)  Spatial resolution 
iv)  Performance parameters 

(a)  Uniformity 
(b) Spatial resolution  
(c) Energy resolution  
(d)  Count sensitivity 

v)   Image quality 

(a)  Count density requirements 
(b)  Contrast improvement: choice of radiopharmaceutical, delayed imaging, 

collimation and view choice 

j)    Emission tomography 

i)  Fundamentals 

(a)  Projections, uniformity, stationary object, center of rotation 
(b)  Filtered backprojection and iterative reconstruction 

ii)    Degrading factors leading to artifacts 

(a)  Attenuation 
(b)  Scattered radiation 
(c)  Spatial resolution 
(d)  Noise 
(e)  Uniformity 
(f)   Motion 

k)   SPECT 

i) 

Instrumentation 

(a)  Scintillation camera systems 
(b)  Cardiac systems 
(c)  SPECT/CT 

ii)    Quality control 

(a)  Planar tests 
(b)  Center of rotation 
(c)  SPECT phantom 

iii)   Corrections 

Page 92 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e  C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Physics 

(a)  Motion 
(b)  Attenuation 
(c)  Scatter 
(d)  Spatial resolution 

iv)  Accreditation 

(a)  ACR 
(b)  IAC 
(c)  The Joint Commission 

l)  PET 

i) 

Instrumentation 

(a)  Coincidence detection 
(b)  Time of flight 
(c)  PET/CT 
ii)    Quality control 

(a)  Normalization 
(b)  Blank scan 
(c)  Uniformity:  artifacts 
(d)  PET phantom 
(e)  Standardized uptake value (SUV) calibration 

iii)   Corrections 

(a)  Random coincidences 
(b)  Scatter 
(c)  Attenuation 
(d)  Spatial resolution 

iv)  Accreditation 

(a)  ACR 
(b)  IAC 
(c)  The Joint Commission 

m)  Internal dosimetry 

i)    Radiation dose parameters 

(a)  Total decays: cumulated activity and residence time 
(b)  Emitted energy: dose equilibrium constant 
(c)  Absorbed fraction 
(d)  Distribution mass: effective of body size 
(e)  S factor 

ii)    Effective half life 

(a)  Physical decay 
(b)  Biological clearance 

iii)   Critical organ 

(a)  Renal clearance 
(b)  GI clearance 

 

 

 

Page 93 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Radioisotope Safety Examination (RISE) 

Radioisotope Safety Examination 

 

(RISE) 

 
General: 
 

(A) 700 hours of training and experience, including a minimum of 80 hours of classroom and 
laboratory training, in basic radionuclide handling techniques applicable to the medical use of 
unsealed byproduct material for imaging and localization studies; and (B) work experience, 
under the supervision of an authorized user who meets the requirements in §§ 35.57, 35.290, 
or 35.390 and 35.290(c)(1)(ii)(G), or equivalent Agreement State requirements. 

Specifics: 

1)   Radiation Physics and Instrumentation  

a)   Radiation detectors/ Radiation monitoring instruments 

i)     Personal dosimeters 
ii)    Area monitors 
 (2) Ion chambers 
 (3) Geiger-Muller (G-M) 
 (4) Scintillators 

b)     Dose calibrators 

i)  Calibration 
ii)    Quality control (QC) 
iii)   Operation and use 

c)    Counting systems and monitoring equipment 

i)  Calibration 
ii)    Quality control (QC) 
iii)   Operation and use 

2)   Radiation Protection 

a)   ALARA concept 
b)   Radiation protection program 
c)    Audit program 
d)   Operating and emergency procedures 
e)   Radiation area designations and safety instructions 

i)  Controlled vs. uncontrolled areas 
ii)    Restricted area 
iii)   Public area 
iv)   Caution signs 
v)  Engineering controls 
vi)   Shielding materials and occupancy factors 
v)  Radioactive contamination control 
 

3)   Mathematics Pertaining to the Use and Measurement of Radioactivity 

a)   Radioactive decay 
b)   Radioactive equilibrium 
c)    Units and conversions 

Page 94 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Radioisotope Safety Examination (RISE) 

4)   Radiation Biology 

a)   Radiation dose:  absorbed dose, dose equivalent, effective dose 
b)   Deterministic effects 
c)    Stochastic effects 
d)   Risks of radiation-induced cancer 
e)   Sources of radiation to the human population (NCRP 160) 

Radon-222 and other natural radioactivity in the earth’s crust 
Internal exposure form Potassium-40 and other natural radioactivity in the food chain 

f)    Medical sources: occupational and patient doses 

Sealed source radioactive material 
Unsealed radioactive material 

 
5)   Management of Radioactive Sources 

a)   Ordering, receiving and opening of packages 
b)   Sealed source regulations 

                             c)    Exempt quantities 

d)   Use records: unit dose, multi-dose vials 
e)   Radiation area surveys 
f)  Waste management/disposal 

i)  Cold trash surveys 
ii)    Waste decay-in-storage surveys and logs 

6)   Regulatory Exposure Limits 

a)   Occupational dose limits 
b)   Pregnant workers 
c)    Public dose 
d)   Safe use of unsealed licensed material 
e)   Respiratory protection and controls 
f)  Conditions requiring individual monitoring of external and internal occupational dose 

7)   Radiopharmaceutical Administration 

a)   Verifying patient identity 
b)   Recording 
c)    Administering/confirming prescribed dose 
d)   Pregnancy considerations 
e)   Fetal radiation dose issues 
f)  Breast feeding recommendations 

8)   Administrative/Practice  Controls and Responsibilities 

a)   Regulatory Agencies 

i)  U.S. Nuclear Regulatory Commission and Agreement States 

(1)  10 CFR Parts 19, 20, 30, 32, 35, 110 
(2)  Guidance documents (NUREG 1556, Vols. 9 and 11) 
(3)  Regulatory guides 

v)    U.S. Department of Transportation 

Transport index 

b)   Personnel 

i)  Technologists 
ii)    Radiation safety officer (RSO) 

 

Page 95 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Radioisotope Safety Examination (RISE) 

iii)   Authorized users (AU) 
iv)  Authorized nuclear pharmacist 
v)   Authorized medical physicist (AMP) 

c)    Licenses 
d)   Written directive (WD) procedures and safety 

i)  Studies requiring WD 
ii)    Replacement of WD with an oral directive 
iii)   Information required in the WD 
iv)  Procedures for administrations requiring a WD 

e)   Patient issues:  selection, preparation, informed consent, understanding and calculation 

of administered activity, counseling of patients and families on radiation safety issues, 
release criteria, follow-up; pregnancy, breast-feeding recommendations 

f)  Safety during 131I sodium iodide therapy greater than 33 mCi 

Inpatient 

i) 
ii)    Outpatient:  release criteria 
iii)   Patient issues:  selection, preparation, informed consent, understanding and 

calculation of administered activity, counseling of patients and families on radiation 
safety issues, release criteria, follow-up; pregnancy, breast-feeding 
recommendations 

g)   Radiopharmacy (“hot lab”) procedures and safety 

i)  Safe procedures for personnel and patients 
ii)    Thyroid bioassays 
iii)   Radionuclide generator operation 

(1)  Measuring and testing the eluate for radionuclidic purity 
(2)  Processing the eluate with reagent kits to prepare labeled radioactive drugs 
(3)  Record keeping 

h)   Radiation safety with radioactive materials 

i)  Surveys 
ii)    Ordering, receiving, and unpacking radioactive materials 
iii)   Contamination control 
iv)  Radioactive waste management 
v)   Qualifications for using radioactive materials 

(1)  Diagnostic (10 CFR 35.200 and 35.100, or equivalent Agreement State 

regulations) 

(2)  Therapeutic (10 CFR 35.300 and 35.1000, or equivalent Agreement State 

regulations) 

9)   Radiation Accidents/Incidents 
       a)   Medical events/reportable and nonreportable events 

i)  Events requiring reporting 
ii)    Information required in the report 
iii)   Notifying the NRC 
iv)  Notifying referring provider/patient 

b)   Radiation spills 
i)  Major spill 
ii)    Minor spill 

 c)   Radiological emergencies involving radioactivity 

i) 

Incidents 

Page 96 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Radioisotope Safety Examination (RISE) 

 
ii)    Purposeful exposures 
iii)   Treatment of radiological casualties 

Page 97 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 
 

 
 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Reproductive/Endocrine Imaging and Therapy 

Reproductive/Endocrine Imaging and Therapy 

1)   Adrenal 

a)   Congenital abnormalities 
b)   Benign masses 
c)    Malignant primary and secondary neoplasms 
d)   Endocrine disorders 
e)   Acquired diseases and conditions 

Infection 

i) 
ii)    Inflammatory conditions 
iii)   Hemorrhage 

2)   Thyroid 

a)   Benign masses 

i)  Goiter 

b)   Malignant masses 
c) 

 Endocrine  disorders 
i)  Hypothyroidism 
ii)    Hyperthyroidism 

3)   Parathyroid 

a)   Benign masses 
b)   Malignant primary and secondary neoplasms 
c)    Endocrine disorders 

i)  Hypoparathyroidism 
ii)    Hyperparathyroidism 

4)   Female genitourinary tract 

a)   Congenital abnormalities 
b)   Infertility 
c)    Menopause 
d)   Uterus and cervix 

i)  Benign and malignant masses 
ii)    Acquired conditions (infection, hemorrhage) 

e)   Ovaries and fallopian tubes 

i)  Benign and malignant masses 

(1)  Cysts and cystic lesions 

ii)    Acquired conditions (infection, hemorrhage) 

(1)  Infections 

(a)  Pelvic inflammatory disease 

(2)  Torsion 
(3)  Ovarian failure 

f)  Vulva and vagina 

Page 98 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Reproductive/Endocrine Imaging and Therapy 

i)  Benign and malignant masses 

(1)  Cysts and cystic lesions 

5)   Obstetrical and Fetal Imaging 

a)   Early pregnancy and placentation 
b)   Ectopic pregnancy 
c)    Fetal biometry and fetal growth 
d)   Congenital fetal anomalies 
e)   Maternal disorders in pregnancy 
f)  Multiple gestations 

6)   Male Genitourinary Tract 

a)   Scrotum, testes, penis, seminal vesicles, vas deferens, ejaculatory ducts 

i)  Congenital abnormalities 
ii)    Benign and malignant masses 
iii)   Trauma 
iv)  Torsion 

b)   Infertility 

7)   Modalities and Techniques 

a)   Fluoroscopy 
b)   Radiography 
c)    Hysterosalpingography 
d)   Ultrasound 

i)  Transabdominal 
ii)    Endovaginal 
iii)   3D ultrasonography 
iv)  Color, power, and spectral Doppler 
v)   Scrotal and endorectal ultrasound of the male lower genitourinary tract 
vi)  Saline infusion sonohysterography 
vii) Thyroid and parathyroid ultrasound 

e)   CT 
f)  MRI 
g)   Image-guided biopsy and drainage 

i)   Thyroid uptake and/or scan - Radioiodine (131I and 123I) 

h)   Thyroid scan - technetium pertechnetate 
i)  Parathyroid scan – 99mTc sestamibi 
j)  Radionuclide studies: diagnosis and treatment of endocrine disorders (includes 

octreotide and MIBG imaging) 

k)   FDG-PET/CT 

Page 99 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 
 

 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Noninterpretive Skills 

Noninterpretive Skills 

The Noninterpretive Skills portion of the ABR examinations is intended to focus on established 
knowledge in the areas of radiology quality and safety, professionalism and ethics, compliance, 
and regulatory and legal issues, as well as basic research and screening concepts. Since the 
range of content relevant to these topics is broad, a separate Study Guide has been produced to 
serve as a syllabus of the “core” knowledge that residents eligible to take the Core Exam and 
Certifying Exam are expected to know. The Study Guide should be considered a major resource 
to identify topics and content for the examination, but it is not the “last word” on these topics, 
nor does it take the place of textbooks, other definitive source material, education you should 
have received during your residency or fellowship training, or continuing education. We also 
draw your attention to the Bibliography and Suggested Reading List at the end of the Study 
Guide and to web links to key public documents, which are available on the websites of the 
major voluntary organizations in radiology, such as ACR, ARRS, and RSNA. We highly 
recommend these “deeper” resources to provide perspective and depth of understanding of 
the concepts that are only superficially outlined here. CLICK HERE to access the NIS Study 
Guide. 

Noninterpretive Skills Study Guide Outline: 

1.   Core Elements of Professionalism 

a) ABIM Physician Charter for Medical Professionalism in the New Millennium 
b) Ethical Considerations Specific to Radiology 
 

2.   Core Concepts of Quality and Safety 

a) Core Concepts of Quality 
b) Introduction to Quality 
c) Quality as a Discipline 
d) 2001 Institute of Medicine Report, Crossing the Quality Chasm 
e) Core Competencies of the ABMS and ACGME 
f) Core Concepts of Safety 
g) 2000 Institute of Medicine Report, To Err is Human 
h) 2015 Institute of Medicine Report, Improving Diagnosis in Health Care 
i) Human Factors 
j) Human Error 
k) Culture of Safety 

3.   Practical Quality and Safety Applications in Healthcare 

a) Practical Quality Applications in Healthcare 
b) Daily Management Systems 
c) Project-based Improvement Methods 
d) Practical Safety Applications in Healthcare 
e) Periprocedural Care 
f) Hand Hygiene 
g) Root Cause Analysis 

Page 100 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Noninterpretive Skills 

4.  Practical Safety Applications in Radiology 

a) MR Safety 
b) Zoning and Screening 
c) Intracranial Aneurysm Clips and Pacemakers 
d) MR and Pregnancy 
e) MR-induced Burns 
f) Quenching 
g) Management of Intravascular Contrast Media 
h) Iodinated Contrast Media 
i) Gadolinium-based Contrast Media 
j) Treatment of Acute Contrast Reactions 

5.  Reimbursement, Regulatory Compliance, and Legal Considerations in Radiology 

a) Reimbursement and Regulatory Compliance 
b) Coding, Billing, and Reimbursement 
c) Patient Privacy and HIPAA 
d) Human Subjects Research 
e) Malpractice and Risk Management 
f) General Principles of Malpractice 
g) Malpractice Related to Diagnostic Errors 
h) Malpractice Related to Procedural Complications 
i) Malpractice Related to Communications Deficiencies 
j) Discoverability of Communications 

Page 101 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 
 

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Thoracic Imaging 

Thoracic Imaging 

1.   Basics of Imaging, including Chest Radiography (CXR), CT and MRI, Ultrasound (US), and 

Percutaneous Intervention 
a)   Indications and limitations of the modalities 
b)   Physics behind image creation, including artifacts on CXR, CT, MRI, and US 

i.  X-ray physics 
ii)    CT physics 

(1)  CT artifacts relevant to thoracic imaging 
(2)  Tradeoffs between noise, dose, and image quality 
(3)  Spatial resolution, contrast resolution, and imaging reconstruction algorithms 
(4)  Contrast injection—principles, protocols, bolus geometry, iodine flux 

iii)   MRI physics 

(1)  MR artifacts relevant to thoracic imaging 
(2)  Trade-off between spatial resolution, temporal resolution, contrast resolution, 

and acquisition time 

(3)  Principles of black blood, edema, and scar imaging 
(4)  Steady-state free precession cine imaging 
(5)  Velocity-encoded cine (phase contrast) imaging—principles, applications, and 

limitations 

c)    3D imaging and post-processing 

i)  Multiplanar reconstruction (MPR) 
ii)    Maximum intensity projection (MIP) and minimum intensity projection (minIP) 
iii)   Volume rendering (VR) 

d)   Patient safety 

i)  Radiation exposure and how technical modifications may modify dose 
ii)    Contrast agents used for thoracic imaging 

2)   Normal Anatomy, including Variants, Encountered on CXR, CT, MRI and US 

a)   Lungs, including tracheobronchial and pulmonary lobar anatomy, and fissures 
b)   Mediastinal and thoracic inlet anatomy 
c)    Chest wall anatomy 

3)   Physiology Relevant to Thoracic Imaging, including Pulmonary Function Tests, Restrictive 

and Obstructive Patterns 

4)   Definition, Identification, and Significance of Signs and Finding Nomenclature in Thoracic 
Radiology. Knowledge should include diseases for which these signs are classic, potential 
alternative diagnoses, or pitfalls [Hansell et al. Fleischner Society: Glossary of Terms for 
Thoracic Imaging. Radiology 2008;246:697-722] 
a)   Air bronchogram 
b)   Air crescent sign 
c)    Deep sulcus sign on a supine radiograph 

Page 102 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Thoracic Imaging 

d)    Continuous diaphragm  sign 
e)    Ring  around  the  artery sign 
f)    Fallen lung sign 
g)   Flat waist sign 
h)   Gloved finger sign 
i)  Golden S sign 
j)    Luftsichel sign 
k)   Hampton hump 
l)    Silhouette sign 
m)  Cervicothoracic sign, tapered margins sign 
n)   Figure 3 sign 
o)   Fat pad sign or sandwich sign 
p)   Scimitar 
q)   Hilum overlay sign and hilum convergence sign 
r)  Beaded septum sign 
s)    Tree-in-bud 
t)    Centrilobular nodules 
u)   Perilymphatic nodules 
v)   Random or miliary nodules 
w)  Crazy paving 
x)    Ground glass halo 
y)   Mosaic attenuation 
z)    Consolidation 

Interlobular and intralobular septal thickening and reticulation 
Juxtaphrenic peak 

Reverse halo sign 
Signet ring sign (also known as pearl ring sign) 

aa)  Ground glass opacity 
bb)  Honeycombing 
cc) 
dd) 
ee)  Secondary pulmonary lobule 
ff)  Mass and nodule 
gg)  Parenchymal and subpleural bands 
hh)  Pleural plaques or pseudoplagues 
ii) 
jj) 
kk)  Split pleura sign 
ll) 
Headcheese sign 
mm)  Thoracoabdominal sign 
nn)  Westermark sign 
oo)  CT angiogram sign 
pp)  Bulging fissure sign 
qq)  Fleischner sign 
rr)     Comet tail sign 
ss)    Thymic sail sign 
tt) 
Split pleura sign 
uu)  Positive bronchus sign 

Page 103 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Thoracic Imaging 

vv)  Double density sign 
ww)   Unilateral hyperlucent lung/hemithorax 
xx)  Opaque hemithorax with contralateral versus ipsilateral mediastinal shift 

5)   Infectious Pneumonia - CXR and CT Findings 

a)   Mycobacterial and fungal 
b)   Viral 
c)    Community- and hospital-acquired bacterial pneumonia 
d)   Pneumonia in the immunocompromised, including patients: 

i)  with HIV/AIDS 
ii)    with post-transplantation status 
iii)   on chemotherapy, receiving corticosteroids, or with immune conditions 

e)   Septic emboli 

6)   Lung Cancer and other Parenchymal Neoplasms 

a)   Solitary pulmonary nodule (SPN) 

i)  Approach to diagnosis (contrast-enhancement,  imaging features) 
ii)    Management (PET, biopsy, follow-up/comparison) 
iii)   Perception and errors in perception 

b)   Screening for lung cancer – current status 
c)    Chronic alveolar disease as a manifestation of neoplasm 
d)   Lung cancer staging 
e)   Manifestations of small cell and non small cell carcinoma, and bronchoalveolar cell 

carcinoma, including common locations for metastases 

f)  Other tumors 

i)  Metastases 
ii)    Carcinoid 
iii)   Hamartoma 
iv)  Lymphoma 
v)   Chondrosarcoma 

7)   The Intensive Care Unit CXR - The Expected Location of the Support Devices and the 

Ability to Recognize Misplaced Lines and Complications (Pneumothorax, Hemothorax, 
Hematoma, Pneumoperitoneum) 
a)   Central lines (including wrong vein and intra-arterial) 
b)   Esophageal tubes/probes (including esophageal, nasogastric, and feeding tubes, 

endobronchial or intrapleural misplacement 

c)    Endotracheal and tracheostomy tubes 
d)   Pulmonary artery (Swan-Ganz) catheters (including peripheral placement and 

pseudoaneurysm formation) 

e)   Chest tubes (including intraparenchymal and intrafissural placement) 
f)  Assist devices 

Page 104 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Thoracic Imaging 

8)   Trauma, including Blunt and Penetrating Trauma 

a)   Acute traumatic aortic injury 
b)   Esophageal injury 
c)    Tracheobronchial injury 
d)   Lung injuries (contusion, shear injury, aspiration, laceration) 
e)   Diaphragm injury, both acute and delayed presentations 
f)  Tension hemopneumothorax, pneumothorax, pneumomediastinum 
g)   Flail chest, skeletal fractures, and dislocations 
h)   Fat emboli 

9)   Congenital Lung and Mediastinal Disease Manifesting in the Adult 

a)   Foregut duplication cysts, including bronchogenic cysts and esophageal duplication cysts 
b)   Bronchial atresia 
c)    Arteriovenous malformations 
d)   Partial anomalous pulmonary venous return 
e)   Left superior vena cava (SVC) and duplicated SVC 
f)  Swyer-James syndrome (unilateral bronchiolitis obliterans) 
g)   Poland syndrome 
h)   Sequestration (intralobar and extralobar) 
i)  Congenital cystic adenomatoid malformation 
j)  Aortic arch anomalies 

10)  Diffuse Lung Disease 

a)   Cystic disease 

i)  Langerhans cell histiocytosis 
ii)    Lymphangioleiomyomatosis 
iii)   Tracheobronchial papillomatosis 
iv)  Lymphocytic interstitial pneumonia 
v)   Cystic metastases 
vi)  Chronic pneumocystis 

b)   Pneumoconioses 

i)  Silicosis/coal workers pneumoconiosis 
ii)    Asbestosis 
iii)   Berylliosis 

c)    Idiopathic /fibrotic 

i)  Usual interstitial pneumonia (UIP) 
ii)    Nonspecific interstitial pneumonia (NSIP) 
iii)   Desquamative interstitial pneumonia (DIP) 
iv)  Acute interstitial pneumonia (AIP) 

d)   Pulmonary edema 

i)  Cardiogenic 
ii)    Noncardiogenic 

e)   Drug toxicity, including chemotherapy agents such as bleomycin and medications such 

as Amiodarone 

Page 105 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Thoracic Imaging 

f)  Sarcoidosis, including CXR staging 
g)   Lymphangitic carcinomatosis 
h)   Differential diagnoses for chronic upper lobe predominant disease and chronic lower 

lobe predominant disease 

11)  Diffuse Alveolar Disease and Inflammatory Conditions 

a)   Pulmonary alveolar proteinosis 
b)   Lipoid pneumonia 
c)    Organizing pneumonia, including cryptogenic 
d)   Eosinophilic pneumonia 
e)   Hypersensitivity pneumonia/extrinsic  allergic alveolitis 
f)  Differential diagnosis of peripheral alveolar opacities 

12)  Central Airways Diseases, Bronchiectasis, and Obstructive Lung Disease 

a)   Tracheal/bronchial tumors or masses 

i)  Squamous cell cancer and papillomas 
ii)    Adenocarcinoma 
iii)   Mucoepidermoid 
iv)  Adenoid cystic carcinoma 
v)   Carcinoid 
vi)  Metastases 

b)   Cystic fibrosis 
c)    Tracheal stenosis 

Inhalation and iatrogenic (such as tracheostomy or endotracheal tube) 

i) 
ii)    Granulomatous disease (Sarcoid, Wegener, tuberculosis) 
iii)   Amyloidosis 
iv)  Conditions that spare the posterior membrane (relapsing polychondritis; 

tracheopathia osteochondroplastica) 

d)   Tracheobronchomalacia 
e)   Bronchiectasis, including upper versus lower lobe predominant bronchiectasis 

Immotile cilia syndrome (Kartagener) 

i) 
ii)    Recurrent aspiration 
iii)   Tracheobronchomegaly  (Mounier-Kuhn) 
iv)  Tuberculosis 

f)  Small airway disease 

i)  Asthma 
ii)    Bronchiolitis obliterans 
iii)   Graft-versus-host disease 

g)   Small airway infection, including Mycobacterium avium-intracellulare (MAI) 
h)   Broncholithiasis 
i)  Allergic bronchopulmonary aspergillosis (ABPA) 
j)  Aspiration and foreign bodies 
k)   Emphysema, including centrilobular, paraseptal, panacinar, and paracicatricial 
l)  Giant bulla 

Page 106 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 
 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Thoracic Imaging 

13) Thoracic Manifestations of Systemic Disease 

a)   Rheumatoid arthritis 
b)   Scleroderma and mixed connective tissue disease 
c)    Systemic lupus erythematosus 
d)   Hepatopulmonary syndrome 
e)   Vasculitis (Wegener, Goodpasture) 
f)    Tuberous  sclerosis  
g)    Neurofibromatosis  
h)   Sickle cell disease 
i)     Polymyositis/dermatomyositis 
j)    Sjögren syndrome 
k)   Metastatic pulmonary calcification 

14) Diseases of the Pleura, Chest Wall, and Diaphragm 

a)   Mesothelioma 
b)   Pleural metastases 
c)    Fibrous tumor of the pleura 
d)   Lipoma 
e)   Empyema 
f)    Chylothorax 
g)   Pleural plaques, including asbestos exposure, hemothorax, prior infection 
h)   Unilateral pleural calcification 
i)     Pleural effusions, including differential diagnosis for unilateral and bilateral effusions 
j)  Diaphragmatic hernias, including post-traumatic, Bochdalek, Morgagni, sliding hiatal 
k)   Disorders of diaphragm motion, including role of sniff test 
l)     Neurofibromatosis 
m)  Chest wall tumors, including metastases, sarcomas, and desmoid tumors 

15) Mediastinal Masses (Including Cardiac and Vascular-related Masses) 

a)   Anterior mediastinum 

i)  Thymic origin, including thymoma, carcinoma, carcinoid, and cyst 
ii)    Germ cell tumors, including seminoma and teratoma 
iii)   Lymphoma 
iv)  Goiter 

b)   Middle mediastinum 
i)  Duplication cysts 
ii)    Lymph node enlargement 
iii)   Esophageal origin, including cancer, diverticulum, achalasia, varices 
iv)  Airway masses 
v)   Vascular masses 

c)    Posterior mediastinum 

i)  Nerve sheath tumors (neurofibromas, schwannomas) 
ii)    Paragangliomas (ganglioneuroma  and ganglioneuroblastoma) 

Page 107 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Thoracic Imaging 

iii)   Spine and paraspinal processes, including extramedullary hematopoiesis, 

metastases, diskitis 

d)   Superior mediastinal / thoracic inlet masses 

i.  Goiter 
ii.    Lymphangioma 

e)   Differential diagnoses of mediastinal  masses based on location and CT attenuation (fat, 

fluid, calcified, enhancing)/MR signal characteristics 
f)  Vascular masses (aneurysms and pseudoaneurysms) 
g)   Diffuse mediastinal disease 

i)  Mediastinitis 
ii)    Fibrosing mediastinitis 

h)   Differential diagnosis for egg-shell calcifications 
i)  Mediastinal lymph node enlargement 

16) Atelectasis and Collapse, including CXR/CT Findings and Differential Diagnosis 

a)   Lobar collapse (right upper, middle, right lower, left upper, lingual, left lower, and 

combined right middle/lower) 

b)   Unilateral lung collapse 
c)    Collapse from an obstructing mass 
d)   Round atelectasis 

17) Pulmonary Arteries 

a.    Acute pulmonary embolism 
b.   Chronic pulmonary embolism 
c.  Pulmonary infarct 
d.   Pulmonary embolism mimics, including pulmonary artery sarcoma 
e.    Pseudoaneurysm 
f.  Vasculitis (Takayasu) 

18) Postoperative and Post-treatment Thorax 

a)   Lung resection, including post-lobectomy,  post-wedge resection, pneumonectomy, and 

post-pneumonectomy syndrome 

b)   Lobar torsion 
c)    Radiation fibrosis and pneumonitis 
d)   Post lung transplantation, including acute, subacute, and chronic complications, single 

and bilateral transplantation 

e)   Post-esophagectomy 
f)  Post-lung volume reduction surgery 
g)   Airway and esophageal stents 
h)   Eloesser flap 

19) Percutaneous Thoracic Interventions 

a.    Aspiration, biopsy and drainage 
b.   Clinical indications and contraindications 

Page 108 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Thoracic Imaging 

c.    Techniques 
d.   Accuracy 
e.    Complications 
f.  Post-procedure care 

Page 109 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

Ultrasound 

1)   Medical and Comprehensive knowledge 

a)   “Hands-on” scanning: recognize the normal appearance as well as the most common 

pathology of  the following: 
i)  Pleural space (effusion) 
ii)    Peritoneal space 

(1)  Ascites 
(2)  Hemorrhage 

iii)   Gallbladder 

(1)  Gallstones 
(2)  Acute cholecystitis 

iv)  Biliary 

(1)  Common bile duct 
(2)  Biliary ductal dilatation 

v)   Liver 

(1)  Masses 
(2)  Steatosis 
(3)  Cirrhosis 

vi)  Kidney 

(1)  Hydronephrosis 
(2)  Stones 
(3)  Mass/cyst 

vii) Pancreas 

(1)  Pancreatitis 
(2)  Mass/cyst 

viii) Retroperitoneal 

(1)  Abdominal mass 
(2)  Cyst 
(3)  Adenopathy 
ix)  Alimentary tract 

(1)  Normal gut signature 
(2)  Appendicitis 
(3)  Intussusception 
(4)  Inflammatory bowel disease 

x)    Thyroid 

(1)  Nodules 
(2)  Diffuse disease 

xi)  Parathyroid 

(1)  Adenoma 
(2)  Hyperplasia 
(3)  Testis/Epididymis/Scrotum 
(4)  Mass/cyst 

Page 110 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

(5)   Torsion  
(6)   Trauma  
(7)  Infection 

xii) Transabdominal/transvaginal pelvis 

(1)  Uterus – measurement 
(2)  Fibroids 
(3)  Adenomyosis 
(4)   Endometrial  stripe  
(5)   Adnexal mass/cyst  
(6)  Free fluid 

xiii) First Trimester Pregnancy 

(1)  Normal 
(2)  Failed early intrauterine pregnancy 
(3)  Ectopic pregnancy 

xiv) Obstetrics 

(1)  Basic fetal biometry 
(2)  Basic second/third trimester fetal anatomy 
(3)  Placental localization 
(4)  Amniotic fluid volume 
(5)  Comprehensive second/third trimester 

xv) Pediatrics 

(1)  Abdomen 
(2)  Spine 
(3)  Hips 
(4)  Neonatal brain 
(5)  GI tract 

xvi) Breast 

(1)  Solid mass/cyst 
(2)  Lymph nodes 
(3)  Breast cancer staging 

xvii) 

Vascular 

(1)  Lower and upper extremity venous (deep vein thrombosis) 
(2)  Lower and upper extremity arterial 
(3)  Carotid and vertebral arteries 
(4)  Abdominal aorta (aneurysm, including how to measure) 
(5)  Abdominal Doppler 
(6)  Inferior vena cava (IVC) 
(7)  Hepatic and renal transplants 

xviii)  Musculoskeletal (MSK) 

(1)  Tendons 
(2)  Mass/cyst 
(3)  Muscle 

xix) US guided procedures 

(1)  Aspiration 

Page 111 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

(2)  Fine-needle aspiration (FNA) 
(3)  Biopsy 
(4)  Line placement 

b)   Physics/instrumentation: The resident should understand the basic principles of physics 

that form the foundation of clinical ultrasound. 
i)  Range of US frequencies used in generating diagnostic images 
ii)    Transducer type: curvilinear, linear, sector, vector, endoluminal 
iii)   Transducer selection for various clinical applications 
iv)  Transducer components and beam characteristics 
v)   Beam formation/focusing 
vi)  Frequency, sound speed, wavelength, intensity, decibels, beam width 
vii) Trade-off of frequency in terms of depth versus resolution 
viii) Mode: grayscale, M-mode, A-mode, B-mode, pulsed wave Doppler, color and power 

Doppler, B-flow 

ix)  Image orientation 
x)    Frame rate 
xi)  Grayscale image optimization 

(1)  Focal zone 
(2)  Power output 
(3)  Gain 
(4)  Time gain compensation 
(5)  Line density 
(6)  Transmit frequency 
(7)  Dynamic range 

xii) Acoustic properties of matter 

(1)  Fluid 
(2)  Cyst 
(3)  Calcification 
(4)  Complex fluid and solid structures, gas, metal, fat 

xiii) Interaction of sound waves with tissues 

(1)  Reflection 
(2)  Attenuation 
(3)  Scattering 
(4)  Refraction 
(5)  Absorption 
(6)  Acoustic impedance 
(7)  Pulse-echo principles 

xiv) Thermal and nonthermal effects on tissue 

(1)  Biological health risks 
(2)  Mechanical index 
(3)  Cavitation 
(4)  Relative risks for different scan modes 
(5)  Thermal and mechanical indices 

xv) Doppler phenomenon, Doppler equation 

Page 112 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

xvi)          Grayscale vs Doppler (trade-off of penetration and resolution) 
xvii)     Optimization of Doppler parameters 

(1)  Color box – size, shape, and angle 
(2)  Transmit frequency 
(3)  Doppler angle 
(4)  Wall filter 
(5)  Pulse repetition frequency 
(6)  Scale, gain 
(7)  Color write priority 
(8)  Sample volume size 

xviii)  Artifacts 

(1)  Beam width 
(2)  Side lobe 
(3)  Slice thickness 

xix) Multiple reflection artifacts - mirror image/reverberation 
xx)  Refractive artifacts, misregistration 

(1)  Ring down 
(2)  Acoustic shadowing and enhancement 
(3)  Speed propagation artifact 
(4)  Anisotropy 

xxi) Doppler artifacts 

(1)  Pulse wave 
(2)  Color imaging, including aliasing 
(3)  Color blooming 
(4)  Soft tissue vibration 
(5)  Flash 
(6)  Motion 

3D/4D volumetric imaging 

Spatial compounding 
Panoramic imaging 
Fusion imaging (transducer tracking) 

xxii) 
xxiii)  Harmonic imaging 
xxiv) 
xxv) 
xxvi) 
xxvii)  Ultrasound contrast agents 
xxviii)   Elastography 
xxix)  Equipment quality assurance 

(1)  Phantoms 
(2)  Spatial/contrast resolution 
(3)  Care of probes 
(4)  Cleaning/disinfection 
(5)  Infection control 

2)   Clinical applications 

a)   General 

i)  Understand the importance of clinical ultrasound protocols. Published guidelines 

from the American College of Radiology (ACR) with or without local modification are 

Page 113 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

acceptable frames of reference. Residents should also be familiar with ACR 
appropriateness criteria as a guide for appropriate clinical use of ultrasound and 
other imaging modalities. 

ii)    Understand the clinical uses and limitations of ultrasound, as well as the appropriate 

integration of other complementary cross-sectional imaging studies, particularly CT 
and MRI. 

iii)   Understand the importance of documentation, reporting, communication and 

reporting of critical findings. 

iv)  Understand the importance of clinical quality assurance, including radiologic- 

pathologic correlation, as well as sonographer-physician discrepancies. 

b)   Abdomen 

i)  Liver 

(1)  Normal echotexture/echogenicity/size/shape 
(2)  Normal variants 
(3)  Diffuse disease 

(a)  Steatosis, including focal steatosis and focal sparing 
(b)  Acute and chronic hepatitis 
(c)  Cirrhosis 
(d)  Edema 

(4)  Masses 
(a)  Cyst 
(b)  Cavernous hemangioma 
(c)  Focal nodular hyperplasia 
(d)  Adenoma 
(e)  Metastasis 
(f)   Hepatocellular carcinoma 
(g)  Lymphoma 
(h)  Cholangiocarcinoma 
(i)   Granuloma  
(j)  Hematoma  
(k) Biloma 
(l)   Abscess 

(i)   Pyogenic/Echinococcal/Amebic 
(m) Post-liver transplantation collections 

(i)   Hematoma/ Biloma/Abscess 

(5)  Trauma 
ii)    Gallbladder 

(1)  Normal size/shape/wall 
(2)  Gallstones 
(3)  Sludge 
(4)  Acute cholecystitis 

(a)  Calculous/acalculous/gangrenous/perforated/emphysematous 

(5)  Other etiologies of wall thickening 

Page 114 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

(a)  Polyp 
(b)  Hyperplastic cholecystosis 
(c)  Carcinoma 
(d)  Porcelain gallbladder 

iii)   Bile ducts 

(1)  Normal intra- and extrahepatic bile duct appearance/size 
(2)   Normal  variants  
(3)    Ductal dilatation 
(4)    Bile duct  stones 
(5)  Cholangitis 

(a)  Primary sclerosing/Pyogenic/Recurrent pyogenic/AIDS 

(6)  Caroli disease 
(7)  Choledochal cysts 
(8)  Pneumobilia 
(9)  Cholangiocarcinoma 

iv)  Pancreas 

(1)  Normal echotexture/echogenicity/size/shape 
(2)   Normal  variants  
(3)    Pancreatic  duct  
(4)  Masses 
(a)  Cyst 
(b)  Pseudocysts 
(c)  Cystic neoplasms 
(d)  Cancer 
(e)  Metastases 
(f)   Lymphoma 
(g)  Islet cell tumor 
(h)  Intraductal papillary mucinous neoplasm (IPMN) 

(5)  Pancreatitis 
(a)  Abscess 
(b)  Pseudocyst 
(c)  Pseudoaneurysm 
(d)  Chronic pancreatitis 

v)   Spleen 

(1)  Normal echotexture/echogenicity/size/shape 
(2)  Normal variants 
(3)  Masses 
(a)  Cyst 
(b)   Lymphoma  
(c)   Metastases  
(d)  Abscess 
(e)  Infarct 
(f)   Granuloma 

(4)  Trauma 

Page 115 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

vi)  Peritoneal cavity 

(1)  Normal anatomy 
(2)  Ascites 
(3)  Hemorrhage 
(4)  Abscess 
(5)  Omental/peritoneal metastasis 
(6)   Omental  infarct 
(7)   Mesothelioma  
(8)  Free air 

vii) Gastrointestinal  tract 

(1)  Normal gut ultrasound signature 
(2)  Acute appendicitis 
(3)  Diverticulitis 
(4)  Inflammatory bowel disease (Crohn disease, ulcerative colitis) 
(5)  Colitis 
(6)  Bowel obstruction (including intussusception, malignancy) 
(7)  Cancer 
(8)  Lymphoma 
(9)  GI stromal tumor (GIST) 
(10)Fistulae, abscess 

viii) Abdominal wall 

(1)  Normal echogenicity/echotexture 
(2)  Hematoma 
(3)  Abscess 
(4)  Hernia 
(5)  Masses 

(a)  Primary tumor 
(b)  Metastasis 
(c)  Lymphoma 
(d)  Desmoids tumor 
(e)  Lipoma 
(f)   Endometriosis 

ix)  Organ transplants: see vascular section 

c)    Urinary Tract and Adrenal Glands 

i)  Kidney 

(1)  Normal echotexture/echogenicity/size/shape 
(2)  Normal variants/congenital anomalies 
(3)  Calculi 
(4)  Hydronephrosis 
(5)  Glomerular & interstitial renal disease 
(6)  Cysts 

(a)  Simple  
(b) Complex 
(c)  Peripelvic 

Page 116 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

(d)  Adult polycystic disease 
(e)  Acquired renal cystic disease 

(7)  Perinephric fluid/collections 
(8)  Masses 

(a)  Angiomyolipoma 
(b)  Oncocytoma 
(c)  Multilocular cystic nephroma 
(d)  Renal cell carcinoma 
(e)  Transitional cell carcinoma 
(f)   Lymphoma 
(g)  Metastasis 

(9)  Infection 

(a)  Pyelonephritis 
(b)  Xanthogranulomatous pyelonephritis 
(c)  Emphysematous pyelonephritis 
(d)  Abscess 
(e)  Perinephric abscess  
(10) Medullary nephrocalcinosis  
(11) Infiltrative disease 
(12) Renal transplant (see vascular section) 

ii)    Ureters 

(1)  Dilatation of the collecting system 
(2)  Megaureter 
(3)  Ureterocele (including ectopic ureterocele) 
(4)  Ureteral stone 
(5)  Pyonephrosis 
(6)  Clot in collecting system 
(7)  Transitional cell cancer 
(8)  Stents 

iii)   Urinary bladder 

(1)  Normal size/shape/wall 
(2)  Calculi 
(3)  Wall thickening 
(4)  Ureteral jets 
(5)  Bladder volume, including post-void residual 
(6)  Masses 

(a)  Transitional cell carcinoma 
(b)  Pheochromocytoma 
(c)  Endometriosis 

(7)  Cystitis, including emphysematous cystitis 
(8)  Hemorrhage 
(9)  Wall thickening 
(10) Bladder outlet obstruction 
(11) Diverticula 

Page 117 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

(12) Ureterocele, including ectopic ureterocele 
(13) Ureterovesical  junction (UVJ) stone  
(14) Fungus balls 

iv)  Adrenal glands 

(1)  Normal echotexture/echogenicity/size/shape 
(2)  Masses 

(a)  Adenoma 
(b)  Pheochromocytoma 
(c)  Myelolipoma 
(d)  Metastasis 
(e)   Lymphoma 
(f)   Cancer 
(g)  Hemorrhage 

v)   Transabdominal and transrectal prostate 

(1)  Normal echotexture/echogenicity/size/shape 
(2)  Benign prostatic hypertrophy 
(3)  Cancer 
(4)  Prostatitis 
(5)  Abscess 

vi)  Retroperitoneum 

(1)  Adenopathy 
(2)  Primary sarcoma 
(3)  Hemorrhage 
(4)  Abscess 

d)   Gynecology 
i)  Uterus 

(1)  Normal echotexture/echogenicity/size/shape 
(2)  Endometrium 

(a)  Normal appearance during phases of menstrual cycle 
(b)  Thickness measurement 

(i)   Premenopausal 
(ii)  Postmenopausal 
(iii) Effects of hormone replacement 

(c)  Normal variants/congenital anomalies 
(d)  Intrauterine device 
(i)   Normal location 
(ii)  Displaced/extruded 

(e)  Endometrial fluid 
(f)   Endometrial polyp 
(g)  Endometrial hyperplasia 
(h)  Endometrial carcinoma 
(i)   Enometritis 

(3)  Myometrium 

(a)  Fibroids 

Page 118 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

(b)  Leiomyosarcoma 
(c)  Adenomyosis 

ii)    Ovary 

(1)  Normal echotexture/echogenicity/size/shape, including physiologic variation 

during phases of menstrual cycle 
(a)  Follicles 
(b)  Corpus luteum 
(c)  Hemorrhagic ovarian cyst 

(2)  Polycystic ovarian disease 
(3)  Ovarian hyperstimulation syndrome 
(4)  Masses/Cysts 

(a)  Simple/hemorrhagic/ruptured  ovarian cyst 
(b)  Endometrioma 
(c)  Cystadenoma/carcinoma 
(d)  Dermoid 
(e)  Fibroma and other stromal tumors 
(f)   Germ cell tumor 
(g)  Metastasis 
(5)  Ovarian torsion 
(6)  Pelvic inflammatory disease 

(a)  Tubo-ovarian abscess 

(7)  Ovarian cancer, including staging 

iii)   Cervix 

(1)  Normal echotexture/echogenicity 
(2)  Stenosis 
(3)  Polyp 
(4)  Cancer 
(5)  Fibroid 

iv)  Fallopian tube 

(1)  Hydrosalpinx 
(2)  Pyosalpinx 
(3)  Postoperative changes 
(4)  Essure devices 

v)   Post-hysterectomy appearance of pelvis 
vi)  Free pelvic fluid 
vii) Peritoneal inclusion cyst 
viii) Saline hysterosonography 

e)   Obstetrics 

i)  First trimester 

(1)  Normal findings of intrauterine gestational sac 

(a)  Size 
(b)  Gestational sac growth 
(c)  Yolk sac 
(d)  Embryo 

Page 119 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

(e)  Cardiac activity, including normal embryonic heart rate 
(f)   Amnion 
(g)  Chorion 
(h)  Chorionic villus sampling (CVS)/Amniocentesis 
(i)   Normal early fetal anatomy/growth 
(j)   Crown-rump length measurement 
(k)  Correlation with β-hCG levels and menstrual dates 

(2)  Multiple gestations (chorionicity and amnionicity) 
(3)  Failed early pregnancy 

(a)  Spontaneous complete/incomplete abortion 
(b)  Anembryonic gestation 
(c)  Embryonic demise 
(d)  Subchorionic hematoma 

(4)  Ectopic pregnancy, including unusual ectopic pregnancy 

(a)  Interstitial 
(b)  Cervical 
(c)  Ovarian 
(d)  Scar (Caesarian delivery) 
(e)  Abdominal 
(f)   Rudimentary horn 

(5)  Gestational trophoblastic disease 
(6)  Nuchal translucency 
(7)  Embryonic structural abnormalities, anencephaly 

ii)    Second and third trimester 

(1)  Normal findings 

(a)  Normal fetal anatomy/situs/development 
(b)  Placenta 
(c)  Biometry 
(d)  Amniotic fluid volume 

(2)  Multiple gestations 
(3)  Common congenital anomalies 
(4)  Recognition of fetal abnormalities that require high-risk obstetrics referral 

(a)  Intrauterine growth retardation 
(b)  Hydrops 
(c)  Holoprosencephaly 
(d)  Hydrocephalus 
(e)  Neural tube defects 
(f)   Multicystic dysplastic kidney 
(g)  Hydronephrosis 
(h)  Anencephaly 
(i)   Chromosomal abnormalities and syndromes 

(i)   Down syndrome 
(ii)  Turner syndrome 

(j)   Hydrops 

Page 120 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

(k)  Congenital infections 
(l)   Chest masses 
(m) Cardiac malformations and arrhythmias 
(n)  Diaphragmatic hernia 
(o)  Abdominal wall defects 
(p)  Abdominal masses 
(q)  Gastrointestinal tract obstruction/abnormalities 
(r)  Ascites 
(s)  Skeletal dysplasias 
(t)   Cleft lip/palate 
(u)  Complications of twin pregnancy 
(v)  Hydranencephaly 

(5)  Borderline findings 

(a)  Nuchal thickening 
(b)  Choroid plexus cyst 
(c)  Echogenic cardiac focus 
(d)  Echogenic bowel 
(e)  Borderline hydrocephalus 

(6)  Oligohydramnios 

(a)  Spontaneous premature rupture of membranes 
(b)  Renal disease 
(c)  Fetal death 
(d)  Intrauterine growth retardation 
(e)  Infection 

(7)  Polyhydramnios 
(8)  Placenta 

(a)  Placenta previa 
(b)  Vasa previa 
(c)  Abruption 
(d)  Percreta-, increta- and accreta 
(e)  Placental masses 
(f)   Succenturiate placenta 

(9)  Cervical appearance and length, cervical incompetence 
(10) Umbilical cord 

(a)  Two-vessel umbilical cord 
(b)  Cord masses 
(c)   Placental  cord  insertion  site 
(d)   Velamentous  cord insertion 
(e)  Cord prolapse 
(f)   Umbilical cord Doppler 
(g)  Fetal cranial Doppler 
(h)  Biophysical profile 
(i)   Guidance for amniocentesis 
(j)   Retained products of conception 

Page 121 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

f)  Thyroid/neck 

i)  Thyroid 

(1)  Normal echotexture/echogenicity/size/shape 
(2)  Hashimoto thyroiditis 
(3)  Graves disease 
(4)  Subacute thyroiditis 
(5)  Characterization of thyroid nodules 

(a)   Benign  nodules  

(i) Colloid cysts  
(ii)  Cysts 

(b)  Malignant nodules 

(i)   Papillary carcinoma 
(ii)  Follicular neoplasm 
(iii) Medullary carcinoma 
(iv) Anaplastic carcinoma 
(v)  Lymphoma 
(vi) Metastasis 

(c)  Non-specific nodules 
(d)  Multinodular goiter 

(6)  National consensus guidelines for performing fine-needle aspiration (FNA) 
(7)  Post-thyroidectomy neck surveillance for recurrence of papillary thyroid cancer – 

role of ultrasound 
(a)  Central versus lateral neck, levels 

ii)    Parathyroid 
(1)  Normal 
(2)  Adenoma 
(3)  Carcinoma 
(4)  Hyperplasia 
iii)   Congenital cysts 

(1)  Branchial cleft cyst 
(2)  Thyroglossal duct cyst 

iv)  Lymph nodes 

(1)  Normal echotexture/echogenicity/size/shape 
(2)  Benign reactive 
(3)  Metastasis (including surveillance for papillary thyroid cancer) 
(4)  Lymphoma 
v)   Salivary glands 

(1)  Normal echotexture/echogenicity/size/shape 
(2)  Benign and malignant neoplasms 

(a)  Pleomorphic adenoma 
(b)  Warthin tumor 
(c)  Adenoid cystic carcinoma 
(d)  Mucoepidermoid carcinoma 

(3)  Infection 

Page 122 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

(4)  Inflammation 
(5)  Stones 

g)   Chest 

i)  Normal anatomy 
ii)    Pleural effusion 
iii)   Atelectasis 
iv)  Pneumonia 
v)   Lung cancer 
vi)  Lung metastasis 
vii) Pleural metastasis 
viii) Adenopathy 

(1)  Mediastinal and axillary 
(2)  Metastasis  
(3)  Lymphoma  
(4)  Reactive 

ix)  Mediastinal tumors 
x)    Chest wall 

(1)  Hematoma 
(2)  Abscess 
(3)    Primary tumor 
(4)   Metastasis  
(5) Lymphoma 
(6)  Lipoma 

h)   Vascular/Doppler 

i)  Aorta and mesenteric branches 

(1)  Normal size/measurements/appearance/Doppler waveform 
(2)  Normal variants 
(3)  Aneurysm 
(4)  Dissection  
(5)  Thrombosis 
(6)  Status post stent graft placement including endoleak 
(7)  Status post surgery 
(8)  Coarctation  
(9)  Stenosis 
(10)Mesenteric ischemia  
(11) Mesenteric aneurysms 
 (12)Pseudoaneurysms 
(13)Mesenteric venous thrombosis 

ii)    Spleen 

(1)  Normal artery and vein size/appearance/Doppler waveform 
(2)  Normal variants 
(3)  Artery 

(a)  Thrombosis 
(b)  Aneurysm 

Page 123 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

(4)  Vein 

(a)  Thrombosis 

(5)  Infarction 

iii)   Lower and upper extremity arterial 

(1)  Normal appearance and Doppler waveforms 
(2)  Stenosis 
(3)  Occlusion/thrombosis 
(4)  Post catheterization complications 

(a)  Pseudoaneurysm/Arteriovenous  fistula/dissection/hematoma 

(5)  Arterial bypass graft 

(a)  Normal and abnormal 

(6)  Peripheral vascular aneurysm 

iv)  Renal artery 

(1)  Normal appearance and Doppler waveform 
(2)  Stenosis 
(3)  Occlusion 
(4)  Bypass grafts 
(5)  Stent/Angioplasty 
(6)  Aneurysm 
(7)  Arteriovenous fistula/malformation 
(8)  Fibromuscular dysplasia 
(9)  Infarction 

v)   Renal vein 

(1)  Normal appearance and Doppler waveform 
(2)  Thrombosis (bland and tumor) 
(3)  Arteriovenous fistula/malformation 

vi)  Carotid artery 

(1)  Normal appearance and Doppler waveforms 
(2)  Atherosclerotic plaque/Fibrointimal  thickening 
(3)  Stenosis 
(4)  Occlusion 
(5)  Waveform analysis 
(6)  Dissection 
(7)  Arteriovenous fistula 
(8)  Aneurysm 
(9)  Pseudoaneurysm 
(10)Status post carotid endarterectomy and stent 

(a)  Normal 
(b)  Restenosis 
(c)  Complications 

vii) Vertebral artery 

(1)  Normal appearance and Doppler waveforms 
(2)  Normal variants 
(3)  Stenosis/Occlusion (proximal or distal) 

Page 124 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

(4)  Subclavian steal syndrome 
(5)   Partial subclavian steal 

viii) Hemodialysis graft/fistula 

(1)  Normal appearance and Doppler waveforms 
(2)  Stenosis 
(3)  Occlusion (including outflow) 
(4)  Lack of maturation 
(5)  Fluid collections 
(6)  Pseudoaneurysms 
(7)  Steal 

ix)  Inferior vena cava 

(1)  Normal appearance and Doppler waveform 
(2)  Thrombosis (bland and tumor) 
(3)  Filter 
(4)  Masses 

x)    Lower and upper extremity venous 

(1)  Normal appearance and Doppler waveform 
(2)  Deep vein thrombosis 
(3)  Arteriovenous fistula 
(4)  Tricuspid regurgitation, right heart failure 
(5)  Chronic venous insufficiency 
(6)  Pre-arterial bypass graft/dialysis access vein mapping 
(7)  Nonvascular causes of leg pain and swelling 

xi)  Hepatic vasculature (native) 

(1)  Normal hepatic artery, portal vein and hepatic vein size/appearance/Doppler 

waveform 

(2)  Normal variants 
(3)  Portal vein 

(a)  Bland thrombosis 
(b)  Tumor thrombus 
(c)  Cavernous transformation 
(d)  Para umbilical vein 
(e)  Varices 

(4)  Hepatic artery 

(a)  Thrombosis 
(b)  Stenosis 
(c)  Aneurysm/Pseudoaneurysm 

(5)  Hepatic vein 

(a)  Bland thrombosis 
(b)  Tumor thrombus 
(c)  Budd-Chiari syndrome 
(d)  Stenosis 

(6)  Infarction 

xii) Hemodynamics of cirrhosis, portal hypertension, and varices 

Page 125 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

xiii) TIPS evaluation 

(1)  Normal appearance and Doppler waveforms 
(2)  Stenosis 
(3)  Occlusion 
(4)  Complications 

xiv) Renal transplant 

(1)  Normal appearance and Doppler arterial and venous waveforms 
(2)  Causes of elevation of arterial resistive index 

(a)  Rejection 
(b)  Acute tubular necrosis 
(c)  Page kidney 
(d)  Hydronephrosis 
(e)  Pyelonephritis 
(f)   Renal vein thrombosis 

(3)  Renal infarction 
(4)  Post-biopsy complications 

(a)  Hematoma 
(b)  Pseudoaneurysm 
(c)  Arteriovenous fistula 

(5)  Renal arterial stenosis/thrombosis 
(6)  Renal vein stenosis/thrombosis 
(7)  Peritransplant fluid collections 
(8)  Post-transplant lymphoproliferative disorder/masses 
(9)  Pyelonephritis 
(10) Clot/pus in the collecting system 

xv) Liver transplants 

(1)  Normal appearance and Doppler arterial and venous waveforms 
(2)  Hepatic artery stenosis/thrombosis 
(3)  Resistive index 
(4)  Portal vein thrombosis/stenosis 
(5)  Hepatic vein thrombosis/stenosis 
(6)  Post-biopsy complications 

(a)  Hematoma 
(b)  Pseudoaneurysm 
(c)  Arteriovenous fistula 

(7)  Inferior vena cava stenosis/thrombosis 
(8)  Intrahepatic and peri-hepatic fluid collections 
(9)  Post-transplant lymphoproliferative disorder 
(10)Abnormalities of the biliary tree 

xvi) Pancreas transplant 

(1)  Normal appearance 
(2)  Arterial and venous thrombosis/stenosis 
(3)  Pancreatitis 
(4)  Peritransplant fluid collections 

Page 126 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e  C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

(5)  Pseudoaneurysm 

i)  Scrotum 

i)  Testes 

(1)  Normal echotexture/echogenicity/size/shape 
(2)   Orchitis 
(3)   Abscess  
(4)  Cysts 

(a)  Intratesticular 
(b)  Tunica cyst 

(5)  Cystic ectasia of rete testis 
(6)  Torsion/Detorsion 
(7)  Microlithiasis 
(8)  Masses 

(a)  Germ cell tumor 
(b)  Lymphoma 
(c)  Metastasis 
(d)  Stromal tumor 
(e)  Epidermoid cyst 
(f)   Infarct/hematoma 
(9)  Focal atrophy/fibrosis 
(10) Sarcoidosis  
(11) Tuberculosis  
(12) Trauma  
(13) Nondescended testis 

ii)    Epididymis 

(1)  Normal echotexture/echogenicity/size/shape 
(2)  Epididymitis 
(3)  Spermatocele/cyst 
(4)  Adenomatoid tumor 

iii)   Other 

(1)  Hydrocele 
(2)  Pyocele 
(3)  Fournier gangrene 
(4)  Scrotal edema 
(5)  Hematocele 
(6)  Varicocele 
(7)  Hernia 
(8)  Nondescended testis 

j)  Pediatrics 

i)    Normal anatomy 

(1)  Abdomen 
(2)  Kidney 
(3)  Brain 
(4)  Neck 

 

 
 

 

Page 127 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

ii)    Brain 

(1)  Intracranial hemorrhage and complications 

(a)  Periventricular leukomalacia 
(b)  Hydrocephalus 

(2)  Shunt evaluation 
(3)  Congenital  brain  malformations  
(a) Agenesis  of corpus  callosum 
(b)  Vein of Galen aneurysm 
(c)  Dandy-Walker malformation 
(d)  Aqueductal stenosis 

iii)   Neonatal spine 

(1)  Tethered cord 
(2)  Intraspinal mass 

iv)  Kidneys 

(1)  Hydronephrosis 
(2)  Stones 
(3)  Hydroureters 
(4)  Anomalies of position and fusion 
(5)  Renal scarring 
(6)  Masses 
(7)  Cystic disease 

v)   Adrenal 

(1)  Hemorrhage 
(2)  Masses (neuroblastoma) 

vi)  Liver 

(1)  Cirrhosis 
(2)  Choledochal cysts 
(3)  Masses 
(4)  Hepatitis/biliary atresia 

vii) Gallbladder 

(1)  Gallstones 
(2)  Biliary stones 
(3)  Hydrops 

viii) Pancreas: acute pancreatitis 
ix)  Spleen 

(1)  Polysplenia 
(2)  Asplenia 

x)    Hip 

(1)  Normal 
(2)  Congenital dislocation 
(3)  Effusion 

xi)  Alimentary tract 

(1)  Intussusception 
(2)  Acute appendicitis 

Page 128 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

(3)  Hypertrophic pyloric stenosis 

xii) Scrotal 

(1)  Torsion 
(2)  Epididymitis 
(3)  Orchitis 
(4)  Masses 
(5)  Undescended testis 

xiii) Ovary 

(1)  Solid and cystic masses 
(2)  Ovarian torsion 

xiv) Uterus 

(1)  Normal appearance and size 
(2)  Imperforate hymen 
(3)  Uterine anomalies 

xv) Neck masses 
xvi) Deep vein thrombosis of upper and lower extremities 
xvii) Hepatic and renal organ transplants 
xviii) Liver and renal Doppler 

k)   Musculoskeletal 

i)  Normal anatomy 

(1)  Tendon 
(2)  Muscle 
(3)  Ligament 
(4) Cartilage  
(5)  Bone 
(6)  Nerve 

ii)    Tendon 

(1)  Tear (partial and full thickness) 
(2)  Tendinopathy/tendinosis 
(3)  Tenosynovitis 

iii)   Muscle 
(1)  Tear 
(2)  Hematoma 
(3)  Abscess 
(4)  Neoplasm 

iv)  Nerve 

(1)  Compression syndromes 
(2)  Neuroma 
(3)  Tumor 

v)   Bone 

(1)  Fracture 
(2)  Tumor 
(3)  Osteomyelitis 

vi)  Ligaments 

Page 129 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

(1)   Plantar  fasciitis  
(2)   Plantar  fibroma 
(3)  Pulley rupture 
vii) Soft tissues/joints 

(1)  Baker cyst 
(2)  Ganglion cyst 
(3)  Lipoma 
(4)  Foreign body 
(5)  Hematoma 
(6)  Cellulitis, abscess 
(7)  Necrotizing fasciitis (soft tissue gas) 
(8)  Joint effusion  
(9) Synovitis 
(10) Primary neoplasm      
(11)  Metastasis  
(12) Lymphoma 

l)  Breast 

i)  Sonomammographic  anatomy 
ii)    Cyst versus solid mass 
iii)   Mastitis/abscess 
iv)  Characterization of cysts 
v)   Lymph node characterization 

(1)  Axillary 
(2)  Supraclavicular 
(3)  Intramammary 

vi)  Characterization of solid masses 

(1)  Benign versus malignant 

(a)  Cyst 
(b)  Fibroadenoma 
(c)  Hamartoma 
(d)  Abscess 
(e)  Hematoma 
(f)   Phyllodes tumor 
(g)  Ductal/lobular carcinoma 
(h)  Carcinoma in situ 
(i)   Metastasis 
(j)   Lymphoma 
(k)  Inflammatory carcinoma 

vii) Architectural distortion 
viii) Intraductal masses/abnormalities, galactocele 
ix)  Screening 
x)    Multifocal/centric malignancy 
xi)  Elastography 
xii) Role of IV contrast 

Page 130 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Ultrasound 

m)  Interventional 

i)  Pre-procedural evaluation 

(1)  Coagulation laboratory studies 
(2)  Anticoagulation medication 
(3)  Stratification of risk for percutaneous procedures 

ii)    Informed consent 
iii)   Sterile technique 
iv)  Techniques for ultrasound-guided invasive procedures: understanding important landmarks and 

pitfalls of percutaneous procedures, including recognition of critical structures to 
be avoided 

v)   Localization of fluid for paracentesis or thoracentesis to be performed by another service 
vi)  Ultrasound-guided paracentesis vii) 
Ultrasound-guided thoracentesis viii) 
Aspiration of fluid collections, cysts ix) 
Biopsy of soft tissue masses 
x)    Fine needle aspiration versus core biopsy in specific applications 

(1)  Focal liver mass 
(2)  Renal mass 
(3)  Thyroid/parathyroid mass 
(4)  Lymphadenopathy 

xi)  Random core liver biopsy 
xii) Random core renal biopsy 
xiii)  Catheter placement for abscess and fluid drainage (pleural, peritoneal, and other 

spaces) 

xiv) Postprocedural evaluation 

(1)  Radiographic studies 
(2)  Patient monitoring 
(3)  Management of complications 

xv) Pseudoaneurysm management: contraindications  and technique of non-surgical 
treatment with ultrasound-guided compression repair versus thrombin injection 

xvi)  Intraoperative ultrasound guidance 

Page 131 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e  C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Urinary Imaging 

Urinary Imaging 

1)   Kidneys 

a)   Malignant tumors 

i)  Primary 
ii)    Secondary 
b)   Benign tumors 
c)    Endocrine tumors 
d)   Cystic disease 
e)   Complicated cysts 
f)  Granulomatous diseases 
g)   Infection/inflammation 
h)   Hemorrhage 
i) 
j)  Trauma/iatrogenic 
k)   Congenital anomalies 
l)  Medical renal disease 
m)  Inherited diseases involving the kidneys (including transplantation) 

Infarction and ischemia 

2)   Ureter 

a)   Malignant tumors 
b)   Benign tumors 
c)    Infection/inflammation 
d)   Hemorrhage 
e)   Trauma/iatrogenic 
f)  Congenital anomalies 
g)   Stricture 
h)   Filling defects 

3)   Bladder and Neobladder 

a)   Malignant tumors 
b)   Benign tumors 
c)    Infection/inflammation 
d)   Hemorrhage 
e)   Trauma/iatrogenic 
f)  Congenital anomalies 

4)   Prostate Gland and Seminal Vesicles 

a)   Malignant tumors 
b)   Benign tumors and hyperplasia 
c)    Infection/inflammation 
d)   Trauma/iatrogenic 
e)   Congenital anomalies 

 

 
 

 
 

 

 

 

 

Page 132 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 

 

 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Urinary Imaging 

5)   Urethra and Penis 

a)   Malignant tumors 
b)   Benign tumors 
c)    Infection/inflammation 
d)   Trauma/iatrogenic 
e)   Congenital anomalies 
f)    Stricture 

6)   Retroperitoneum 

a)   Malignant tumors 

i)  Primary 
ii)    Secondary 
b)   Benign tumors  
c)    Hemorrhage 
d)   Trauma/iatrogenic 
e)   Congenital anomalies 
f)    Aortic aneurysm 
g)   Retroperitoneal fibrosis 
h)  Pelvic  lipomatosis  
i)    Venous anomalies  
j)    Fournier gangrene 

7)   Vascular Diseases Affecting the Genitourinary Tract 

a)   Aneurysms 
b)   Stenoses 
c)    Malformations 
d)   Fistulae 
e)   Occlusions 
f)    Congenital anomalies 

8)   Intravascular Contrast Media 

a)   Extravasation 
b)   Physiology 
c)    Adverse reactions (idiosyncratic and nonidiosyncratic) 
d)   Prevention and treatment of adverse reactions 

9)   Urolithiasis (Including Kidney, Ureter, Bladder) 

10) Techniques 

a)   Excretory urography 
b)   Cystography 
c)    Urethrography (including antegrade and retrograde) 
d)   CT (including CT urography, CT angiography) 
e)   MRI (including MR urography, MR angiography) 

Page 133 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e  C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

Urinary Imaging 

f)  Ultrasound (including Doppler and color flow) 
g)   Hysterosalpingography 

 

 
 

 

Page 134 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e   

 
 

 
 

 

 

 

 

C o r e   E x a m i n a t i o n   S t u d y   G u i d e 

 

Vascular Imaging 

Vascular Imaging 

1)   Normal and Variant Anatomy as Depicted by Various Imaging Modalities (US, MRI, CT, 

and angiography) 
a)   Arterial (excluding heart and CNS since that content will be covered in neurology and 

cardiac sections) 

b)   Venous (again excluding heart and CNS) 

2)   Vascular Anatomy/Pathology before and after Intervention. Examples include: 

a)   Aortic aneurysms before and after stent graft placement 
b)   Arterial and venous stenosis/occlusions before and after endovascular procedures, such 

as angioplasty, stent placement, lysis, or thrombectomy 

c)    Anatomy and pathology seen before and after open vascular procedures. Procedures 

include bypass grafts for tissue perfusion and dialysis access. 

3)   Vascular Pathology as Depicted by Various Imaging Modalities. Categories include: 

a)   Congenital anomalies 
b)   Inflammatory conditions such as vasculitis 
c)    Neoplasia 
d)   Embolic phenomena 
e)   Trauma – blunt and penetrating 
f)  Atherosclerosis 

4)   Physics Knowledge Needed to Safely Operate a C-arm Fluoroscopy Unit 

a)   Radiation protection 
b)   Optimal use of radiation 
c)    Digital subtraction angiography (DSA), including its artifacts 

Page 135 

C o r e  E x a m i n a t i o n  S t u d y  G u i d e  